S&P 500 Financials Sector SEC Filings — March 06, 2026

06-03-2026

Seaboard Corporation's DEF 14A proxy statement solicits votes for its 2026 Annual Meeting on April 20, 2026, at 8:30 a.m. local time at the DoubleTree Hotel in Overland Park, Kansas, to elect five directors until 2027, approve on an advisory basis the compensation of Named Executive Officers, and ratify KPMG LLP as independent auditors for the fiscal year ending December 31, 2026. The record date is February 19, 2026, with 957,794 shares of common stock outstanding, requiring a quorum of 478,898 shares. Principal stockholder Ellen S. Bresky beneficially owns 714,040.24 shares or 74.5%, primarily through Seaboard Flour LLC (358,068.69 shares, 37.4%) and SFC Preferred, LLC (346,155.55 shares, 36.1%).

• ·Annual Meeting location: DoubleTree Hotel, 10100 College Boulevard, Overland Park, Kansas 66210.
• ·Voting on director election requires plurality of votes cast; withhold and broker non-votes have no effect.
• ·Advisory vote on NEO compensation and auditor ratification each require majority of shares present and voting; abstentions treated as against.
• ·Proxy materials available at https://www.seaboardcorp.com/investors.
• ·Company address: 9000 West 67th Street, Merriam, Kansas 66202.

06-03-2026

High Wire Networks, Inc. entered into a Global Settlement and Mutual Release Agreement effective March 3, 2026, with Thoth Aerospace Inc., Dennis O'Leary, and Mark W. Porter, settling Porter's disputed claims of approximately $804,345 (including $265,000 principal, $203,964 interest, and $335,382 unpaid compensation) for a total of $150,000, resulting in cancellation of all related promissory notes. This settlement clears prior related-party liabilities recorded as $335,382 accrued payroll and $468,964 notes payable as of September 30, 2025, and facilitates closing of a Securities Exchange Agreement under which Thoth will acquire control of the Company via share exchange. Porter will resign as CEO and director upon closing, with payments to be made from 5% of proceeds from future ELOC put orders.

• ·December 2023 Note originally $165,000; amended June 28, 2024; 2021 Note amended June 28, 2024
• ·Payments to Porter: within 5 business days of each ELOC Put Order receipt, no fixed deadline for full payment
• ·All Notes deemed cancelled upon Agreement execution; Porter to deliver marked originals
• ·Company to recognize gain/loss on debt extinguishment per GAAP in SEC filings

06-03-2026

PMV Pharmaceuticals reported FY2025 net loss of $77.7M, a 32% increase from $58.7M in FY2024, driven by R&D expenses rising 19% to $69.9M amid rezatapopt advancement, while G&A expenses fell 39% to $16.3M; cash and equivalents dropped to $112.9M from $183.3M, with net cash used in operations up to $73.6M from $51.3M, providing runway into Q2 2027. Clinical highlights include on-track PYNNACLE Phase 2 enrollment, FDA Orphan Drug Designation for rezatapopt in TP53 Y220C ovarian cancer, NEJM publication of Phase 1 data, and planned NDA submission in Q1 2027, supported by Phase 2 data showing 34% ORR across cohorts and up to 50% in ovarian cancer. However, cash burn acceleration highlights financial pressures despite promising trial progress.

• ·Median duration of response 7.6 months across all cohorts; 8.0 months in ovarian cancer cohort.
• ·Most frequent TRAEs (>15%): nausea, fatigue, blood creatinine increased, ALT increased (mostly Grade 1-2).
• ·FDA Orphan Drug Designation granted March 2, 2026 for rezatapopt in TP53 Y220C positive ovarian, fallopian tube, and primary peritoneal cancer.
• ·Phase 1 PYNNACLE results published in New England Journal of Medicine.
• ·Updated ovarian cancer ORR data presented at 2026 European Society of Gynecologic Oncology Congress.

06-03-2026

Cohen & Company Inc. reported strong Q4 and FY 2025 results with total revenue of $102.7M in Q4 (up 454% YoY from $18.5M) and $275.6M for FY (up 246% YoY from $79.6M), driven by investment banking ($54.7M in Q4, up 568% YoY but down 20% QoQ) and principal transactions ($31.5M in Q4). Net income attributable to the company was $8.1M ($1.48/share) in Q4 and $14.4M ($4.35/share) for FY, versus a FY 2024 loss; however, asset management revenue declined slightly 2% YoY to $8.8M for FY, and losses from equity method affiliates widened to $16.8M for FY. The board declared a $0.25 quarterly dividend and $0.70 special dividend per share, payable April 3, 2026.

• ·CCM ranked number one in SPAC IPO underwritings by left book run deals and in de-SPAC advisory per SPAC Research.
• ·Q4 principal transactions revenue included $33.0M from Columbus Circle Capital Corp I and ProCap Financial business combination.
• ·Loss from equity method affiliates was $5.1M in Q4 2025 vs $12.7M in Q3 2025 and $0.7M in Q4 2024.
• ·Income tax benefit of $2.3M in Q4 2025 included $2.8M deferred tax benefit from valuation allowance reduction.
• ·Prior special dividend of $2.00 per share announced Dec 2025 and paid Jan 2026.
• ·Conference call held March 6, 2026 at 10:00 a.m. ET.

06-03-2026

Allarity Therapeutics, Inc. entered into a Notes Purchase Agreement dated March 2, 2026, with Streeterville Capital, LLC, agreeing to issue and sell a Promissory Note A-1 with $10.93M principal (including $900k OID and $30k transaction expenses) and a secured Promissory Note B with $10M principal, for a total purchase price of $20M. The B Note is secured by cash collateral in a Deposit Account at Lakeside Bank under a DACA and Pledge Agreement, with obligations guaranteed by subsidiaries ALLR Holdings, LLC, Allarity Acquisition Subsidiary, Inc., and Allarity Therapeutics Europe ApS. The agreement includes restrictive covenants on new debt, liens, equity issuances, and SEC reporting requirements.

• ·Closing Date: March 2, 2026
• ·A-1 Note cash payment: $10M directly to Company
• ·B Note cash payment: $10M to Lakeside Bank under DACA
• ·Transaction relies on Section 4(a)(2) of 1933 Act and Rule 506(b)
• ·Covenants prohibit Restricted Issuances, new liens/encumbrances, equity sales in subsidiaries, and require timely SEC filings and listing maintenance

06-03-2026

GT Biopharma reported no revenues for the three and nine months ended September 30, 2025, with R&D expenses decreasing 51% YoY to $0.6M and 46% to $2.1M respectively in the three and nine-month periods, while SG&A rose 20% YoY to $2.7M in Q3 but fell 30% YoY to $4.7M YTD, leading to improved operating losses of $3.4M (-6% smaller) and $6.8M (-36% smaller). However, non-operating items including a $28.7M loss on Greenshoe Rights initial recognition drove a Q3 net income of $8.3M but a larger nine-month net loss of $22.6M (worsened 141% YoY); cash and equivalents declined to $2.5M from $4.0M at year-end 2024 amid $8.9M operating cash burn.

• ·Stock-based compensation included $379K in Q3 2025 SG&A (vs $0 in 2024) and $386K YTD 2025 (vs $222K 2024).
• ·Current liabilities decreased to $1.3M at Sep 30, 2025 from $5.9M at Dec 31, 2024.
• ·Total assets stable at $4.3M Sep 30, 2025 vs $4.2M Dec 31, 2024; stockholders' equity turned positive to $3.0M from -$1.7M.
• ·Financing activities provided $7.5M net cash nine months 2025 (vs $3.0M 2024), including $6.5M from Series L preferred issuance.
• ·Net cash decrease of $1.4M nine months 2025; operating cash burn improved to $8.9M from $10.4M YoY.

06-03-2026

Pantages Capital Acquisition Corporation entered into a Business Combination Agreement on November 18, 2025, with MacMines Austasia Pty Ltd, Horizon Mining Limited (Pubco), and others, pursuant to which a merger sub will merge with Purchaser, surviving as a wholly-owned subsidiary of Pubco, with Purchaser's securities converting into Pubco Ordinary Shares subject to redemptions. The agreement includes customary conditions to closing such as board resignations, no material adverse effects, and compliance with covenants, with termination possible by mutual consent or March 31, 2026 if conditions are unmet. Concurrent agreements include a Seller Lock-Up for 50% of securities until 6 months post-closing or $12.50/share threshold, support agreements from Seller and Sponsor, and planned Registration Rights.

• ·Merger Agreement signed November 18, 2025; outside date for termination March 31, 2026.
• ·Seller Lock-Up period: from Closing until earliest of 6-month anniversary or $12.50/share for 20 trading days in 30-day period.
• ·Securities traded as PGACU (Units), PGAC (Class A Ordinary Shares), PGACR (Rights) on Nasdaq.
• ·No fractional Pubco Ordinary Shares issued; rounded down to nearest whole share.

06-03-2026

Golden Entertainment, Inc. filed a DEFM14A proxy statement seeking shareholder approval for the F Reorganization, taxable Distribution, and tax-free Merger under Section 368(a), part of the Master Transaction Agreement to separate real estate assets (PropCo) and operations (OpCo), with completion expected in mid-2026 subject to gaming approvals and other conditions. The transactions aim to unlock real estate value highlighted as undervalued since May 2024, with preliminary sale-leaseback indications from VICI, Party A, and Party B ranging $941.2M to $1.0968B at cap rates of 7.5%-8.5%; however, prior outreach to multiple parties yielded no other actionable proposals, and Mr. Sartini (CEO/Chairman) has differing interests via control of OpCo Buyer.

• ·Filing date: March 06, 2026
• ·Special Meeting to approve Transactions; results filed within 4 business days
• ·Conditions include gaming and liquor law approvals, tax opinions for Merger as Section 368(a) reorganization
• ·Preliminary multiples: 11.77x-12.50x (VICI April 10), 12.12x-12.90x (VICI April 16), 11.76x (Party B), 12.58x (Party A), 13.33x (Golden proposed)
• ·Party A structure proposed non-pro rata spinoff (Sartini family 5% OpCo, public 95%)

06-03-2026

Spring Valley Acquisition Corp. III (SVAC) is pursuing a business combination with General Fusion Inc. via a SPAC merger announced January 21, 2026, involving SVAC's continuance to British Columbia, amalgamation with NewCo, and renaming to General Fusion Group Ltd., targeting a NASDAQ listing mid-2026. The fireside chat highlights General Fusion's magnetized target fusion technology progress, with Lawson Machine 26 operational and funded through 2028 milestones (1 keV heating, 10 keV, 100% Lawson Criterion), backed by $230M SPAC trust as excess capital plus committed private funding, aiming for a 150 MW first-of-a-kind plant by 2035. No financial declines or challenges are noted beyond standard SPAC redemption risks, which are mitigated by secured funding.

• ·F-4 registration statement filed recently (early March 2026)
• ·Lawson program milestones: 1 keV heating, 10 keV heating, 100% Lawson Criterion by 2028
• ·Commercial systems demonstrations planned for execution starting 2027
• ·SPAC trust capital ($230M) considered 'gravy' beyond committed private funding sufficient for multi-year operations even with 100% redemptions

06-03-2026

Monroe Capital Corporation (MRCC) filed a Rule 425 supplementing disclosures in response to shareholder lawsuits alleging misleading information in the Joint Proxy Statement for the proposed Asset Sale to Monroe Capital Income Plus Corporation (MCIP) and subsequent merger with Horizon Technology Finance Corporation (HRZN), with the HRZN Board unanimously recommending approval ahead of the March 13, 2026 special meeting. Supplemental projections show pro forma combined NII per share improving from $1.05 in 2026 to $1.24 in 2030 and NAV per share rising from $6.55 to $7.89; however, dividends remain flat at $1.00 per share across years, MRCC standalone NII dips to $0.26 in 2027 before slight recovery to $0.31, and HRZN standalone NII remains largely flat around $1.02-$1.06.

• ·Merger Agreement and Asset Purchase Agreement both dated August 7, 2025
• ·Joint Proxy Statement dated January 16, 2026; delivered January 20, 2026
• ·Putative class action complaints filed starting January 30, 2026 in Delaware Court of Chancery and New York Supreme Court
• ·HRZN Special Meeting: March 13, 2026 at 2:30 p.m. ET, 312 Farmington Avenue, Farmington, Connecticut 06032
• ·Projections prepared as of June 30, 2025 by MC Advisors and HRZN Advisor
• ·Financial advisors: Houlihan Lokey (MRCC Special Committee), Oppenheimer (HRZN Special Committee)

06-03-2026

Johnson Controls International plc held its Annual General Meeting (AGM) on March 4, 2026, with 556,390,065 ordinary shares represented, approving all proposals including the election of 11 directors to the Board (reduced from 12 after Patrick Decker opted not to stand for reelection), ratification of PricewaterhouseCoopers LLP as independent auditors, authorization for market purchases of company shares, and Board authority to allot shares up to a nominal value of US$1,286,103 (approximately 20% of issued ordinary share capital). All director nominees received strong support, with FOR votes ranging from 487 million (Jean Blackwell) to 515 million (Joakim Weidemanis), alongside approvals for executive compensation advisory vote and waiver of pre-emption rights. No proposals failed, reflecting broad shareholder alignment.

• ·Proposal 2.a (auditor ratification): 520,720,132 FOR, 35,018,103 AGAINST, 651,830 ABSTAIN
• ·Proposal 2.b (auditor remuneration): 543,530,855 FOR, 12,401,799 AGAINST, 457,411 ABSTAIN
• ·Proposal 3 (share repurchases): 553,051,315 FOR, 1,647,206 AGAINST, 1,691,544 ABSTAIN
• ·Proposal 4 (treasury share re-allotment): 551,864,210 FOR, 2,736,338 AGAINST, 1,789,517 ABSTAIN
• ·Proposal 5 (executive compensation): 486,785,469 FOR, 31,871,518 AGAINST, 1,295,508 ABSTAIN

06-03-2026

This DEFA14A supplement to the proxy statement/prospectus for dMY Squared Technology Group, Inc.'s business combination with Horizon details biographies and roles for new Holdco executives and director nominees, including Catherine Fitzsimons as General Counsel (effective May 11, 2026, sister of CEO Dr. Joseph F. Fitzsimons), Danielle Lambert, Jill Turner, and Peter Oey. It outlines expected Holdco board independence (majority independent), committee compositions (Audit: Peter Oey Chair, Harry You, Jill Turner; Compensation: Jill Turner Chair, Peter Oey; Nominating: Danielle Lambert Chair, Harry You), and updates employment agreements and beneficial ownership tables with revised dates (March 6, 2026) and share counts. No financial performance metrics are provided, with neutral structural updates ahead of closing.

• ·DMY is a blank check company (SIC 6770) incorporated in MA, headquartered in Las Vegas, NV.
• ·Beneficial ownership tables updated from dates January 28, 2026 (DMY) / December 31, 2025 (Horizon) to March 6, 2026.
• ·Employment agreements include confidentiality, non-compete, and non-solicit restrictions for executives including Greg Gould and Catherine Fitzsimons.
• ·Peter Oey qualifies as audit committee financial expert.
• ·100% Redemptions Scenario assumes full redemption of 2,325,987 Public Shares, with PIPE sufficient for Minimum Cash Condition.

06-03-2026

Covenant Logistics Group, Inc. (CVLG) filed a Form S-3 shelf registration statement on March 6, 2026, enabling potential future offerings of common stock, preferred stock, debt securities, rights, and warrants through various distribution methods, with proceeds usage to be specified in supplements. As of February 25, 2026, 20,383,043 Class A shares and 4,700,000 Class B shares were outstanding, with Class B shares (100% owned by David Parker and Jacqueline Parker) providing double voting rights and control over corporate actions. The prospectus incorporates risk factors from the 2025 10-K and warns of potential declines in securities value without highlighting any financial performance metrics.

• ·Class B common stock convertible 1:1 to Class A at any time and automatically converts upon transfer outside Parker family.
• ·No shares of preferred stock issued and outstanding as of February 25, 2026.
• ·Annual Report on Form 10-K referenced for year ended December 31, 2025.
• ·Quarterly Report on Form 10-Q filed August 7, 2025, includes Articles of Incorporation as exhibit.

06-03-2026

On March 4, 2026, Alphabet's Leadership Development, Inclusion and Compensation Committee approved a new triennial equity compensation package for CEO Sundar Pichai, recognizing his strong performance, including unchanged on-target values for $126M in PSUs and $84M in GSUs from the 2022 award, plus $130M target Waymo BPUs and $45M target Wing BPUs tied to Other Bets performance. However, his annual salary remains flat at $2M (unchanged since 2020) with no eligibility for an annual bonus. All awards are performance-based with potential 0-200% vesting ranges relative to targets, subject to TSR, unit value growth, and continued employment.

• ·PSUs vest based on Alphabet TSR vs. S&P 100 over 2026-2027 (tranche 1) and 2026-2028 (tranche 2).
• ·GSUs vest 1/12th on March 25, 2026, then 1/36th monthly through January 1, 2029.
• ·Waymo/Wing BPUs vest after 3-year period based on per-unit value increase (0-200%), settling in Common Units.
• ·Award agreements to be filed in 10-Q for quarter ending March 31, 2026.
• ·Upon death, unvested GSUs accelerate; performance equity vests at target.

06-03-2026

MarketWise reported Q4 2025 Billings of $78.9 million, up 42% YoY, and FY 2025 Billings of $271.2 million, up 13.4% YoY from $239.1 million, with CFFO improving to $46.0 million from -$22.2 million; however, net revenue declined 19.7% YoY to $328.1 million for FY 2025, and paid subscribers fell to 374 thousand from 506 thousand. The company beat FY 2025 guidance, raised FY 2026 targets to $300 million Billings and $50 million CFFO, increased its regular dividend by 25% with a $1.80 per Class A share target, and plans to resume its $50 million share buyback program. Paid subscribers remained relatively flat QoQ, reflecting a strategic shift to higher-value customers.

• ·Q4 2025 New 'Marketing' Billings $57.5M, Net 'Renewal' Billings $17.5M, Other Billings $3.9M.
• ·ARPU $670 as of Q4 2025.
• ·Partnership tax distributions $49.8M for FY 2025, expected ~$35M for FY 2026.
• ·Rejected acquisition proposal from M&C at $17.25 per share on Feb 17, 2026.
• ·Q3 2025 cash $50.5M, increased $20M to $70.1M by Dec 31, 2025.
• ·65% of customers have lifetime spend over $500 as of Dec 31, 2025.

06-03-2026

AGNC Investment Corp. filed a DEFA14A Definitive Additional Materials proxy statement on March 06, 2026, related to their 2026 proxy notice card. The filing consists primarily of boilerplate SEC Schedule 14A disclosures with no substantive financial, operational, or voting updates provided. No quantitative metrics, period comparisons, or material changes are disclosed.

06-03-2026

06-03-2026

Quipt Home Medical Corp. announced it obtained a final order from the Supreme Court of British Columbia approving its previously announced plan of arrangement (the 'Arrangement') under the Arrangement Agreement dated December 14, 2025, with 1567208 B.C. Ltd. and REM Aggregator, LLC. The transaction remains subject to customary closing conditions and is expected to complete by March 16, 2026, after which Quipt's common shares will be delisted from the Toronto Stock Exchange (TSX) and Nasdaq Capital Market (NASDAQ). No financial metrics were disclosed in the filing.

• ·Filing submitted on March 6, 2026, reporting event dated March 5, 2026.
• ·Press release attached as Exhibit 99.1.

06-03-2026

BP's 2025 sales and other operating revenues remained essentially flat at $189.3B compared to $189.2B in 2024, while underlying RC profit declined 16% YoY to $7.5B amid weaker performance across segments. Net debt improved slightly to $22.2B from $23.0B, supporting progress toward the $14-18B target by end-2027, and total dividends distributed rose modestly to $5.1B from $5.0B. However, upstream production dropped 12% YoY to 785 mboe/d, proved reserves fell 9% to 1,198 mmboe, ROACE was 13.9% missing the >16% 2027 target, and employee engagement score declined to 66% from 70%.

• ·2026 guidance: Upstream reported production slightly lower/underlying broadly flat vs 2025 (2025 actual 2.3 mmboe/d); Total capex $13-13.5B; Divestments $9-10B; Gulf of America oil spill payments ~$1.6B pre-tax.
• ·Primary targets progress: Adjusted free cash flow growth >20% CAGR 2024-27 (2025 data not specified); Structural cost reduction $2.8B cumulative since 2023 vs $5.5-6.5B by end-2027.
• ·Adjusting items before tax: Net impairment and losses on sale $(6,035)M in 2025.

06-03-2026

Waste Connections, Inc. announced plans to offer senior unsecured notes in a public offering, subject to market and other conditions, with proceeds intended to repay a portion of borrowings under its revolving credit facility. BofA Securities, J.P. Morgan, PNC Capital Markets LLC, and Truist Securities are acting as joint book-running managers. No specific offering size or terms were disclosed, and the offering is pursuant to a shelf registration statement filed on October 24, 2024.

• ·Serves customers across 46 U.S. states and six Canadian provinces
• ·Shelf registration statement filed with SEC on October 24, 2024

06-03-2026

Oxford Square Capital Corp.'s investment portfolio ended 2025 at $251.7M, down 3.4% from $260.9M at end-2024, driven by $92.1M acquisitions (down 18% YoY), net unrealized depreciation of $24.3M (vs. $75.7M gain prior year), and realized losses of $16.8M. NAV per share declined from $2.09 in Q1 FY25 to $1.69 in Q4 FY25 amid stock prices trading at premiums to discounts relative to NAV, while quarterly distributions remained stable at $0.105 per share. Debt portfolio at Dec 31, 2025 showed 83.7% fair value in Grade 2 but 16.3% in Grade 3 requiring closer monitoring, with no Grade 4/5 investments.

• ·Year 1 incentive fee: Total Capital Gains Incentive Fee = 0% paid to Oxford Square Management.
• ·Year 2 incentive fee example: 1.6% paid (20% of 8% net capital gains).
• ·Year 3 incentive fee example: 2.0% paid (20% of 10% net capital gains).
• ·2025 portfolio sales: HealthChannels $8.2M, Quest Software $1.6M, Alvaria $1.0M.
• ·Q4 FY26 (through Mar 2, 2026) stock: High $1.98, Low $1.72, Distribution $0.105.

06-03-2026

Ares Real Estate Income Trust Inc. (ZARE) reported strong portfolio growth with total investments rising 28% YoY to $8.5B as of Dec 31, 2025, driven by industrial (+43%) and other properties, alongside total revenues up 19.5% YoY to $499M and property NOI increasing 21.6% to $285M. However, the company posted a widened net loss of $127M (vs $57M in 2024), with net loss to common stockholders at $68M and EPS at $(0.37); same-store NOI declined 2.1% YoY to $213M amid residential NOI down 6.9% and flat/slight declines in other segments. FFO dropped sharply to $16M from $89M, while AFFO fell to $27M from $40M.

• ·Cash from operating activities improved to $254M from negative $169M YoY.
• ·Interest expense increased 33.5% YoY to $251M.
• ·Same store average percentage leased: Residential 92.5% (up from 92.0%), Office 77.7% (down from 78.2%).
• ·Total stockholders' equity $655M as of Dec 31, 2025.

06-03-2026

APEX Tech Acquisition Inc. consummated its initial public offering (IPO) on February 27, 2026, selling 11,197,131 public units at $10.00 each, generating gross proceeds of $111.97M. Simultaneously, the company closed a private placement of 208,971 units to its sponsor, APEX INNOVATION ACQUISITION CORP., for $2.09M in proceeds. A total of $111.97M in net proceeds from both transactions was deposited into a trust account for the benefit of public shareholders.

• ·Audited balance sheet as of February 27, 2026 included as Exhibit 99.1
• ·Securities traded on The New York Stock Exchange
• ·Company address: 13501 Katy Fwy, Houston, TX 77079

06-03-2026

ReserveOne Holdings, Inc. (Pubco), a wholly-owned subsidiary of ReserveOne, Inc., disclosed communications via X, LinkedIn, and an interview at the Hong Kong DAT Summit regarding its proposed business combination with M3-Brigade Acquisition V Corp., originally agreed on July 7, 2025. CEO Jaime Leverton positioned ReserveOne as the only diversified digital asset treasury company set to go public, with ~80% allocation to Bitcoin and the balance to yield-generating altcoins like Ethereum and Solana. While highlighting investor exposure to the broader crypto ecosystem, extensive forward-looking risks were noted, including deal completion uncertainties, high crypto volatility, regulatory hurdles, and potential high redemptions.

• ·Business Combination Agreement entered July 7, 2025
• ·Communications posted March 5, 2026
• ·SEC Commission File No. 333-291982 for M3-Brigade
• ·Registration Statement on Form S-4 filed, including proxy statement/prospectus

06-03-2026

NewLake Capital Partners, Inc. (NLCP) reported FY2025 total revenue of $51.1M, up 1.9% YoY from $50.1M, driven by slight increases in rental income (+1.2%) and fees, with net income attributable to common stockholders rising 0.8% YoY to $26.3M and AFFO up marginally to $43.8M. However, total assets declined 2.5% YoY to $420.8M from $431.5M, net real estate assets fell 4.3% to $370.0M primarily due to $15.5M depreciation, and net cash from operations dipped 2.1% to $42.5M. The portfolio totals $458M in investments across 1.7M sq ft, with 63.5% of rents from leases expiring after 2035 but 30.6% exposed in 2034.

• ·Vacant properties include Massachusetts (145,852 sq ft), Nevada (56,536 sq ft), and Pennsylvania (38,031 sq ft).
• ·Revolving Credit Facility unchanged at $7.6M.
• ·Accumulated Depreciation increased to $57.9M from $44.7M.
• ·Loan Receivable net $4.9M with Current Expected Credit Loss of $71K.
• ·Annualized Base Rent per Leased Square Foot weighted average $32.11.

06-03-2026

Willow Lane Acquisition Corp. filed a Rule 425 communication highlighting a case study on Boost Run's rapid launch of a GPU-native managed Kubernetes service in under 45 days using vCluster, managing 1K+ GPUs without requiring new platform engineering hires. This underscores Boost Run's operational efficiency and enterprise-grade capabilities (SOC 2, ISO 27001, ISO 27701, HIPAA certified) ahead of their business combination originally agreed on September 15, 2025. No financial metrics or performance declines were disclosed.

• ·Case study published March 5, 2026; SEC filing date March 6, 2026
• ·Boost Run certifications: SOC 2, ISO 27001, ISO 27701, HIPAA
• ·Upcoming SEC filings: Registration Statement on Form S-4 including proxy statement/prospectus
• ·Business Combination Agreement dated September 15, 2025

06-03-2026

Granite Ridge Resources reported revenues of $450.3M for 2025, up 18% YoY from $380.0M, driven by strong production growth of 28% to 11.7 MBo e with oil volumes up 31% and net producing wells up 21% to 245. However, lower average oil prices ($61.63/Bbl, down 16% YoY) and higher lease operating expenses per Boe ($7.27, up 16%) contributed to a 22% decline in net operating income to $46.4M and impairments rising to $44.7M; net income rose 30% YoY to $24.4M but was down 70% from 2023 levels amid increased debt to $385M.

• ·Net cash used in investing activities increased to $410M in 2025 from $311M in 2024 due to higher capex.
• ·Long-term debt rose to $368M at Dec 31 2025 from $205M at Dec 31 2024.
• ·Retained earnings turned negative at -$17.3M at Dec 31 2025 after $57.7M dividend declaration.
• ·Equity investments declined to $11M current + $0 long-term at Dec 31 2025 from $32M + $0.
• ·Common stock dividend declared at $0.44 per share for 2025.

06-03-2026

Liberty Media Corporation announced on March 5, 2026, that Renee L. Wilm will transition from her roles as Chief Legal Officer and Chief Administrative Officer across Liberty Media, Liberty Live Holdings, Inc., and Liberty Broadband Corporation to Senior Advisor effective later this year. In her new role, she will continue providing strategic guidance and counsel while supporting key initiatives. She will remain Chief Legal Officer at GCI Liberty, Inc., with no immediate disruptions or financial impacts disclosed.

06-03-2026

On March 5, 2026, Liberty Live Holdings, Inc. announced that Renee L. Wilm will transition from her role as Chief Legal Officer and Chief Administrative Officer to Senior Advisor, effective later this year. In her new position, Ms. Wilm will continue providing strategic guidance and counsel to the leadership team while supporting key initiatives. The announcement was made by Liberty Media Corporation.

• ·Event reported date: March 5, 2026
• ·Filing date: March 6, 2026
• ·Securities registered: Series A Liberty Live Group Common Stock (LLYVA) and Series C (LLYVK) on Nasdaq Stock Market LLC
• ·Registrant is an emerging growth company

06-03-2026

Canadian Imperial Bank of Commerce (CIBC) filed a Form F-3 registration statement with the SEC on March 5, 2026, to register up to $20 billion in senior debt securities for potential sale on a delayed or continuous basis pursuant to Rule 415, with specific terms to be detailed in future prospectus supplements. The filing highlights risks including geopolitical tensions, regulatory changes, and cyber threats, but provides no current financial performance metrics or period-over-period comparisons. Securities are not insured by CDIC or FDIC and may be subject to bail-in conversion under Canadian law.

• ·Registrant address: 81 Bay Street, CIBC Square, Toronto, Ontario, Canada M5J 0E7
• ·U.S. agent for service: 300 Madison Avenue, 6th Floor, New York, New York 10017
• ·Securities may be bail-inable under subsection 39.2(2.3) of the CDIC Act

06-03-2026

On March 5, 2026, Liberty Broadband Corporation announced that Renee L. Wilm will transition from her role as Chief Legal Officer and Chief Administrative Officer to Senior Advisor, effective later this year. In her new role, Ms. Wilm will continue providing strategic guidance and counsel to the leadership team while supporting key initiatives. No other changes or financial impacts were disclosed.

• ·Announcement made by Liberty Media Corporation.
• ·Transition effective later in 2026.

06-03-2026

On March 5, 2026, PROCEPT BioRobotics Corporation's board of directors increased its size from eight to nine members and appointed Daniel Puckett as a new Class III director, effective immediately, also naming him to the Audit Committee. Puckett, determined to be independent under SEC and Nasdaq rules, brings extensive CFO experience from Shockwave Medical, Inc. and other firms. His term expires at the 2027 annual stockholder meeting, with standard non-employee director compensation and indemnification.

• ·Puckett served as CFO of Shockwave Medical from April 2016 to February 2024.
• ·No arrangements or understandings for his appointment; no reportable transactions under Item 404(a) of Regulation S-K.
• ·Proxy statement on non-employee director compensation filed April 25, 2025; indemnification agreement form from S-1/A filed September 8, 2021.

06-03-2026

Nortech Systems Incorporated entered into Waiver and Amendment No. 4 to its Credit Agreement with Bank of America, N.A. on February 27, 2026, waiving financial covenant defaults on Consolidated Leverage Ratio, Fixed Charge Coverage Ratio, and Consolidated EBITDA for the quarter ended December 31, 2025. The amendment revises definitions, borrowing base, covenants, commitment levels, borrowing rates, and limits on foreign investments, signaling ongoing financial pressures despite positive operating benefits from prior restructurings. The company is negotiating a new asset-backed lending facility expected to close soon.

• ·Restructuring activities conducted in Q4 2024 and Q1 2025
• ·Waiver and Amendment filed as Exhibit 10.1

06-03-2026

Chime Financial reported total revenue of $2.19B for the year ended December 31, 2025, up 31% YoY from $1.67B in 2024, driven by 73% growth in platform-related revenue to $686M and 18% increase in payments revenue to $1.50B, alongside 19% growth in active members to 9.5M and 16% rise in purchase volume to $134B. However, net loss ballooned to $1.01B from $25M due to a surge in stock-based compensation to $1.09B and transaction/risk losses more than doubling to $407M, with transaction margin declining to 69% from 74%; operating expenses swelled to $2.96B, particularly in technology/development (+202% to $935M). Adjusted EBITDA improved to positive $127M (6% margin) from a $7M loss.

• ·Gross margin remained flat at 88% YoY.
• ·Cost of revenue increased 27% YoY to $263M.
• ·Technology and development expenses rose 202% YoY to $935M.
• ·Net loss per share diluted: $(4.27) in 2025 vs $(0.39) in 2024.
• ·ARPAM increased 5% YoY to $257.

06-03-2026

Dave Inc. priced a $175 million (upsized from $150 million) offering of 0% Convertible Senior Notes due 2031, expecting $168 million in net proceeds (or $192.1 million if the $25 million option is exercised fully), to be used for $15.1 million in capped call transactions, $70.5 million to repurchase 334,000 shares, and general corporate purposes including additional repurchases. The notes feature an initial conversion price of $279.13 per share (32.5% premium over $210.67 closing price on March 4, 2026) and a capped call cap price of $421.34 (100% premium). No performance declines noted, but capped calls aim to mitigate dilution risks from potential conversions.

• ·Offering expected to close on March 9, 2026, subject to customary conditions.
• ·Notes mature on April 1, 2031; redeemable after April 6, 2029 under specific conditions.
• ·Initial conversion rate: 3.5825 shares per $1,000 principal amount.

06-03-2026

Pattern Group Inc. (PTRN) reported strong revenue growth of 39.3% YoY to $2.5B in 2025 from $1.8B in 2024, with cost of goods sold up 39.0% and sales & marketing expenses rising 46.8%. However, profitability declined sharply as net income fell to $16.2M from $67.9M, operating income dropped to $25.4M from $87.2M, and operating margin compressed to 1.0% from 4.9% amid higher operating expenses reaching 99.0% of revenue. Adjusted EBITDA improved to $152.9M from $100.7M, supported by a $104.3M share-based compensation charge and a $32.7M stock amendment expense.

• ·Net cash provided by operating activities increased to $99.4M in 2025 from $70.3M in 2024.
• ·Net cash used in investing activities doubled to $39.8M in 2025 from $20.4M in 2024.
• ·Net cash provided by financing activities swung to $53.7M inflow in 2025 from $2.9M outflow in 2024.
• ·2025 provision (benefit) for income taxes was ($17.0M) compared to $23.4M in 2024.
• ·2023 Adjusted EBITDA was $64.7M and net income $41.3M.

06-03-2026

Tri Pointe Homes, Inc. (TPH) filed a DEFA14A Definitive Additional Materials proxy statement on March 06, 2026, pursuant to Section 14(a) of the Securities Exchange Act of 1934. The filing indicates no fee required and contains no substantive proposals, financial data, or voting items in the provided excerpt. No performance metrics, positive or negative, are disclosed.

• ·Filed by the Registrant (☒)
• ·Definitive Additional Materials (☒)
• ·No fee required (☒)

06-03-2026

News Corporation filed an 8-K on March 6, 2026, reporting on its ongoing $1B stock repurchase program authorizing acquisitions of Class A (NWSA) and Class B (NWS) common stock. The filing attaches Exhibits 99.1 and 99.2 with information provided to the Australian Securities Exchange (ASX) on respective dates, fulfilling daily disclosure requirements under ASX rules. No specific repurchase transactions are detailed in the filing body.

• ·Securities: Class A Common Stock (NWSA, par value $0.01) and Class B Common Stock (NWS, par value $0.01), traded on Nasdaq Global Select Market
• ·Event date: March 5, 2026; Filing date: March 6, 2026

06-03-2026

Crown PropTech Acquisitions entered into Non-Redemption Agreements with certain investors on March 5, 2026, whereby its sponsor, CIIG Management III LLC, will assign economic interests in one Class B ordinary share for each 40 public shares not redeemed at the March 9, 2026 Extraordinary General Meeting (EGM). These agreements aim to increase funds remaining in the trust account post-EGM by discouraging redemptions, supporting approval of a 12-month extension of the initial business combination deadline from March 11, 2026 to March 11, 2027, though they are not expected to affect approval likelihood. The sponsor holds 5,662,000 Class B ordinary shares, of which 2,194,988 are already subject to prior similar agreements.

• ·EGM record date: February 13, 2026
• ·Proxy Statement filed with SEC: February 27, 2026
• ·Assignment accrues monthly beginning April 11, 2026 until business combination completion
• ·Transfer of assigned shares conditioned on business combination closing and execution of Joinder to January 17, 2023 Letter Agreement

06-03-2026

Guidewire Software reported strong H1 FY26 revenue growth of 25% YoY to $692M, driven by 32% increase in subscription and support revenue to $459M, achieving net income of $91M versus a $28M loss in H1 FY25. However, license revenue remained essentially flat at $101M YoY for H1 and declined 7% in Q2, while services showed negative gross profit in Q2; cash and equivalents dropped $290M to $408M amid investing outflows and $148M stock repurchases. Total assets slightly declined to $2.69B from $2.72B.

• ·Operating cash flow increased to $44.6M from $23.7M YoY for H1.
• ·Stock-based compensation expense $90.1M for H1 FY26 vs $79.0M prior.
• ·Business acquisition for $33.3M net of cash in H1 FY26.
• ·Convertible senior notes net $676.3M as of Jan 31, 2026.

06-03-2026

On March 5, 2026, Spirit Aviation Holdings, Inc. entered into a Consent and Waiver with certain holders of its common stock and warrants, who represent a majority of Registrable Securities, waiving rights under Sections 2.1, 2.2, and 2.3 of the March 12, 2025 Registration Rights Agreement to permit the company to terminate the Form S-1 registration statement (File No. 333-288706). This action occurs during the company's ongoing Chapter 11 bankruptcy cases filed on August 29, 2025, with explicit warnings that trading in common stock is highly speculative and could result in significant or complete loss for holders.

06-03-2026

Cresco Labs Inc., a foreign private issuer, filed its Form 40-F annual report for FY2025 ended December 31, 2025, incorporating the AIF, MD&A, and audited consolidated financial statements for 2025 and 2024. Management concluded that disclosure controls and procedures were not effective, and material weaknesses persist in internal control over financial reporting (ICFR) related to IT general controls in program change-management and job monitoring, despite remediation of prior weaknesses in logical access, service organization controls, and account reconciliations. As of December 31, 2025, the company had 158,940,757 Special Subordinate Voting Shares, 343,232,815 Subordinate Voting Shares, 81,492 Proportionate Voting Shares, and 500,000 Super Voting Shares outstanding.

• ·Material weaknesses in ICFR due to ineffective ITGCs in program change-management and job monitoring controls.
• ·Remediation completed in 2025 for prior material weaknesses in logical access controls, service organization control report reviews, and account reconciliations.
• ·Company qualifies as an emerging growth company and foreign private issuer under MJDS.

06-03-2026

Adapti, Inc. (ADTI) announced the resignation of Marilu Brassington as CFO, principal accounting officer, and Board member effective March 2, 2026, with no disagreements noted; the separation agreement includes $15,000 in wages, up to $80,000 in contingent consulting fees tied to Reg A Offering fundraising milestones of $500,000 each, $60,000 in common stock, and accelerated vesting of 50,000 stock options. Adam Nicosia, the current CEO, was appointed interim principal financial and accounting officer effective the same date, leveraging his 18+ years of sales and marketing experience across brands generating over $500M in retail sales, with no additional compensation. The company retained an outside consulting firm to assist.

• ·Stock option exercise price: $3.08; originally granted August 14, 2025; exercisable until August 13, 2030
• ·Separation Agreement dated March 5, 2026; includes 7-day revocation period
• ·Transitional services from Ms. Brassington through March 31, 2026
• ·Filing date: March 6, 2026; earliest event: March 2, 2026

06-03-2026

Atlantis Glory Inc. (AGLY) reported zero revenue for FY 2025, unchanged from FY 2024, with net loss improving slightly to $39,199 from $40,480 (3% narrower YoY). However, total liabilities rose 23% to $210,628 from $171,429, driven by increased amounts due to related parties ($195,108 from $161,029), while stockholders' deficit deepened to $(210,628). The company holds zero assets and cash, fully reliant on related party financing to cover operating cash usage.

• ·Accumulated deficit increased to $(1,146,407) as of Dec 31, 2025 from $(1,107,208) as of Dec 31, 2024.
• ·Cash and cash equivalents remained at $0 at year-end for both 2025 and 2024.
• ·EPS basic and diluted flat at $(0.00) for both FY 2025 and FY 2024.
• ·Total assets $0 as of Dec 31, 2025 and 2024.

06-03-2026

Where Food Comes From, Inc. (WFCF) issued a proxy statement for its annual shareholder meeting on April 9, 2026, via conference call, seeking approval for electing six directors (including nominees John Saunders and Leann Saunders), ratifying Haynie as independent auditors (Proposal 2), advisory approval of executive compensation (Proposal 3), and a three-year frequency for future say-on-pay votes (Proposal 4). Record date is February 3, 2026, with 5,050,455 shares of common stock outstanding and eligible to vote. No financial performance data or period comparisons are provided in the filing.

• ·Meeting held via conference call: Domestic Toll Free 1-877-407-8289, International 1-201-689-8341, Conference Code 13759029.
• ·Proxy voting deadlines: Internet/telephone until 10:00 AM MT on April 9, 2026.
• ·Board recommends FOR all six director nominees, FOR auditor ratification, FOR say-on-pay, and THREE YEARS for frequency.
• ·Quorum requires majority of outstanding shares; Proposal 1 uses plurality vote.

06-03-2026

FTAI Aviation Ltd. announced the immediate appointment of Nicholas McAleese as Chief Financial Officer and Michael Hazan as Chief Accounting Officer, succeeding Eun (Angela) Nam, who is departing after 12 years to pursue an opportunity outside the aviation industry and will assist in the transition. The company highlighted the new executives' internal experience and contributions since 2022 and 2017, respectively, while expressing thanks to Ms. Nam. No financial impacts or disruptions were mentioned.

• ·Nicholas McAleese joined FTAI in 2022 from roles at BHG Financial, Breather, and PwC.
• ·Michael Hazan joined in 2017, previously at Fortress Investment Group and PwC.
• ·Eun (Angela) Nam served FTAI for the last twelve years.

06-03-2026

First United Corporation announced that its Board of Directors declared a cash dividend of $0.26 per share on March 4, 2026, payable on May 1, 2026, to holders of record as of the close of business on April 17, 2026. The announcement was included in a press release filed as Exhibit 99.1.

• ·Filing signed by Tonya K. Sturm on March 6, 2026

06-03-2026

Algonquin Power & Utilities Corp. (AQN) filed its Form 40-F annual report for the fiscal year ended December 31, 2025, incorporating the Annual Information Form, audited consolidated financial statements, and MD&A as exhibits. As of December 31, 2025, the company had 768,351,419 common shares outstanding and confirmed no off-balance sheet arrangements. The filing discloses the company's transition to a pure-play regulated utility since Q1 2025 following the sale of its renewable energy business (excluding hydro), with no specific period-over-period financial metrics provided in the Form 40-F itself.

• ·Designated Dilek Samil and Christopher Lopez as independent audit committee financial experts.
• ·Audited by Ernst & Young LLP (PCAOB ID: 1263).
• ·No off-balance sheet arrangements as of December 31, 2025.
• ·Discontinued presentation of certain non-GAAP metrics (Adjusted EBITDA, Adjusted Funds from Operations) post-sale of renewable energy business excluding hydro.

06-03-2026

Via Transportation, Inc. reported FY2025 revenue of $434.3M, up 29% YoY from $337.6M in 2024, driven by 31% Platform revenue growth to $434.3M (with Legacy revenue declining to $0 from $6.8M), customer count rising 23% to 821, and Platform ARR increasing 30% to $476M. Gross profit grew 31% to $171.8M with margin expansion to 40% from 39%. However, operating expenses rose 16% to $248.4M, narrowing operating loss to $76.6M from $83.9M but widening net loss to $96.4M from $90.6M due to a $10.9M loss on extinguishment of convertible notes.

• ·Stock-based compensation expense totaled $31.3M in FY2025, up 47% from $21.2M in FY2024.
• ·Interest expense increased to $7.3M in FY2025 from $4.3M in FY2024.
• ·FY2023 revenue was $248.9M, with net loss of $116.7M attributable to common stockholders.

06-03-2026

Jade Biosciences reported $336.2M in cash, cash equivalents, and investments as of December 31, 2025, up significantly from $69.4M at year-end 2024, following $180M in private placement proceeds, providing runway into H1 2028. Pipeline advances include JADE101 Phase 1 interim data in Q2 2026, Phase 2 initiation mid-2026, JADE201 first-in-human in Q2 2026, and JADE301 nomination with Phase 1 in H1 2027. However, R&D expenses rose 62% QoQ to $28.5M in Q4 2025 and 198% YoY to $93.1M for FY2025, G&A increased 167% QoQ to $6.4M and 374% YoY to $20.4M, driving net loss up 6% QoQ to $31.9M and 171% YoY to $127.4M.

• ·Total assets $349.8M as of Dec 31, 2025 (vs $72.8M Dec 31, 2024)
• ·Total liabilities $17.3M as of Dec 31, 2025 (down from $119.6M Dec 31, 2024)
• ·Stockholders’ equity $332.5M as of Dec 31, 2025 (vs deficit of $46.8M Dec 31, 2024)
• ·Company inception date June 18, 2024

06-03-2026

Nuveen AMT-Free Quality Municipal Income Fund extended the final mandatory redemption date of its Series 4 Variable Rate Demand Preferred Shares, aggregate liquidation preference $489.5M, from September 11, 2026, to September 11, 2056, effective March 5, 2026. The preferred shares feature weekly dividends set by a remarketing agent with a liquidity provision and are senior to common shares in liquidation and dividends. No performance declines or flat metrics were reported in this disclosure.

• ·Fund's fiscal year end is October 31.
• ·Series 4 shares are not registered under the Securities Act of 1933 and cannot be offered or sold without exemption.

06-03-2026

Genesco Inc. reported Q4 FY26 net sales of $800M, up 7% YoY from $746M, with comparable sales +9% driven by Journeys (+12%), while full-year FY26 sales rose 5% to $2.4B with comp sales +6%; operating income increased 11% to $51.3M in Q4 and 24% to $17.3M for the year on an adjusted basis. However, gross margins declined 100bps to 45.9% in Q4 and 90bps adjusted for FY26 due to promotions at Schuh and tariff pressures at Genesco Brands, with Brands sales down 27% in Q4 and 4% FY, Johnston & Murphy flat FY sales, and FY27 outlook showing total sales down 1% to flat despite 1-2% comp growth.

• ·E-commerce sales 31% of retail sales in Q4 FY26 (vs 30% prior), 25% FY26 (flat YoY).
• ·6 stores opened and 15 closed in Q4 FY26; net 42 store closings FY26.
• ·FY27 guidance: adj EPS $1.90-$2.30; tax rate ~30% (7-8% first three quarters due to valuation allowance).
• ·No share repurchases in Q4 FY26.

06-03-2026

Humana Inc. filed DEFA14A additional proxy materials on March 6, 2026, notifying employees and stockholders of the 2026 Annual Meeting on April 16, 2026, at 1:00 p.m. ET via virtual webcast at www.virtualshareholdermeeting.com/HUM2026. Retirement Savings Plan 401(k) participants with Humana Common Stock Fund shares as of the February 27, 2026 record date can vote by April 8, 2026, 11:59 p.m. EDT through Charles Schwab/Broadridge. Key proposals include election of 10 directors, ratification of PricewaterhouseCoopers LLP as auditors, advisory vote on executive compensation, approval of the 2026 Stock Incentive Plan, and a stockholder proposal on golden parachutes.

• ·Record date: February 27, 2026
• ·Proxy statement filed and available starting March 6, 2026
• ·Notice and Access Card mailing for non-electronic stockholders
• ·Stockholder materials request deadline: April 2, 2026
• ·General voting deadline: April 15, 2026, 11:59 PM ET
• ·ProxyVote.com control numbers: V83468-P45111, V83469-P45111
• ·Company address: 101 East Main Street, 10th Floor, Louisville, KY 40202
• ·Contact: CorporateSecretary@humana.com

06-03-2026

Wheeler Real Estate Investment Trust, Inc. processed redemptions of 6,502 shares of Series D Cumulative Convertible Preferred Stock on March 5, 2026, at approximately $41.72 per share (including accrued dividends), settling via issuance of 143,914 shares of common stock at a volume-weighted average price of $1.88. This triggered a further adjustment to the conversion price of its 7.00% Subordinated Convertible Notes due 2031 to approximately $1.04 per share (24.12 shares per $25 principal), a 45% discount to $1.88. Cumulatively, 1,777,083 Series D shares have been redeemed with approximately 393,000 common shares issued; as of March 6, 2026, 1,433,983 common shares and 1,640,295 Series D shares remain outstanding.

• ·Next Series D redemption deadline: March 25, 2026; next Holder Redemption Date: April 6, 2026
• ·Redemption forms and FAQs available at https://ir.whlr.us/series-d/series-d-redemption

06-03-2026

Western Alliance Bancorporation disclosed a material non-cash impairment charge of $126.4 million on March 2, 2026, due to counterparties breaching a commercial loan facility and forbearance agreement by failing to make a required $42.125 million principal payment and discontinuing future payments. The outstanding loan balance is $126.4 million, with the charge to be recognized in Q1 2026. The Bank has asserted claims and will pursue legal remedies for recovery, though outcomes remain uncertain amid forward-looking risks.

• ·Filing date: March 6, 2026
• ·Date of earliest event: March 2, 2026
• ·Securities: Common Stock (WAL), Depositary Shares WAL PrA on NYSE

06-03-2026

Prudential Financial, Inc.'s subsidiary, The Prudential Gibraltar Financial Life Insurance Co., Ltd. (PGFL), issued a press release on March 6, 2026, disclosing instances of unauthorized removal of information by certain PGFL employees seconded to financial institutions in Japan. The Company furnished an English translation of the press release as Exhibit 99.1 under Item 7.01 Regulation FD Disclosure. No financial impacts or further details on the scope of the incident were provided.

• ·Filing signed by Brian P. Spitser, Vice President and Assistant Secretary.

06-03-2026

Total revenues grew 19.6% YoY to $1.36B in 2025 from $1.14B in 2024, with the Options segment driving growth to $1.11B (up 30.0% YoY), while Equities revenues declined 18.3% to $153M and International revenues fell 56.6% to $15M. Revenues less cost of revenues surged 56.2% to $431M, and Adjusted EBITDA increased 142.6% to $199M with a 46.2% margin, but GAAP net loss attributable to MIH was $70M versus $102M net income in 2024, driven by a $108M loss on debt extinguishment and other non-operating items. Operating income improved to $92M from a $2.8M loss, though Futures and Corporate/Other segments posted operating losses.

• ·Loss on extinguishment of debt: $108M in 2025
• ·Unrealized loss on derivative assets: $55M in International segment 2025
• ·Basic EPS: $(1.00) in 2025 vs $1.68 in 2024
• ·Adjusted diluted EPS: $1.82 in 2025 (up 193.5% YoY)
• ·Futures operating loss: $57M in 2025 (worsened from $47M loss in 2024)

06-03-2026

The Middleby Corporation (NASDAQ: MIDD) appointed Glenn Eisenberg to its Board of Directors effective March 1, 2026, expanding the board to twelve members. Eisenberg brings extensive experience as former CFO of Labcorp (a $13B global life sciences company) and The Timken Company, along with current board roles at Solventum (NYSE: SOLV) and Lumexa Imaging (NASDAQ: LMRI). CEO Tim FitzGerald and Chairman Gordon O’Brien highlighted his expertise in financial discipline, manufacturing, and capital allocation to support Middleby's strategic transformation in commercial foodservice.

• ·Eisenberg retired from Labcorp in December 2024 and continues as Special Advisor.
• ·Joined Solventum board in April 2024 (Audit Committee Chair); Lumexa Imaging in March 2025 (Audit and Compensation Committees).
• ·Previous roles: President and COO of United Dominion Industries; various senior finance roles at SPX Corporation.

06-03-2026

Intensity Therapeutics, Inc. received a Nasdaq letter on March 5, 2026, confirming regain of compliance with Listing Rule 5550(a)(2) Minimum Bid Price Requirement after maintaining a $1.00 closing bid price for 10 consecutive business days from February 19 to March 4, 2026. This resolves prior notices from June 6, 2025 (initial 180-day period to December 3, 2025) and December 4, 2025 (extension to June 1, 2026). The company issued a press release on March 6, 2026, announcing the compliance.

• ·Initial Nasdaq deficiency notice issued June 6, 2025, for 30 consecutive business days below $1.00 bid price.
• ·Second Nasdaq letter on December 4, 2025, granted additional 180 calendar days until June 1, 2026.

06-03-2026

McKesson Corporation (MCK) filed a Form 8-K on March 6, 2026, under Items 7.01 and 9.01, announcing a news release issued the same day, attached as Exhibit 99.1, in compliance with Regulation FD. The filing details the company's registered securities, including common stock (MCK), 1.625% Notes due 2026 (MCK26), and 3.125% Notes due 2029 (MCK29). It was signed by Britt J. Vitalone, Executive Vice President and Chief Financial Officer.

06-03-2026

BCE Inc. filed its Form 40-F annual report for the fiscal year ended December 31, 2025, incorporating audited consolidated financial statements and MD&A via exhibits. The company acquired Ziply Fiber on August 1, 2025, which contributed 2% to consolidated revenues but negatively impacted net earnings by 1%. Disclosure controls and procedures were deemed effective as of December 31, 2025, excluding Ziply Fiber, with no material changes to internal controls over financial reporting.

• ·Common shares outstanding: 932,525,817
• ·Total First Preferred Shares outstanding: 131,755,879 across multiple series
• ·Ziply Fiber disclosure controls excluded from evaluation; full integration planned for Q3 2026
• ·Audit Committee comprises six independent members with three designated financial experts

06-03-2026

Altimmune, Inc. reported revenues of $41K for the year ended December 31, 2025, up 105% YoY from $20K, driven by minimal grant or collaboration income, while R&D expenses declined 19% to $66.4M, contributing to a reduced net loss of $88.1M (7% improvement) versus $95.1M in 2024. However, G&A expenses rose 34% to $28.1M, total cash increased to $43.8M supported by $207M in financing inflows despite $132M investing outflows and $68M operating cash burn.

• ·Shares outstanding increased to 110.9M from 72.4M YoY.
• ·Term loan noncurrent liability of $34.3M as of Dec 31, 2025 (none in 2024).
• ·Key audit matter on accrued R&D expenses ($6.1M) and prepaid R&D ($3.0M) as of Dec 31, 2025.
• ·Filing date: March 06, 2026.

06-03-2026

Immuneering reported 64% overall survival at 12 months in its ongoing Phase 2a trial of atebimetinib + mGnP in first-line pancreatic cancer patients (N=34), well above the 35% GnP standard of care benchmark, with a favorable tolerability profile. Cash, cash equivalents, and marketable securities stood at $217M as of December 31, 2025, up significantly from $36.1M at year-end 2024, providing runway into 2029; R&D expenses declined 37% YoY to $9.3M in Q4 and 13% to $42M for FY2025. However, G&A expenses rose 22% YoY to $4.5M in Q4 and 8% to $17.3M for FY2025, contributing to a FY2025 net loss of $56M ($1.27/share), improved from $61M ($2.04/share) in FY2024 but still reflecting ongoing unprofitability.

• ·On track for expanded pancreatic cancer cohort data readout in 1H 2026.
• ·Dose first patient in Phase 3 MAPKeeper 301 trial mid-2026.
• ·Dosing in Phase 2 atebimetinib + Libtayo® NSCLC trial to begin 2H 2026.
• ·Added to Nasdaq Biotechnology Index on Dec 22, 2025.
• ·13.4 months median follow-up in Phase 2a trial as of Dec 15, 2025 data cutoff.

06-03-2026

United States Antimony Corporation (UAMY) filed an 8-K on March 6, 2026, under Item 3.01 notifying of delisting or failure to satisfy a continued listing rule or standard, a material negative development for shareholders. The filing also furnishes Exhibit 99.1, a press release under Item 7.01 (Regulation FD Disclosure), which includes forward-looking statements on the company's plans and potential benefits from a joint venture. No financial metrics or period comparisons were provided.

• ·Filing items include 3.01 (Notice of Delisting/Failure to Satisfy Rule), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits).
• ·Exhibit 99.1 is a Press Release dated March 6, 2026, furnished but not deemed 'filed' under the Exchange Act.

06-03-2026

Aptiv PLC announced that its subsidiary Aptiv Swiss Holdings Limited commenced a cash tender offer to purchase up to $1.35B aggregate consideration of several senior notes (including 3.250% due 2032, 5.150% due 2034, 5.750% due 2054, 4.400% due 2046, 4.150% due 2052, 3.100% due 2051, and 5.400% due 2032), conditional on the spin-off of its Electrical Distribution Systems business into Versigent and receipt of at least a $1.7B special dividend from Versigent. Separately, Aptiv announced conditional redemption of the entire $401M outstanding 4.650% Senior Notes due 2029 at a make-whole premium, expected on April 7, 2026, subject to the same conditions. No financial performance metrics were reported.

• ·Tender Offer to Purchase dated March 6, 2026
• ·Redemption of 2029 Notes expected April 7, 2026
• ·All transactions subject to Spin-Off consummation and $1.7B minimum special dividend

06-03-2026

For the nine months ended December 31, 2025, Virtuix Holdings Inc. reported net sales growth of 41% YoY to $3.0M and gross profit of $0.9M versus a $0.4M loss in the prior year, driven by lower cost of goods sold and sharply reduced operating expenses (G&A down 57% YoY); however, the net loss narrowed to $6.9M from $12.0M YoY amid high interest expense and debt extinguishment loss. Q3 2025 net sales declined 24% YoY to $1.0M, resulting in a $2.7M net loss versus $2.0M prior year, while selling expenses surged 199% YoY. Balance sheet reflects total assets up 10% to $6.4M with cash doubling to $1.1M, but current liabilities rose 48% to $8.7M due to increased notes payable, deepening stockholders' deficit to $3.0M from $0.8M.

• ·Preferred stock fully converted/reclassified to common stock by Dec 31 2025 (0 shares outstanding vs 21.7M at Mar 31 2025)
• ·Current notes payable doubled to $5.3M from $2.6M QoQ
• ·Inventory slightly down 5% QoQ to $1.4M
• ·Deferred revenue decreased 59% QoQ to $0.7M
• ·Financing activities: $3.0M from convertible notes, $1.9M preferred stock issuance
• ·Loss on debt extinguishment $123K in nine months 2025

06-03-2026

Signing Day Sports, Inc. (SGN) issued a Form 425 filing with a press release reminding stockholders of the special meeting on March 13, 2026, to vote on the proposed Business Combination with BlockchAIn Digital Infrastructure, Inc. and affiliates, originally agreed on May 27, 2025 and amended thereafter. Proxy materials were distributed to stockholders of record as of January 20, 2026, and upon approval, BlockchAIn shares are expected to trade on NYSE American under ticker 'AIB'. No financial metrics or performance data were disclosed in the filing.

• ·Special Meeting at 10:00 a.m. Pacific Time on March 13, 2026, at 8355 East Hartford Rd., Suite 100, Scottsdale, AZ 85255.
• ·Business Combination Agreement dated May 27, 2025; Amendment No. 1 dated November 10, 2025; Amendment No. 2 dated December 21, 2025.
• ·Previous disclosures in 8-K filings on May 28, 2025, November 12, 2025, and December 22, 2025.
• ·Proxy materials mailed as announced on February 17, 2026.

06-03-2026

AgEagle Aerial Systems Inc. (dba EagleNXT, NYSE: UAVS) announced a strategic investment in Israel's Aerodrome Group Ltd., a developer of precision loitering munitions, to boost capabilities in autonomy and precision strike technologies. The investment includes a reserved right for EagleNXT to establish a U.S.-based joint venture, subject to mutual agreement and regulatory approvals. This aligns with EagleNXT's mission in uncrewed systems for defense and other sectors, with CEO Bill Irby highlighting its role in enhancing security and operational effectiveness.

• ·EagleNXT’s platforms achieved FAA approvals for Operations Over People (OOP) and Beyond Visual Line of Sight (BVLOS)
• ·EASA C2 certification in Europe
• ·Inclusion on the U.S. Department of Defense’s Blue UAS list
• ·Forward-looking statements subject to risks including investment success and regulatory approvals for joint venture

06-03-2026

Cheniere Energy, Inc. (NYSE: LNG) announced its intention to offer Senior Notes due 2036 and Senior Notes due 2056, subject to market and other conditions. Proceeds from the offering will be used for general corporate purposes, including repayment or refinancing of existing indebtedness (such as under Cheniere Corpus Christi Holdings, LLC’s term loan facility), funding capital expenditures, working capital, and other business opportunities. The Notes will rank pari passu with Cheniere's existing senior notes due 2028 and due 2034; the offering is not registered under the Securities Act.

• ·Filing date: March 06, 2026
• ·Offer not registered under the Securities Act of 1933; may not be offered or sold in the US absent registration or exemption

06-03-2026

NextTrip, Inc. (NTRP) announced on March 6, 2026, that it signed an agreement with J. Bradley Hilton’s Hilton Advisory Group to accelerate its premium wellness travel products across JOURNY.tv and Five Star Alliance. The press release is furnished under Item 7.01 (Regulation FD Disclosure) as Exhibit 99.1 and includes forward-looking statements regarding future performance.

• ·Filing includes Exhibit 99.1: Press Release dated March 6, 2026
• ·Registrant details: Nevada incorporation, Commission File Number 001-38015, IRS EIN 27-1865814, address 3900 Paseo del Sol, Santa Fe, New Mexico 87507

06-03-2026

Reborn Coffee, Inc. increased its Board size from six to seven members on March 2, 2026, and appointed independent director Alex Yeon to fill the vacancy and serve on the Audit Committee with no compensation. On March 3, 2026, the Board appointed existing director Jung Jae Lim as Co-Chief Executive Officer alongside Jay Kim, with no additional compensation for Lim, who resigned from the Audit Committee due to loss of independence. Lim brings over 20 years of logistics and supply chain expertise from CEO roles at KCC Mexico Overseas Logistics, TJ America, and TJ Korea Inc.

• ·Alex Yeon determined independent under Nasdaq Rule 5605(a)(2).
• ·No family relationships or related party transactions involving Yeon or Lim.
• ·Jung Jae Lim received Bachelor of Language and Literature from Dankook University.
• ·Filing date: March 6, 2026; Event dates: March 2-3, 2026.

06-03-2026

Hurco Companies reported a Q1 FY2026 net loss of $3.5M ($0.54/share), improved from $4.3M ($0.67/share) YoY, while sales and service fees declined 8% to $42.9M from $46.4M, with decreases across all regions: Americas -8%, Europe -5%, and Asia Pacific -15%. Orders increased 5% to $42.0M, led by 18% growth in Americas, but fell 2% in Europe and 6% in Asia Pacific; gross margin improved to 19% from 18%, though SG&A expenses rose to 26% of sales from 22%. Cash remained stable at $48.0M and working capital was $169.5M.

• ·Income tax expense $0.5M Q1 FY2026 vs $2.0M Q1 FY2025.
• ·Full valuation allowance recorded against Italian, U.S., and Chinese deferred tax assets as of Jan 31 2026.
• ·Inventory turns flat at 1.0x.
• ·Capital expenditures $0.6M Q1 FY2026 vs $0.6M Q1 FY2025.
• ·No total debt outstanding.
• ·Days sales outstanding 51 vs 42 QoQ.

06-03-2026

Adial Pharmaceuticals reported FY2025 financial results with cash and equivalents at $5.9M (up from $3.8M in FY2024), a reduced net loss of $8.0M (vs. $13.2M prior year, improved ~39%), R&D expenses down 19% ($609K decrease), but G&A expenses up 2% ($125K increase). The company advanced AD04 regulatory progress including positive FDA feedback and EOP2 meeting, expanded IP with patents through 2045, secured partnerships like Cytel and Genomind, U.S. manufacturing with Cambrex/Thermo Fisher, and a framework for $60M Europe deal with Molteni, while regaining Nasdaq compliance. Cash is projected to fund operations into H2 2026.

• ·Nasdaq compliance regained on Feb 24, 2026 (notice Feb 23, 2026), matter now closed.
• ·Molteni collaboration framework announced March 3, 2026, subject to definitive agreement.
• ·International patent application for AD04 published Jan 14, 2026 (filed July 2024), potential protection to 2045.
• ·Six-figure milestone payment received from Adovate on May 13, 2025 for Phase 1 trial of ADO-5030.

06-03-2026

Stanley Black & Decker's 2026 Proxy Statement discloses no related party transactions since the start of fiscal 2025 and details non-employee director compensation for 2025, including an annual cash retainer of $125,000, annual RSUs valued at $200,000 (up from $185,000), and additional retainers for committee chairs and roles like Lead Independent Director ($45,000 aggregate RSUs). Total 2025 compensation ranged from $20,408 (prorated for new/short-term directors) to $649,955 (Andrea J. Ayers), with aggregate equity grant fair value of $1.76M; major shareholders include Vanguard (12.0%) and insiders own less than 1%. Human capital strategy is overseen by the CEO and CHRO, with annual talent reviews presented to the Board.

• ·No related party transactions requiring disclosure since beginning of fiscal 2025.
• ·Ownership data as of February 25, 2026; director changes include Laschinger joining November 1, 2025, Poul retiring at 2025 Annual Meeting.
• ·Chief Human Resources Officer (CHRO) reports to CEO; annual talent reviews with Compensation Committee and full Board.

06-03-2026

The Goodyear Tire & Rubber Company's DEF 14A proxy statement outlines its corporate governance practices, including a separated Chairman (Ms. Koellner) and CEO (Mr. Stewart) roles since January 29, 2024, with 83% independent director nominees and full independence on key committees. The Board oversees risks through committees, with 2025 meeting counts of 6 for the full Board and 5, 4, 3, 4, and 0 for Audit, Human Capital & Compensation, Corporate Responsibility & Compliance, Finance, and Governance committees, respectively, alongside emphasis on management succession and the Goodyear Forward transformation plan. No financial performance metrics or declines are discussed.

• ·Board leadership separation effective since January 29, 2024; Ms. Koellner served as Lead Director from June 30, 2019 to January 29, 2024.
• ·Mr. Wessel appointed director in December 2005 via USW nomination.
• ·Governance Committee considers director nominees based on integrity, experience, diversity, and independence standards.

06-03-2026

Eightco Holdings Inc. (ORBS) filed an 8-K on March 6, 2026, under Items 7.01 and 9.01, disclosing a press release providing an operational update, attached as Exhibit 99.1 and furnished pursuant to Regulation FD. The information is explicitly not deemed 'filed' under the Exchange Act or subject to its liabilities. No specific financial or operational metrics were detailed in the filing.

• ·Registrant is an emerging growth company.
• ·Common Stock: $0.001 par value, traded as ORBS on Nasdaq.
• ·Principal executive offices: 101 Larry Holmes Drive Suite 313, Easton, PA 18042.

06-03-2026

Mammoth Energy Services reported Q4 2025 revenue from continuing operations of $9.5M, down 5% YoY from $10.0M and 13% QoQ from $10.9M, with full-year revenue at $44.3M, down 3% YoY from $45.6M; net loss widened to $12.3M in Q4 (vs $9.6M YoY) but improved FY to $63.8M from $183.1M. While rental services revenue surged 175% YoY to $3.3M and infrastructure grew 200% to $1.2M, natural sand proppant declined 67% YoY to $1.7M and accommodation fell 17% FY YoY; Adjusted EBITDA remained negative at ($6.8M) Q4, though FY improved significantly to ($17.4M). Four divestitures generated over $150M in cash, bolstering liquidity to $158.3M at year-end, with $65M+ deployed into high-growth aviation rentals.

• ·SG&A expense FY 2025: $19.6M vs $114.5M in 2024 (83% decline, due to lower expected credit losses on PREPA settlement).
• ·Drilling services FY revenue flat at $3.7M vs $3.6M YoY (+3%).
• ·As of Mar 3, 2026, total liquidity $156.6M (cash $89.6M, marketable securities $28.8M).
• ·Q4 sand avg sales price $18.56/ton vs $22.54 YoY (-18%).

06-03-2026

Clover Health Investments, Corp. (CLOV) published written responses to a selection of frequently asked supplemental shareholder questions related to its fourth quarter 2025 earnings announcement on March 6, 2026. The Q&A is furnished as Exhibit 99.1 to this Form 8-K and available on the company's investor relations website. This disclosure is pursuant to Regulation FD and not deemed 'filed' for purposes of the Exchange Act.

• ·Related to fourth quarter 2025 earnings announcement.
• ·Securities registered: Class A Common Stock, par value $0.0001 per share (CLOV).
• ·Remote-first company with no physical headquarters; communications to secretary@cloverhealth.com.

06-03-2026

Deric Eubanks voluntarily terminated his employment with Ashford Hospitality Advisors, LLC effective March 31, 2026, without Good Reason, in exchange for a $1.8M Non-Compete Payment paid over 12 months, a $0.2M transition payment through June 30, 2026, continuation of $3.3M deferred cash grants vesting per original schedule, and eligibility for a prorated 2025 Cash Incentive Bonus aligned with AINC executives. He will provide up to 40 hours/month consulting and 20 hours/week part-time transition assistance remotely. The agreement includes mutual general releases, non-disparagement, and reaffirmed restrictive covenants including 12-month non-compete and 24-month non-solicitation periods.

• ·Consulting services: up to 40 hours per month remotely during deferred cash grants vesting period.
• ·Transition assistance: up to 20 hours per week remotely from March 31 to June 30, 2026.
• ·Non-compete period: 12 months post March 31, 2026.
• ·Non-solicitation and standstill periods: 24 months post March 31, 2026.
• ·Original Employment Agreement effective January 1, 2023.
• ·Payments subject to 8-day revocation period; Non-Compete Payment starts first payroll in April 2026.

06-03-2026

ASP Isotopes Inc. issued a press release on March 6, 2026, announcing a memorandum of understanding (MOU) between Quantum Leap Energy LLC and a large U.S. energy company to evaluate support for advancing the enriched uranium fuel supply chain in the United States. No financial terms or quantitative impacts were disclosed in the filing.

• ·Filing date: March 6, 2026
• ·Items reported: 7.01 (Regulation FD Disclosure), 9.01 (Financial Statements and Exhibits)

06-03-2026

Deric Eubanks voluntarily terminates employment with Ashford Hospitality Advisors, LLC on March 31, 2026, without Good Reason, in exchange for a release and waiver agreement. He receives a $1.8M Non-Compete Payment paid over 12 months, $200K transition payment through June 30, 2026, eligibility for a prorated 2025 Cash Incentive Bonus, and continued vesting of $3.3M in deferred cash grants and 13,490 AINC shares subject to compliance with consulting and restrictive covenants. Mutual releases, non-disparagement, and ongoing non-compete (12 months), non-solicitation (24 months) obligations are affirmed.

• ·Non-compete period: 12 months post-termination
• ·Non-solicitation and standstill periods: 24 months post-termination
• ·Payments subject to 8-day revocation period and compliance with consulting (remote, reasonable requests)
• ·Original employment agreement effective January 1, 2023

06-03-2026

Warner Music Group Corp. held its Annual Meeting of Stockholders on March 3, 2026, electing all eleven director nominees with overwhelming support (For votes ranging from 7.55B to 7.63B shares out of approximately 7.64B total votes cast, minimal Against votes under 80M). Stockholders also ratified KPMG LLP as the independent registered public accounting firm for fiscal year 2026 with 7.63B For votes and negligible opposition (13.3M Against). No broker non-votes for Proposal 2, indicating strong consensus.

• ·Proxy statement filed with SEC on January 20, 2026.
• ·Proposal 1 broker non-votes: 11,989,796 shares.
• ·Proposal 2: Against 13,299,930 shares; Abstain 33,513 shares.

06-03-2026

Future Vision II Acquisition Corp. (FVNNR), a SPAC, filed its 10-K annual report for the year ended December 31, 2025, highlighting ongoing risks related to completing an initial business combination within 18-24 months from IPO closing, potential conflicts of interest among officers and directors, and PRC-related regulatory hurdles. The filing details acquisition criteria focused on revenue growth, free cash flow generation, and public company benefits but notes no business combination has occurred, with financial statements covering the period from inception (January 30, 2024). Risks include dilution from convertible loans up to $1.5M and founder shares purchased at $0.017 per share.

• ·Financial statements cover year ended December 31, 2025 and period from January 30, 2024 (inception) through December 31, 2024.
• ·Initial business combination deadline: 18 months from IPO closing (extendable to 24 months).
• ·PRC regulatory risks including data security oversight by Cyberspace Administration of China and potential need for approvals.

06-03-2026

ArteLo Biosciences, Inc. (ARTL) filed an 8-K on March 6, 2026, reporting material modifications to the rights of security holders (Item 3.03), amendments to articles of incorporation or bylaws (Item 5.03), other events (Item 8.01), and financial statements/exhibits (Item 9.01). The filing falls under the subcategory of Charter/Bylaws Amendments, indicating potential changes to corporate governance structure. No financial metrics or period-over-period comparisons were disclosed in the available filing details.

• ·Filing accession number: 0001640334-26-000395
• ·Company CIK: 0001621221
• ·SIC: 2834 (Pharmaceutical Preparations)
• ·Incorporated in NV, located in CA, Fiscal Year End: December 31
• ·Former names: Knight Knox Development Corp. (through 2017-02-06), Reactive Medical Inc. (through 2017-04-17)

06-03-2026

GXO Logistics, Inc. appointed Mark Suchinski as Chief Financial Officer effective April 1, 2026, bringing over three decades of finance, operations, and supply chain experience, particularly in aerospace and defense. CEO Patrick Kelleher stated that the leadership team is now fully in place to drive faster growth and higher margins. The company operates over 150,000 team members across more than 1,000 facilities totaling more than 200 million square feet.

• ·Mark Suchinski previously served as CFO for The GEO Group, Inc. and Spirit AeroSystems.
• ·Patrick Kelleher joined GXO in August 2025.
• ·Suchinski holds a Bachelor of Business Administration from DePaul University.

06-03-2026

Harley-Davidson, Inc. intends to enter a Rule 10b5-1 trading plan on or before March 13, 2026, to repurchase a modest amount of its common stock over the coming months, depending on market conditions, consistent with its measured approach to share repurchases announced on the Q4 2025 earnings call on February 10, 2026. The company plans to provide updated information on its share repurchase strategy during the Q1 2026 earnings call. No specific repurchase volumes, pricing, or timelines were disclosed.

• ·Q4 2025 earnings call held on February 10, 2026
• ·SEC filing dated March 6, 2026 under Item 8.01 Other Events

06-03-2026

On March 4, 2026, BiomX Inc. (PHGE) announced the immediate resignations of CEO Jonathan Solomon and Chairman Dr. Russell Greig from their positions and board roles, with no disagreements on company matters. The Board appointed Michael Oster as new CEO and Amir Shalom as Class I Director (term expiring 2027), while noting no compensatory arrangements for Oster yet and standard prorated director pay for Shalom. Effective March 5, 2026, board committees were restructured with Liat Bidas as Audit and Nominating/Governance Chair, and Amir Shalom as Compensation Chair.

• ·Resignations and appointments effective immediately on March 4, 2026; committee assignments effective March 5, 2026.
• ·No arrangements, family relationships, or disclosable transactions involving new appointees Amir Shalom or Michael Oster.
• ·Amir Shalom deemed independent under NYSE American rules; standard indemnification agreement to be entered.

06-03-2026

Servier announced a definitive agreement to acquire Day One Biopharmaceuticals, Inc. (Nasdaq: DAWN) for $21.50 per share in cash, representing a total equity value of approximately $2.5B, a 68% premium over the March 5, 2026 closing price and 86% over the one-month VWAP. The transaction, which positions Servier as a leader in pediatric low-grade glioma and expands its oncology pipeline, is expected to close in Q2 2026 subject to customary conditions including majority tender and U.S. antitrust clearance. No financial declines or flat metrics reported, though forward-looking statements highlight risks such as failure to meet closing conditions.

• ·Servier invests nearly 20% of brand-name sales in R&D
• ·Day One Board recommends shareholders tender shares
• ·Advisors: Baker McKenzie (Servier legal), Fenwick & West LLP (Day One legal)

06-03-2026

Marriott Vacations Worldwide Corporation announced that Executive Vice President and General Counsel James Hunter will transition from his role on March 9, 2026, and retire on April 1, 2026, after nearly 20 years of service, including key roles in expansions, the 2011 spin-off from Marriott International, and the 2018 merger with ILG. CEO Matt Avril expressed thanks for Hunter's contributions in building teams and industry leadership, noting he will remain in an advisory role through retirement to ensure a smooth transition. The announcement highlights the company's 120 vacation ownership resorts and approximately 700,000 owner families.

• ·Hunter began in-house legal career at Marriott International in 1994, supporting global development in Asia-Pacific.
• ·Relocated to Orlando in 2006 to lead Law Department of Marriott Vacation Club International.
• ·Hunter will assume presidency of Florida Citrus Sports in April 2026.

06-03-2026

Tiptree Inc. reported Q4 2025 net income attributable to common stockholders of $5.9M ($0.04 diluted EPS), down from $19.5M ($0.49 EPS) in Q4 2024, and full-year 2025 net income of $34.9M ($0.76 EPS), down from $53.4M ($1.34 EPS) in 2024, reflecting sharp revenue declines in continuing operations (Q4: $3k vs $372k; year: $488k vs $1.52M) and lower discontinued operations income ($15.2M vs $26.3M Q4; $73.8M vs $85.7M year). However, the company announced agreements to sell Fortegra for $1.65B (est. $1.12B proceeds) on Sep 26, 2025, and Reliance First Capital for ~$50M on Oct 31, 2025, yielding pro-forma book value of $923M ($24.40/share) post-transactions. Book value per share rose 9.4% YoY to $13.45, and a $0.06/share dividend was declared.

• ·Total expenses Q4 2025: $8.6M, down 10% YoY from $9.6M.
• ·Cash dividends paid per share FY 2025: $0.24 vs $0.49 in 2024.
• ·Assets held for sale Dec 31, 2025: $6.77B vs $5.64B in 2024.
• ·Fortegra and Reliance closings anticipated mid-2026 and H1 2026, pending approvals.

06-03-2026

Honeywell announced that Honeywell Aerospace Inc. has launched a private offering of up to $16B in senior notes and entered into $3B five-year and $1B 364-day revolving credit facilities to finance the planned spin-off of Aerospace, expected in Q3 2026. Proceeds from New Money Notes will fund a cash distribution to Honeywell and related fees, while Exchange Notes settle prior debt obligations. However, the offering size, timing, and terms are subject to market conditions, with significant risks including potential delays, failure to complete the spin-off, or lack of anticipated benefits.

• ·Notes offered only to qualified institutional buyers under Rule 144A and non-U.S. persons under Regulation S
• ·Notes guaranteed by Honeywell until Spin-Off completion, after which guarantees are automatically released
• ·Closing of Notes offering not contingent on Spin-Off completion

06-03-2026

Off The Hook YS Inc. (OTH) filed an 8-K on March 6, 2026, under Items 7.01 (Regulation FD Disclosure) and 9.01, announcing via press release an exclusive live investor webinar and Q&A session on March 11, 2026. The press release is attached as Exhibit 99.1 and is not deemed 'filed' for liability purposes. No financial or operational metrics were disclosed.

• ·Common Stock, $0.001 par value, trading symbol OTH on NYSE American LLC
• ·Emerging growth company: Yes

06-03-2026

GSK plc reported 2025 turnover of £32.7B, up 4% AER and 7% CER from £31.4B in 2024, driven by strong operating profit growth of 97% AER to £7.9B and profit attributable to shareholders more than doubling to £5.7B. However, performance was mixed across products, with growth in Dovato (+20% AER), Jemperli (+84%), and Shingrix (+6%) offset by declines in Triumeq (-25%), Seretide/Advair (-19%), and Rotarix (-7%). Vaccine sales totaled £9.2B, flat AER but +2% CER, while R&D expenses rose 18% to £7.5B.

• ·Scope 1 & 2 emissions from energy/sales revenue improved to 8.8 tonnes CO2e/£m in 2025 from 10.6 in 2024.
• ·Total energy used decreased to 2,482 GWh in 2025 from 2,577 GWh in 2024.
• ·% renewably sourced electricity reached 99% in 2025, up from 90% in 2024.
• ·Total waste reduced to 39,000 metric tonnes in 2025 from 47.3k in 2024.

06-03-2026

Chilean Cobalt Corp. amended its binding earn-in and option agreement with NeoRe SpA on March 2, 2026, clarifying the NeoRe Rare Earth Project properties at 6,300 hectares across 21 mining concessions without altering financial terms. The company issued a press release announcing land expansion by 2,100 hectares through 7 new concessions, initial drilling of 192 meters with intercepts up to 1,060 ppm TREE and surface samples over 800 ppm, and an accelerated program targeting Tranche 1 completion by July 2026. Exploration has identified over 20 additional targets, with ongoing metallurgical testing of more than 100 samples supported by University of Concepción and CORFO.

• ·Amendment filed March 6, 2026, references prior 8-K on January 14, 2026.
• ·Drilling transition to execution phase with two parallel crews planned.
• ·Conceptual engineering initiated for modular processing including crushing and milling circuit.
• ·CORFO award supports analytical and metallurgical work.

06-03-2026

Nuvve Holding Corp. announced a partnership with OMNIA Global to address a 1GW development pipeline over the next 24 months, supported by financing, starting with a 50MW/75MWh battery energy storage system (BESS) in Sweden expected to commence operations in Q2 2026. Nuvve will own and manage the facility, providing market access services, with potential revenues of $260,000–$325,000 per MW-year amid favorable Swedish market conditions. The deal includes exclusive rights to support OMNIA's projects and a right of first refusal for future ownership stakes, expanding Nuvve's European footprint.

• ·Filing date: March 06, 2026
• ·First project operations expected: Q2 2026
• ·Pipeline timeframe: next 24 months
• ·Nuvve headquartered in San Diego, California

06-03-2026

Escalade Incorporated appointed Patrick J. Griffin as full-time Chief Executive Officer and President on March 5, 2026, transitioning from his interim role held since October 29, 2025. Mr. Griffin, previously Vice President of Corporate Development and Investor Relations and a Director since August 2012, has no family relationships with other executives or material interests in transactions under Regulation S-K. No changes were made to his compensation from the offer letter dated November 10, 2025.

• ·Mr. Griffin, age 56, previously served as President of Martin Yale Group, a former Escalade subsidiary, and in various roles since 2002.
• ·Additional details in Form 10-K for year ended December 31, 2025, and proxy statement filed March 28, 2025.

06-03-2026

Bluejay Diagnostics reported $5.2 million in cash and cash equivalents and $6.0 million in stockholders’ equity as of December 31, 2025, bolstered by a $3.8 million warrant-inducement financing in April 2025 and a $4.5 million PIPE in October 2025, with approximately 972,000 shares outstanding following February 2026 warrant exercises that avoided new dilution. The company highlighted progress in the SYMON™ II clinical study, manufacturing scale-up, and Symphony™ platform readiness for regulatory submission. However, it incurred net losses of $6.8 million for FY 2025 and anticipates needing at least $20 million in additional capital through the end of FY 2027.

• ·IL-6 Test designed for ~20 minutes sample-to-result time
• ·No regulatory clearance yet for Symphony System; requires FDA authorization

06-03-2026

GMTech Inc. (GMTH) reported strong FY2025 performance with revenue surging to $3.48M from $53K in FY2024 (6,487% YoY growth), gross profit of $2.66M, and net income of $413K versus a $33K loss prior year. However, cash and equivalents plummeted 85% to $17K from $108K due to $241K net cash used in investing activities for inventories ($802K) and notes receivable ($238K), while operating cash flow improved to $143K positive from $55K used. Total assets expanded to $1.38M but liabilities rose sharply to $851K, driven by $616K deferred revenue.

• ·Deferred revenue arose from $4.5M customer prepayments, with $3.48M recognized as revenue, $410K cash refunds, and minor FX effect.
• ·EPS basic and diluted: $0.03 FY2025 vs $0.00 FY2024.
• ·Weighted average shares: 12M FY2025 vs 9.1M FY2024.
• ·Shares issued in FY2024: 7M for $140K proceeds.

06-03-2026

Solitron Devices, Inc. (SODI) has issued a proxy statement for its 2025 Annual Meeting on April 24, 2026, seeking stockholder approval for the re-election of Charles M. Gillman as Class III director for a term until the 2028 Annual Meeting, ratification of Whitley Penn LLP as independent auditors for the fiscal year ending February 28, 2026, and a non-binding advisory vote on named executive officer compensation. The record date is February 27, 2026, with 2,147,703 shares of common stock outstanding entitling holders to vote. The Board consists of five directors divided into three staggered classes, with no financial performance metrics or period comparisons disclosed in the filing.

• ·Annual Meeting time: 10:00 a.m. Eastern Time at 901 Sansburys Way, West Palm Beach, Florida 33411
• ·Proxy materials mailing date: on or about March 10, 2026
• ·Fiscal year reference: ended February 28, 2025 (10-K available)
• ·Voting quorum: majority of issued and outstanding shares present in person or by proxy
• ·Majority voting standard for uncontested director elections with contingent resignation provision
• ·Committee memberships: Audit (Dwight P. Aubrey, John F. Chiste); Compensation (Dwight P. Aubrey, David W. Pointer, Charles M. Gillman); Nominating (John F. Chiste, David W. Pointer, Charles M. Gillman)

06-03-2026

For the three months ended January 31, 2026, John Wiley & Sons reported net revenue of $410M, up 1.3% YoY, with Research segment growth of 2.5% offsetting a 0.9% decline in Learning; operating income rose 21% to $63M. Over nine months, revenue was slightly down 0.5% YoY to $1.23B due to a 6.8% drop in Learning despite 5% Research growth, but net income surged to $86M from $16M and operating cash flow doubled to $103M, aided by $114M in divestiture proceeds. Total assets declined 4.9% to $2.56B, while shareholders' equity was nearly flat at $750M.

• ·Accounts receivable declined to $200M from $228M YoY.
• ·Contract liabilities dropped sharply to $293M from $463M.
• ·Interest expense decreased 17% YoY in 9M to $34M.
• ·Weighted average shares outstanding declined to 52.9M basic (9M) from 54.2M.

06-03-2026

Entergy Mississippi, LLC entered into an Underwriting Agreement on March 4, 2026, for the sale of $650M aggregate principal amount of its First Mortgage Bonds, 5.05% Series due April 15, 2036. The sale closed on March 6, 2026, pursuant to the Company's Registration Statement on Form S-3 (No. 333-289302-02). No comparative financial metrics or performance data were disclosed.

• ·Bonds traded under symbol EMP on New York Stock Exchange
• ·Filing includes multiple legal opinions and consents from firms: Morgan, Lewis & Bockius LLP, Friday, Eldredge & Clark, LLP, Wise Carter Child & Caraway, Professional Association, Husch Blackwell LLP

06-03-2026

Broadridge Financial Solutions, Inc. declared a quarterly cash dividend of $0.975 per share, payable on April 8, 2026, to stockholders of record at the close of business on March 16, 2026. The announcement was made via press release on March 6, 2026.

• ·Filing date: March 6, 2026
• ·Record date: March 16, 2026
• ·Payment date: April 8, 2026

06-03-2026

The Mexico Fund, Inc. (MXF) filed an 8-K on March 6, 2026, reporting an event on February 28, 2026, to furnish its February 2026 Monthly Summary Report from the Investment Adviser under Regulation FD (Items 7.01 and 9.01). The report is included as Exhibit (i). No specific financial metrics, changes, or performance data are disclosed in the filing body.

• ·Principal executive offices: 6700 Alexander Bell Drive, Suite 200, Columbia, Maryland 21046
• ·Telephone: (614) 469-3265
• ·State of incorporation: Maryland
• ·Commission File Number: 811-02409
• ·I.R.S. Employer Identification No.: 13-3069854
• ·Securities: Common Stock (MXF) on New York Stock Exchange

06-03-2026

Tri-Continental Corporation (NYSE: TY, TYPR) filed an 8-K on March 6, 2026, under Items 7.01 (Regulation FD Disclosure) and 9.01 (Financial Statements and Exhibits), furnishing a press release dated March 6, 2026 as Exhibit 99.1. No specific financial metrics, performance data, or material updates are detailed in the filing itself.

• ·Commission File Number: 811-00266
• ·I.R.S. Employer Identification No.: 13-5441850
• ·Principal executive offices: 290 Congress Street, Boston, Massachusetts 02210
• ·Telephone: 800-345-6611
• ·Securities: Common Stock (TY) and Preferred Stock (TYPR) on The New York Stock Exchange

06-03-2026

On February 28, 2026, Lynn Stockwell was removed as Chief Executive Officer, Executive Chair of the Board, and Board member of Drugs Made In America Acquisition Corp. following issues with the sponsor of its affiliate, Drugs Made In America Acquisition II Corp., which improperly withdrew $1.1M from the affiliate's working capital account between September 26 and September 30, 2025, including a $566,269 overpayment and at least $200,000 more for unrelated expenses. Roger Bendelac was appointed as the new CEO effective the same date, with compensation to be determined later. The resignations stem from the sponsor's inability to repay overpayments as directed on February 12, 2026.

• ·Sponsor withdrawals from affiliate occurred between completion of affiliate's IPO on September 26, 2025, and September 30, 2025; additional withdrawals between September 30, 2025, and December 31, 2025.
• ·Affiliate Board directed sponsor to return full overpayment on February 12, 2026; learned on same date sponsor unable to repay.
• ·Stockwell agreed to resign on February 18, 2026, at request of both Company and Affiliate Boards; resignation effective February 28, 2026 upon receipt.

06-03-2026

On February 28, 2026, Lynn Stockwell was removed as Chief Executive Officer, Executive Chair, and Board member due to the Sponsor's improper withdrawals totaling $1.1M from working capital post-IPO, including a $566k overpayment that was not returned despite Board demands. Roger Bendelac was appointed as the new CEO effective the same date, with compensation to be determined later. The incident highlights governance issues but ensures leadership continuity.

• ·Sponsor withdrawals occurred between IPO completion on September 26, 2025, and September 30, 2025 ($1.1M), with additional overpayment adjustments through December 31, 2025.
• ·Board directed Sponsor to return full overpayment on February 12, 2026; Stockwell agreed to resign on February 18, 2026.
• ·Roger Bendelac, 69, has over 30 years in investment banking; no family relationships or related party transactions with the Company.

06-03-2026

Chatham Lodging Trust completed the acquisition of six Hilton-branded hotels (589 rooms) for $92 million ($156,000 per room), featuring younger properties (average age 10 years) with higher RevPAR ($116 vs. $101 for sold hotels) and EBITDA margins (42% vs. 27%), following sales of six older hotels for ~$100 million over the past 18 months. The company increased its quarterly common dividend by 11% to $0.10 per share, payable April 15, 2026. This accretive deal (10% cap rate, adds ~$10M Hotel EBITDA or 12% increase, +$0.10 adjusted FFO/year) raises net debt to EBITDA ratio by 50 basis points.

• ·Acquired hotels located in Joplin, Mo. (two), Effingham, Ill. (two), Paducah, Ky. (two).
• ·Dividends payable April 15, 2026 to shareholders of record March 31, 2026.
• ·Acquisition funded with available cash and revolving credit facility borrowings.
• ·Acquired portfolio included in Chatham results for only 10 months in 2026.

06-03-2026

Vertiv Holdings Co (VRT) filed an 8-K on March 6, 2026, under Items 8.01 (Other Events) and 9.01 (Financial Statements and Exhibits), with a filing size of 251 KB. No specific financial metrics, period-over-period comparisons, or detailed event descriptions are available in the provided filing index. The document appears to report a general update with potential exhibits.

• ·CIK: 0001674101
• ·SIC: 3679 (Electronic Components, NEC)
• ·Fiscal Year End: December 31
• ·State of Incorporation: DE
• ·Business Address: 505 N. Cleveland Ave., Westerville, OH 43082
• ·Accession Number: 0001628280-26-015494

06-03-2026

Independent Bank Corporation's 10-K for FY ended December 31, 2025, reports total loans of $4.276B and deposits of $4.762B, with the bank maintaining well-capitalized status. Revenue mix shifted with interest and fees on loans rising to 75.7% in 2025 from 70.7% in 2024 and 68.1% in 2023; however, other interest income declined to 9.8% from 11.8% and 14.4%, while non-interest income fell to 14.5% from 17.4% and 17.5%. The company operates 56 branches in Michigan, employs 735 full-time and 91 part-time staff, and had 20.6M shares outstanding as of March 5, 2026.

• ·One loan production facility in Ohio (Fairlawn).
• ·Acquisition of Traverse City State Bank completed in April 2018.
• ·Annual Meeting of Shareholders scheduled for April 21, 2026.

06-03-2026

Highwater Ethanol, LLC held its 2026 annual members' meeting on March 5, 2026, electing David Eis, William Garth, and David Moldan as governors by plurality vote for terms expiring in 2029. All nominees received majority support with no reported opposition votes.

06-03-2026

Republic Bancorp, Inc. reported robust 2025 financial results, with net income surging 30% YoY to $131.3M, diluted EPS up 29% to $6.72, ROA improving 25% to 1.84%, and ROE rising 17% to 12.31%, fueled by net interest income growth to $334.7M (up 7% YoY) and NIM expansion to 5.05% from 4.85%. Average interest-bearing deposits grew 6% or $203M, with costs declining to 2.26% from 2.67%, reducing interest expense by 10% or $9.6M. However, the Traditional Bank booked a $4.8M specific provision on a $16M C&I participation loan in Q4 2025 amid borrower revenue declines and expense pressures, while TRS Refund Advances and Other RPG loans saw average balances decrease.

• ·Noninterest-bearing deposits average balance declined $42.6M YoY to $1.33B in 2025.
• ·Allowance for credit losses stable at approx. $92M in 2025 vs 2024.
• ·Stockholders’ equity average grew to $1.07B in 2025 from $965M in 2024.

06-03-2026

FIRST FINANCIAL BANKSHARES INC (FFIN) filed its DEF 14A proxy statement for the 2026 annual shareholder meeting on April 28, 2026, at 10:30 a.m. CT in Abilene, Texas, with a record date of March 2, 2026. Shareholders are asked to vote on Proposal 1: election of directors; Proposal 2: ratification of independent auditors; and Proposal 3: advisory vote on named executive officer compensation, including detailed 2025 compensation discussion and analysis with equity awards data for PEO and Non-PEO NEOs across years 2021-2025. No specific financial performance metrics or period-over-period changes are detailed in the visible content.

• ·Annual meeting location: Abilene Convention Center, 1100 North 6th Street, Abilene, Texas.
• ·RSVP for post-meeting luncheon required by April 15, 2026, via phone 325.627.7038 or email awatkins@ffin.com.
• ·Live video stream available at www.ffin.com/live-events; replay post-event.
• ·Proxy materials available at www.ffin.com/sec.

06-03-2026

Peoples Bancorp Inc. (PEBO) filed its DEF 14A proxy statement for the virtual annual shareholder meeting on April 23, 2026, at 10:00 a.m. EDT, with a record date of February 23, 2026. Key proposals include electing eleven directors for one-year terms expiring at the 2027 meeting, an advisory vote to approve named executive officers' compensation as disclosed, and ratification of Ernst & Young LLP as independent auditor for the fiscal year ending December 31, 2026. No financial performance metrics or period-over-period comparisons are detailed in the filing excerpt.

• ·Meeting held solely via live webcast at www.proxydocs.com/pebo; no in-person attendance.
• ·Shareholder proposals for 2027 annual meeting must be received by December 2026 (specific date not provided in excerpt).

06-03-2026

CENTRAL PACIFIC FINANCIAL CORP (CPF) filed Definitive Additional Proxy Materials (DEFA14A) on March 06, 2026, pursuant to Section 14(a) of the Securities Exchange Act of 1934. The filing was made by the registrant with no fee required. No specific proposals, financial data, or other substantive details are provided in the document.

• ·Filing Type: DEFA14A (Definitive Additional Materials)
• ·Filed by the Registrant

06-03-2026

SunOpta Inc. filed a DEFA14A proxy statement supplement on March 6, 2026, related to a proposed transaction requiring shareholder approval at a special meeting. The filing provides boilerplate information on forward-looking statements, directs investors to the definitive management information circular and proxy statement (preliminary filed February 27, 2026), and notes availability of director/executive information in recent 10-K and other SEC filings. No specific financial metrics, transaction details, or performance data are disclosed.

• ·Preliminary management information circular and proxy statement filed February 27, 2026
• ·Annual Report on Form 10-K for fiscal year ended January 3, 2026, filed March 4, 2026
• ·Proxy statement for 2025 annual meeting filed April 11, 2025

06-03-2026

Amtech Systems, Inc. held its 2026 Annual Meeting of Shareholders on March 4, 2026, with 72.73% voter turnout from 14,394,885 eligible shares. All three proposals passed: election of six directors (though Robert M. Averick and Michael M. Ludwig received significant withheld votes of 2.75M and 2.54M respectively), ratification of KPMG LLP as auditors for FY ending September 30, 2026 (overwhelming approval with 10.28M for votes), and advisory approval of named executive officer compensation (5.46M for vs. 2.74M against). Significant opposition on certain director elections and executive pay highlights mixed shareholder sentiment.

• ·Proxy statement dated January 23, 2026.
• ·Fiscal year ending September 30, 2026.

06-03-2026

Camden National Corporation reported net income of $65.2M for 2025, up 23% YoY from $53.0M in 2024, fueled by the January 2, 2025 acquisition of Northway Financial, Inc., which drove net interest income to $203.3M (+53% YoY) and total assets to $6.97B (+20% YoY). However, non-interest expenses surged 38% YoY to $154.8M due to $9.3M in merger costs, return on average equity declined slightly to 9.96% from 10.36%, and tangible book value per share dipped to $29.69 from $29.91. Adjusted metrics reflected stronger results, including adjusted net income of $74.4M (+39% YoY) and adjusted return on average tangible equity of 17.27%.

• ·Dividends declared per share remained flat at $0.42 quarterly across all quarters in 2025 and 2024.
• ·Adjusted pre-tax, pre-provision income increased to $109.6M in 2025 from $66.2M in 2024.
• ·Non-GAAP efficiency ratio improved to 54.46% in 2025 from 62.05% in 2024.

06-03-2026

Crexendo, Inc. (CXDO) filed an 8-K on March 6, 2026, under Items 7.01 and 9.01, announcing the posting of an investor presentation dated March 3, 2026, to its website at www.crexendo.com/investor, attached as Exhibit 99.1. The information is furnished pursuant to Regulation FD and not deemed filed or incorporated by reference into other filings. No financial metrics or performance data are disclosed in the filing itself.

• ·Commission File Number: 001-32277
• ·IRS Employer Identification No.: 87-0591719
• ·Principal Executive Offices: 1225 West Washington St, Suite 213, Tempe, AZ 85288
• ·Telephone: (602) 714-8500

06-03-2026

PPL Electric Utilities Corporation reached a non-unanimous settlement in principle on March 5, 2026, in its distribution rate case filed with the Pennsylvania Public Utility Commission on September 30, 2025, resolving all issues with broad stakeholder agreement despite limited opposition from two parties on maximum registered peak load. The settlement supports continued investments in a safe, reliable electric system while emphasizing customer affordability, with a Joint Petition for approval to be filed on March 10, 2026. PPL anticipates a PUC ruling by the end of Q2 2026 but cannot predict the outcome.

• ·Letter advising Administrative Law Judges of settlement posted on docket March 6, 2026
• ·Settlement subject to approval by Administrative Law Judges and PUC

06-03-2026

ArcelorMittal's total sales declined 1.7% YoY to $61.4B in 2025 from $62.4B in 2024, driven by drops in Brazil (-9.9%), Europe (-3.9%), and Sustainable Solutions (-2.1%), despite gains in Mining (+21.4%) and North America (+3.7%). Operating income rose 9.6% YoY to $3.6B, with strong growth in North America (+68.3%), Sustainable Solutions (+149.1%), and Europe (+35.2%), but offset by a sharp decline in Brazil (-56.5%) and flat Mining performance (+2.5%). North America saw crude steel production up 2.9% to 7.8M tonnes, though long product shipments fell 4.3%.

• ·North America flat product shipments: 8,378 thousand tonnes (+4.4% YoY)
• ·North America long product shipments: 2,378 thousand tonnes (-4.3% YoY)
• ·North America average steel selling price: $1,014/tonne (+2.9% YoY)
• ·North America total steel shipments: 10,283 thousand tonnes (+2.2% YoY)

06-03-2026

SB Financial Group, Inc. reported net income of $13.974M for the year ended December 31, 2025, up 21.8% YoY from $11.47M, with diluted EPS rising 27.3% to $2.19, driven by net interest income growth of 21.4% to $48.453M amid 12.8% loan expansion to $1.181B and 13.4% deposit growth to $1.307B. However, noninterest income was essentially flat at +0.5% ($17.107M), noninterest expenses increased 9.4% to $46.999M, provision for loan losses surged 953% to $1.306M, and available-for-sale securities declined 6.4% to $188.626M. Total assets grew 12% to $1.545B, while the company repurchased 31,519 shares in Q4 2025 at an average price of $20.60, leaving 199,050 shares remaining under the program.

• ·Nonaccruing loans declined 17% YoY to $4.579M (0.39% of total loans).
• ·Nonperforming assets fell 15.1% to $4.683M (0.30% of total assets).
• ·Allowance for credit losses increased 6.7% to $16.114M (1.36% of loans).
• ·Return on average assets improved to 0.93% from 0.84%; ROE to 10.38% from 9.19%.
• ·Cash dividend payout ratio declined to 27.54% from 32.87%; dividends declared $0.60 per share (up from $0.56).

06-03-2026

CKX Lands, Inc. announced on March 5, 2026, that directors Keith Duplechin and Daniel J. Englander notified the company of their retirement from the board and will not stand for re-election at the 2026 annual meeting of stockholders. They will continue serving until their terms expire at the meeting. The decisions were not due to any disagreement with the company's operations, policies, or practices.

06-03-2026

Arrow Financial Corp's FY2025 net income surged 48% YoY to $44M from $30M in FY2024, with basic EPS rising to $2.65 from $1.77, driven by 19.2% growth in net interest income to $133M and NIM expansion to 3.19% from 2.74%; ROA improved to 1.00% and ROE to 10.66%. Noninterest income grew 15.5% to $32M, while efficiency ratio improved to 61.97% from 67.68%. However, noninterest expenses rose 5.8% to $103M, net loans charged-off increased to 0.19% of average loans from 0.09%, and provision for credit losses edged up to 0.21% from 0.16%.

• ·Tier 1 Leverage Ratio at 9.68% as of Dec 31, 2025 (up slightly from 9.60% in 2024)
• ·Nonperforming Assets as % of Total Assets improved to 0.20% in 2025 from 0.50% in 2024
• ·Average Assets grew to $4.39B in 2025 from $4.27B in 2024
• ·Cash Dividends Per Share increased to $1.14 in 2025 from $1.09 in 2024

06-03-2026

Information Services Group Inc. reported total revenues of $244.7M for the year ended December 31, 2025, down 1% from $247.6M in 2024, with Americas up 1% to $160.9M but offset by declines in Europe (-3% to $65.5M) and Asia Pacific (-13% to $18.3M). Operating expenses fell 6% to $226.9M, driving net income higher to $9.3M from $2.8M and Adjusted EBITDA up 28% to $32.2M from $25.1M. Cash provided by operating activities improved to $29.0M from $19.9M.

• ·Adjusted net income increased to $16.5M from $9.97M YoY.
• ·Adjusted net income per diluted share rose to $0.33 from $0.20.
• ·Net cash used in investing activities was $4.9M in 2025 vs provided by $19.0M in 2024.
• ·Gain on sale of business declined 84% to $0.7M from $4.5M.
• ·Total other expense, net worsened to $(3.3M) from $(0.5M).

06-03-2026

On March 5, 2026, Lakeland Financial Corporation's board of directors amended its share repurchase program, increasing the total authorization from $30M to $60M for common stock repurchases until April 30, 2027. As of that date, approximately $34M remains available under the amended program. Repurchases may occur via open market, block trades, or private negotiations, though the program does not obligate any specific purchases and can be modified or suspended at any time.

• ·Repurchases authorized in open market, block trades, or privately negotiated transactions

06-03-2026

One Liberty Properties Inc (OLP) acquired 13 industrial properties for $188.8 million, including $112.3 million in mortgage debt, expected to generate $13.3 million in 2026 rental income and representing 15.1% of 2026 base rent. The company sold ten properties for $58.9 million in net proceeds with an $18.7 million gain, which accounted for a minor 2.4% of 2025 rental income (down from 5.0% in 2024), and two joint venture properties yielding a $2.4 million share of proceeds and $991,000 gain. Mortgage debt stands at $522.5 million with a stable 4.88% weighted average interest rate and 5.8-year remaining term.

• ·Pending sale of vacant retail property in Cary, North Carolina expected in March 2026 with $192K 2025 and $460K 2024 rental income, net.
• ·Pending sale of retail property in Newport News, Virginia expected in April 2026 with $360K 2025 and $340K 2024 rental income, net.
• ·Mortgage debt fixed rates range from 3.05% to 6.42% with prepayment penalties.
• ·Pending Cary property: $93K dep/amort and $45K mortgage interest in 2025; $93K dep/amort and $110K interest in 2024.
• ·Pending Newport News property: $115K dep/amort in 2025 and $113K in 2024.

06-03-2026

MacKenzie Realty Capital, Inc. (Nasdaq: MKZR) closed an additional $1 million loan agreement with Streeterville Capital, a division of Chicago Venture Partners, to purchase approximately $1,000,000 of CNL Healthcare Properties, Inc. (CHP) shares at $4.55 per share. CHP is expected to close a merger with SNDA this month, with shares receiving approximately $6.90 per share, positioning this as a profitable strategy per CEO Robert Dixon. The move aligns with the company's long-term approach to strengthen its balance sheet and cash flow through non-traded REIT shares.

• ·MacKenzie Realty Capital founded in 2013; intends to invest at least 80% of total assets in real property and up to 20% in illiquid real estate securities.
• ·Intended real property portfolio: approximately 50% multifamily and 50% boutique class A office.
• ·100% ownership of multifamily subsidiary MacKenzie Apartment Communities, Inc.

06-03-2026

Drilling Tools International Corp reported FY2025 revenue of $159.6M, up 3% YoY from $154.4M, driven by strong Eastern Hemisphere growth of 78% to $23.5M, however Western Hemisphere revenue declined 3% to $148.6M and total segment EBITDA fell 5% to $50.0M amid a 59% drop in Eastern EBITDA. The company swung to a net loss of $3.8M or $(0.11) per share from prior-year profit of $3.0M, with Adjusted EBITDA slightly down to $39.3M from $40.1M; balance sheet remained stable at $222.2M total assets while operating cash flow improved significantly to $19.9M.

• ·Cash decreased to $3.6M from $6.2M YoY.
• ·Operating cash flows surged to $19.9M from $6.1M due to working capital improvements.
• ·Goodwill impairment of $1.9M recorded in FY2025.
• ·Business combinations involved issuance of 888,041 shares valued at $2.9M.
• ·Purchase of treasury stock for $1.3M.

06-03-2026

Northrim Bancorp reported net income of $64.6M for 2025, surging 75% YoY from $37.0M in 2024, fueled by net interest income growth of 20% to $135.6M and other operating income jump of 84% to $77.2M, while assets expanded 8% to $3.29B and ROE rose to 21.7% from 14.7%. However, nonperforming loans increased to $11.3M (0.49% of portfolio) from $7.5M (0.35%), provision for credit losses rose 19% to $3.9M, and other operating expenses grew 16% to $122.1M. Dividend per share increased slightly to $0.64 from $0.62.

• ·Five-year compound growth rate for net income: 14%
• ·Tangible book value per share: $12.47 (2025) vs $9.79 (2024)
• ·Allowance for credit losses to portfolio loans stable at 1.03% (2025 and 2024)
• ·Total employees grew 3% over five years to 516 FTE
• ·Common shares outstanding five-year CAGR: -2%

06-03-2026

On March 3, 2026, Patrick Berard, a member of LKQ Corporation's Board of Directors, notified the company of his decision to decline nomination for re-election at the 2026 Annual Meeting of Stockholders, expected in May 2026. Mr. Berard will continue serving in his role until that meeting. No immediate changes to the board composition or operations are indicated.

• ·Filing signed on March 6, 2026
• ·LKQ Corporation incorporated in Delaware, IRS Employer Identification No. 36-4215970

06-03-2026

GAAP net income declined nearly 10% YoY to $23.4M in 2025 from $26.0M in 2024, primarily due to $7.9M in merger-related expenses from the Susquehanna acquisition, though adjusted net income rose 15% to $29.8M. Net interest income increased 16% to $91.9M driven by 7.3% average loan growth and 8.3% deposit growth, lifting NIM to 3.61% from 3.30%; however, noninterest expenses excluding merger costs rose 7.8% to $80.0M. GAAP EPS fell to $1.46 from $1.69, while adjusted EPS improved to $1.85.

• ·Average brokered deposits decreased $50.4M to $11.1M; average borrowed funds decreased $44.3M.
• ·Trust revenue increased $284k to $8.2M due to equity appreciation and estate fees.
• ·Other noninterest income up $407k to $5.6M including credit enhancement fees (+$117k), merchant services (+$66k).
• ·Debit card interchange revenue up $347k to $4.6M.
• ·Other noninterest expense up $1.2M to $11.5M.

06-03-2026

Columbia Financial Corp (CCFN) reported total assets of $1.625B as of Dec 31, 2025, up 2% from $1.593B in 2024, with net interest income rising 19.7% YoY to $61.8M (tax-equivalent) and net interest margin expanding to 4.08% from 3.46%. However, non-performing assets increased 18% to $12.0M (0.72% of total assets) from $10.1M (0.63%), with allowance coverage of non-performing assets declining to 83% from 97%. Stock prices showed upward trajectory with 2025 highs reaching $56.82 vs $44.00 in 2024 Q4.

• ·Non-accrual loans increased to $11.5M from $10.0M YoY.
• ·Loans past due 90 days or more rose to $135K from $0.
• ·Allowance for credit losses as % of gross loans declined to 0.85% from 0.88%.
• ·2025 Q4 stock high $56.82 (up from 2024 Q4 $44.00); dividends stable at ~$0.45/Q except Q2 $0.95.

06-03-2026

On March 6, 2026, CNL Healthcare Properties, Inc. held its Annual Meeting where shareholders approved the merger transactions under the November 4, 2025 Merger Agreement with Sonida Senior Living, Inc., with 90.4M votes for, 1.0M against, and 2.7M abstentions out of 175.3M outstanding shares (51.6% approval of entitled votes). All five director nominees received strong support with approximately 86M for votes each, though 1.5-1.8M against and 6.2-6.3M withheld per nominee. PricewaterhouseCoopers LLP was ratified as auditors with 89.5M for, 0.7M against, and 4.0M abstentions.

• ·Record date for voting eligibility: December 30, 2025
• ·Merger Agreement dated November 4, 2025
• ·Directors elected until 2027 Annual Meeting or merger consummation
• ·Auditor ratification for fiscal year ending December 31, 2025
• ·Adjourn proposal not presented due to sufficient merger votes

06-03-2026

Flushing Financial Corp's total mortgage loan portfolio declined 1.7% YoY to $5.23B at December 31, 2025, from $5.32B, while commercial business loans decreased 0.5% to $1.41B; however, CRE mortgage originations rose 30% to $211M and total commercial originations increased 33% to $273M. Non-performing loans rose 25% YoY to $42M (0.63% of gross loans) from $33M (0.49%), with non-performing assets up 15% to $59M (0.68% of total assets). Deposits experienced a net decrease of $97M in 2025 after prior growth, though total borrowings fell 47% to $485M.

• ·Mortgage loan charge-offs in 2025: $4.1M (up from $0.4M in 2024)
• ·Commercial business loan charge-offs in 2025: $7.3M (down slightly from $7.5M in 2024)
• ·Total securities available for sale fair value: $1.39B at end 2025 (down from $1.50B in 2024)
• ·FHLB-NY advances balance: $184M at end 2025 (down 71% from $629M in 2024)

06-03-2026

FIRST Community Bankshares Inc. reported net income of $48.8 million for 2025, down 5.45% from $51.6 million in 2024, with ROA declining to 1.52% from 1.60% and ROE to 9.64% from 10.03%; net interest income FTE fell slightly to $125.1 million while NIM remained nearly flat at 4.42% (down 0.02 percentage points). However, noninterest income rose 8.88% to an unspecified amount driven by service charges, credit quality improved with non-performing loans at 0.61% (down 0.22 percentage points) and lower net charge-offs, and adjusted net income declined modestly by 2.34% to $51.1 million. Noninterest expenses increased 8.01% due to higher salaries, merger costs for the Hometown acquisition (completed January 23, 2026), and other expenses.

• ·Merger-related expenses of $2.91 million in 2025 associated with Hometown acquisition completed January 23, 2026.
• ·Salaries and employee benefits increased $4.73 million YoY.
• ·Book value per share $27.30 on Dec 31, 2025, down $1.43 from 2024 due to special dividends totaling $3.07 per share.
• ·Average loans $2.35B in 2025 vs $2.48B in 2024.
• ·Loan-to-deposit ratio 88.81% on Dec 31, 2025.
• ·Return on average tangible common equity 13.92% for 2025.

06-03-2026

MOBIX Labs, Inc. is seeking shareholder approval at its annual meeting for the election of three Class II directors (David Aldrich, Frederick Goerner, and Keyvan Samini), ratification of PricewaterhouseCoopers LLP as independent auditors for FY2026, and authorization for a reverse stock split (1:10 to 1:50 ratio) to address Nasdaq minimum bid price noncompliance, with a compliance extension until April 27, 2026. Auditor fees declined 19.5% YoY to $1.56M in FY2025 (ended Sep 30, 2025) from $1.93M in FY2024, while all other fees remained flat at $2,000. The board recommends voting for all proposals amid ongoing efforts to maintain Nasdaq listing.

• ·Nasdaq noncompliance notice received April 28, 2025; initial 180-day compliance period ended October 27, 2025; extension granted to April 27, 2026.
• ·PWC has audited financial statements since 2022.
• ·Board structure: three classes with staggered three-year terms; Class B holders elect three Class B Directors (one per class).

06-03-2026

Starwood Real Estate Income Trust, Inc. (SREIT)'s Board unanimously recommends that stockholders reject a tender offer from Offerors to purchase up to 10,126,353 Class I shares at $15.00 per share (24.4% discount to $19.85 NAV) and up to 9,533,647 Class S shares at $14.30 per share (28.6% discount to $20.02 NAV), both as of January 31, 2026. The Board highlights the company's strong $22.5B portfolio of 598 income-producing properties at 93% occupancy and confidence in long-term value creation, while noting limited share repurchase capacity since December 2022 and correcting Offerors' false claim of over $2B in outstanding redemptions (actual ~$1B). Directors and executives do not intend to tender shares.

• ·No material agreements, arrangements, or conflicts of interest with Offerors.
• ·No transactions in shares by officers, directors, affiliates, or subsidiaries in the 60 days prior to filing.
• ·Company not engaged in negotiations for mergers, asset sales, or changes to distribution policy in response to the offer.

06-03-2026

Terex Corporation announced that Stephen Johnston will no longer serve as VP, Chief Accounting Officer, and Controller effective March 2, 2026, as part of ongoing integration following its merger with REV Group, Inc.; he will assist with transition and there was no disagreement on company matters. Joseph LaDue, 46, previously VP, Corporate Controller and Chief Accounting Officer at REV since December 2022, was appointed to the role on the same date with an annual base salary of $357,500, target incentive bonus of 40% of salary, and initial long-term incentive award of $139,000. No family relationships or material transactions involving LaDue were noted.

• ·Joseph LaDue served as VP, Corporate Controller and Chief Accounting Officer at REV since December 2022, in corporate controller roles at REV since 2018, and worked 13 years at KPMG LLP including as audit senior manager.
• ·Joseph LaDue is a certified public accountant.

06-03-2026

Great Southern Bancorp, Inc. reported net income of $71M for the year ended December 31, 2025, up 15% YoY from $62M in 2024, driven by a 6% increase in net interest income to $200M and no provision for credit losses on loans. However, total assets declined 6% YoY to $5.6B, net loans receivable fell 7% to $4.4B, and deposits decreased 3% to $4.5B amid higher interest expense pressures. Non-performing assets improved 15% to $8.1M (0.14% of average total assets), while foreclosed assets ticked up slightly to $6.0M.

• ·Tier 1 capital ratio for Great Southern Bancorp, Inc. at 14.1% as of Dec 31, 2025 (up from 12.8% in 2024).
• ·Efficiency ratio improved to 61.91% in 2025 from 64.40% in 2024.
• ·Subordinated debentures balance stable at $25.8M across 2023-2025.
• ·Average subordinated notes balance declined sharply to $34.1M in 2025 from $74.7M in 2024.

06-03-2026

The 2026 Proxy Statement for First Bancorp, Inc. (FNLC) details governance practices, including the Audit Committee's financial expertise led by independent Chair F. Stephen Ward, procedures for related party transactions exceeding $120,000 (none in 2025 except ordinary loans of $28.3M to directors/executives, or 1.21% of total loans), and no adopted written policy but established review processes. Director compensation from the Bank totaled $291,100 in 2025, with 54% reinvested via stock purchase plan and no fees paid to the Company for directorships. Executive officer bios highlight long tenures and recent promotions/appointments in 2025-2026.

• ·Director fees structure: Chair $44,600 annual; others $1,400 monthly retainer, $1,050 per board meeting, $700 per committee meeting.
• ·Code of Business Conduct and Ethics re-approved Sept 25, 2025; available on investor website.
• ·Internal audits outsourced except loan review; Bank regulated by OCC, FDIC, Federal Reserve.
• ·Ms. Kachmar joined Board Feb 2025; several executives promoted Feb 2025.

06-03-2026

NI Holdings reported direct written premiums of $289.8M for FY 2025, down 15.3% YoY, and net earned premiums of $270.7M, down 12.7% YoY, primarily due to strategic reductions in the Non-Standard Auto segment including exits from Illinois, South Dakota, and Arizona. The combined ratio deteriorated to 109.9% for the year (up 9.2 points YoY) and 109.6% for Q4 (up 29.6 points), driven by unfavorable reserve development, catastrophe losses exceeding $20M reinsurance retention in North Dakota, and increased liability claim severity, resulting in a FY net loss of $10.4M versus a prior-year loss of $6.1M. However, net investment income grew 6.9% YoY to $11.7M, supported by higher fixed income balances and favorable rates, while Home and Farm saw growth from new business and rate increases.

• ·Loss and LAE ratio increased 7.3 pts YoY to 74.2% for FY and 21.9 pts to 67.7% for Q4.
• ·Expense ratio up 1.9 pts YoY to 35.7% for FY and 7.7 pts to 41.9% for Q4.
• ·Return on average equity -4.3% for FY 2025 vs 2.8% prior year.
• ·Historic Q2 2025 catastrophe in North Dakota exceeded $20M reinsurance retention, triggering reinstatement premiums.
• ·Company conversion to stock form on March 13, 2017.

06-03-2026

Sezzle Inc. (SEZL) filed a Form 8-K on March 6, 2026, under Items 7.01 and 9.01, announcing that it may commence investor and analyst presentations using a new Investor Presentation (Exhibit 99.1) starting March 6, 2026. The presentation is furnished, not filed, and is intended to be considered alongside the company's SEC filings and public announcements, with no obligation to update. The filing was signed by CEO Charles Youakim.

• ·Registrant incorporated in Delaware, Commission File Number 001-41781, IRS Employer ID 81-0971660.
• ·Principal executive offices: 700 Nicollet Mall, Suite 640, Minneapolis, MN 55402; Telephone: +1 (651) 240 6001.
• ·Securities: Common Stock, par value $0.00001 per share, trading as SEZL.

06-03-2026

Cass Information Systems, Inc. filed its DEF 14A proxy statement on March 6, 2026, for the Annual Meeting of Shareholders on April 21, 2026, seeking approval to elect seven directors for one-year terms, an advisory vote on executive compensation, and ratification of KPMG LLP as the 2026 independent auditor. The record date is March 2, 2026, with 12,908,298 common shares outstanding entitled to vote. The filing includes standard disclosures on corporate governance, director compensation, executive compensation analysis, pay versus performance, and CEO pay ratio, with no reported changes in performance metrics.

• ·Annual Meeting location: The Bogey Club, 9266 Clayton Road, Saint Louis, Missouri 63124 at 8:00 a.m. local time
• ·Proxy materials and 2025 Form 10-K available at www.investorvote.com/cass and www.cassinfo.com
• ·Company address: 12444 Powerscourt Drive, Suite 550, St. Louis, Missouri, 63131

06-03-2026

Rackspace Technology reported FY2025 revenue of $2.69B, down 1.9% YoY from $2.74B, with gross profit declining 5.1% to $506M amid higher cost of revenue margin (81.1%), while SG&A expenses fell 14.2% to $607M and no goodwill or asset impairments occurred (vs. $735M and $20M in 2024). Net loss narrowed 73.7% to $226M, and Non-GAAP Operating Profit rose 19.4% to $126M, boosted by Public Cloud segment profit up 52.9% to $68M, but Private Cloud profit dropped 14.3% to $252M. Overall performance showed cost controls and segment divergence amid revenue contraction.

• ·Restructuring and transformation expenses: $32.3M in FY2025 (down from $58.5M in FY2024)
• ·Amortization of intangible assets: $146.9M in FY2025 (down from $154.1M in FY2024)
• ·Interest expense: $82.7M in FY2025 (down 15.6% from $98.0M in FY2024)
• ·Corporate functions segment loss improved to $(193.9)M in FY2025 from $(233.0)M in FY2024

06-03-2026

Columbia Financial, Inc. (CLBK) reported total loans receivable of $8.3B at December 31, 2025, up 4.7% YoY from $7.9B in 2024, supported by strong multifamily ($233M originated) and commercial real estate ($325M originated) loan growth. Average deposits increased 4.3% YoY to $8.2B with a reduced weighted average rate of 2.39% versus 2.56% in 2024; however, total securities fair value rose modestly 8.4% YoY to $1.5B amid declines in mortgage-backed securities amortized cost (flat) and certain originations like one-to-four family loans (down 4.2% to $118M). Borrowings showed mixed trends with FHLB advances end balance up 9.6% to $1.2B but maximum outstanding down 21.4% YoY.

• ·Multifamily loans: $1.68B (21.0% of gross loans) with 59.0% avg LTV and 1.59 DSCR at Dec 31, 2025.
• ·Investor Owned CRE total: $1.85B (23.1% of gross loans) with subcategories like Retail/Shopping centers $542M (1.57 DSCR).
• ·Equity compensation plans approved by stockholders: weighted avg exercise price $16.22.

06-03-2026

On March 2, 2026, HireQuest, Inc. entered into new employment agreements effective the same date with CEO Richard Hermanns (annual base salary $430,000, 25,000 restricted shares), CFO C. David R. Hartley (annual base salary $260,000, 10,000 restricted shares), and Chief Legal Officer John McAnnar (annual base salary $260,000, 10,000 restricted shares), each with an initial term through August 31, 2027. The agreements include performance-based bonuses tied to pre-tax income, Adjusted EBITDA growth, sales improvements, and other metrics, along with severance provisions up to 18 months base salary for the CEO and 6 months for others upon certain terminations. No financial performance metrics or period-over-period changes were reported.

• ·Employment agreements include 60 days' notice for termination without cause.
• ·Restricted shares vest 50% on second anniversary of March 2, 2026, and 6.25% per fiscal quarter for the next eight quarters.
• ·Hermanns severance without cause/good reason: 18 months base salary; Hartley/McAnnar: up to 6 months (1 month per year of service).
• ·Change of control triggers automatic 1-year extension and 150% base salary lump-sum severance if terminated.

06-03-2026

On March 2, 2026, James River Group Holdings, Inc. amended CEO Frank D’Orazio’s target short-term incentive plan award from 100% to 150% of his base salary and his target long-term incentive plan award from 100% to 200% of his base salary. The company also amended its Code of Conduct to enhance provisions on confidential information obligations and to clarify compliance with the Employee Handbook, with no waivers granted. These changes reflect enhanced executive compensation incentives alongside routine governance updates.

• ·Event reported date: March 2, 2026; Filing date: March 6, 2026
• ·Amended Code of Conduct filed as Exhibit 14.1 and available at https://jrvrgroup.com/our-group/governance/corporate-governance

06-03-2026

DATASEA INC. (DTSS) is holding a Special Meeting to vote on a proposed merger with its wholly-owned BVI subsidiary DIT, under which DATASEA will merge into DIT and cease to exist as a Nevada entity, with DIT surviving under BVI law; the Board unanimously recommends approval of both the Merger Proposal and Share Exchange Proposal. Upon effectiveness, 2,000,000 Common Stock shares held by each of Zhixin Liu and Fu Liu will convert to 2,000,000 Class B Ordinary Shares of DIT, while all other shares convert to Class A Ordinary Shares. As of the Record Date (March 4, 2026), there were 10,447,153 shares of Common Stock outstanding.

• ·Record Date: March 4, 2026
• ·Special Meeting check-in begins 9:30 am, starts at 10:00 am (specific date referenced as conformed period April 3, 2026)
• ·Annual Report on Form 10-K for fiscal year ended June 30, 2025 filed with SEC on September 26, 2025
• ·Voting requires majority of shares present and entitled to vote; abstentions treated as votes against, broker non-votes have no effect
• ·Vote tabulation by West Coast Stock Transfer, Inc.

06-03-2026

National Energy Services Reunited Corp. (NESR) reported total revenue of $1.32B for the year ended December 31, 2025, up 1.7% YoY from $1.30B in 2024, driven by 2.6% growth in the MENA segment to $1.32B. However, Rest of World revenue declined 57% YoY to $8.1M from $18.8M, reflecting underperformance outside core markets. The 10-K extensively details risks including oil price volatility, geopolitical instability in MENA, competitive pressures, and the company's transition from foreign private issuer status effective January 1, 2026.

• ·As of January 1, 2026, NESR is no longer a foreign private issuer and must comply with U.S. domestic issuer requirements under the Exchange Act and Nasdaq rules.
• ·Domestic (BVI) revenue remained at $0 across 2023-2025.
• ·Extensive risk disclosures include oil/gas price volatility, MENA geopolitical tensions (e.g., U.S.-Israel-Iran conflict), currency fluctuations, debt covenants, and ESG/climate pressures.

06-03-2026

On March 2, 2026, Michele Farmer voluntarily resigned as Chief Accounting Officer of Pacific Biosciences of California, Inc. (PACB) effective March 21, 2026, with no disagreements or severance, and CFO Jim R. Gibson will serve as principal accounting officer without compensation changes. On March 5, 2026, PACB entered a binding term sheet with Personal Genomics of Taiwan, Inc. (PGI) to settle litigation, gaining a worldwide royalty-free license to U.S. Patent No. 7,767,441 and a 5.5-year covenant not to sue, but requiring fixed payments of $8M in Q1 2026 and $5M annually in Q1 2027-2029 (potentially $7M in 2027 if 2026 revenue meets $165M/$180M thresholds). The settlement provides litigation certainty and supports growth but incurs significant cash outflows totaling $23M-$25M.

• ·Ms. Farmer’s resignation is not connected to any disagreement on operations, policies, or accounting practices.
• ·No arrangements or understandings between Mr. Gibson and others for his appointment as principal accounting officer.
• ·Information on Mr. Gibson incorporated from Proxy Statement filed April 23, 2025.
• ·Covenant not to sue runs with the patents and binds PGI’s successors and transferees.
• ·Settlement includes release of claims for damages prior to and during covenant term.

06-03-2026

Cantor Equity Partners II, Inc. (CEPT), a SPAC, reported total assets surging to $246.8M as of December 31, 2025 from $0.1M in 2024, driven by $246.6M in Trust Account investments post-IPO with 24M Class A shares subject to redemption at $10.43/share totaling $250.2M. Net income improved to $17.5k in 2025 from a $70.7k loss in 2024, boosted by $6.5M interest income, however operational losses widened dramatically to $1.85M from $70.7k amid $1.77M G&A costs, plus a $4.6M fair value loss on forward sale securities, resulting in shareholders' deficit expanding to $9.6M from $68k. Comprehensive income reached $155.6k including $138k unrealized gains on debt securities.

• ·Class B ordinary shares retroactively adjusted for 1M share capitalization on May 1, 2025.
• ·Weighted average Class A public shares: 15,846,575; Private placement: 382,959; Class B: 6M.
• ·Administrative expenses – related party: $79.7k in 2025 (none in 2024).

06-03-2026

Ardmore Shipping Corp's 20-F annual report highlights estimates of liquidity needs for 2026 and longer term to fund capital expenditures, acquisitions, refinancing, and general corporate activities. It discusses risks including adverse impacts from oil price declines potentially reducing growth opportunities and high debt levels limiting financing flexibility. The company emphasizes its low cost structure for operating expenses and overhead, with operations primarily under time charters, commercial pools, and spot charters where it bears vessel operating expenses.

• ·Filing date: March 06, 2026
• ·Vessel operating expenses include crewing, repairs and maintenance, insurance, stores, lube oils, communication expenses, and technical management fees

06-03-2026

IRADIMED CORP reported FY2025 revenue of $83.8M, up 14% YoY from $73.2M in FY2024, driven by strong U.S. growth (+16% to $70.6M) and devices revenue (+16% to $60.0M), including robust increases in MRI IV pumps (+19%) and Ferro Magnetic Detection Systems (+111%). However, international revenue grew modestly at 5% (to $13.3M, down to 16% of total), services revenue declined 4% to $3.9M, and gross margin remained flat at 77%. Operating expenses improved to 45.5% of revenue from 47.0%, boosting income from operations margin to 31.2% from 30.0% and net income margin to 26.8% from 26.3%.

• ·Research and development expenses declined to 3.5% of revenue from 3.9% YoY.
• ·General and administrative expenses improved to 21.2% of revenue from 21.8%.
• ·Sales and marketing expenses decreased to 20.8% of revenue from 21.3%.
• ·Other income, net declined to 2.6% of revenue from 3.2%.

06-03-2026

ArcBest provided preliminary Q1 2026 (Jan-Feb) operating trends under Regulation FD, with Asset-Based segment showing +1% YoY billed revenue/day QTD driven by +6% tonnage/day but offset by flat shipments/day, -1% revenue/shipment, and -5% revenue/CWT; Asset-Light segment reported +6% revenue/day and +13% shipments/day YoY but -7% revenue/shipment and purchased transportation at 87% of revenue. Expectations include Asset-Light non-GAAP operating income up to $2M (excluding $3M purchase accounting amortization) and Asset-Based operating ratio rising 100-200 bps sequentially versus historical 260 bps seasonality.

• ·January 2026 had 20.5 workdays vs 22.0 in January 2025, while February had 20.0 workdays both years.
• ·Asset-Based February tonnage/day +2% YoY driven by +2% weight/shipment, but revenue/CWT -2%.
• ·Asset-Light February shipments/day +12% YoY led by Managed, but revenue/shipment -3%.
• ·Asset-Based sequential from Jan to Feb: shipments/tonnage +1%, revenue/shipment +2%.
• ·Asset-Light sequential from Jan to Feb: revenue/day +10%, shipments +7%, revenue/shipment +3%.

06-03-2026

Agilent Technologies, Inc. announced on March 5, 2026, that Rodney Gonsalves, Vice President, Corporate Controller, and Principal Accounting Officer, will retire in January 2027, with the exact date to be determined later. The departure is not due to any disagreement on accounting practices, financial statements, internal controls, or operations. The advance notice provides time for a comprehensive search for a replacement and an orderly transition.

• ·Form 8-K filed on March 6, 2026, covering Items 5.02 and 9.01

06-03-2026

Rambus Inc. filed Definitive Additional Proxy Materials (DEFA14A) on March 06, 2026, pursuant to Section 14(a) of the Securities Exchange Act of 1934. The filing indicates no fee was required and serves as supplemental proxy information to prior materials. No specific proposals, financial data, or voting matters are detailed in the provided header.

• ·Filing categorized as Definitive Additional Materials
• ·Payment of Filing Fee: No fee required

06-03-2026

Unity Bancorp, Inc. (UNTY) filed definitive additional proxy materials (DEFA14A) for its 2026 Annual Meeting of Shareholders on April 23, 2026, held virtually at 8:00 A.M. local time via meetnow.global/MCJW47X. The proxy solicits votes for the election of five director nominees (George Boyan, Wayne Courtright, David D. Dallas, Robert H. Dallas, Peter E. Maricondo) and ratification of Wolf & Company, P.C. as independent auditors for the year ending December 31, 2026, with the Board recommending FOR all proposals. No financial performance data or period comparisons are included in the materials.

• ·Proxy holders: James A. Hughes and George Boyan
• ·Voting options: Online at www.investorvote.com/UNTY, phone 1-800-652-VOTE (8683), or mail

06-03-2026

On March 4, 2026, the Compensation Committee of FibroBiologics, Inc. approved a new annual base salary of $400,000 for Chief Financial Officer Jason D. Davis, effective January 1, 2026. Mr. Davis' target annual non-equity incentive compensation remains unchanged at 40% of base salary. No other officer changes or departures were reported.

• ·Filing Date: March 6, 2026
• ·Date of Earliest Event: March 4, 2026
• ·Salary Effective Date: January 1, 2026

06-03-2026

Offerpad Solutions Inc. was notified by the NYSE on March 3, 2026, of non-compliance with Section 802.01C of the NYSE Listed Company Manual, as the average closing price of its Class A common stock (OPAD) was below $1.00 over a consecutive 30 trading-day period, triggering a potential delisting risk. The company stated its intent to cure the deficiency within a six-month period, potentially through a reverse stock split requiring stockholder approval at its next annual meeting, while its stock continues to trade on the NYSE subject to other listing standards. No immediate delisting will occur, but failure to regain compliance could lead to transfer to a lower market tier.

• ·Cure period: six months from March 3, 2026
• ·Compliance cure condition: closing share price of at least $1.00 and average of $1.00 over 30 trading days ending last day of any month during cure period
• ·Press release issued March 6, 2026 (Exhibit 99.1)
• ·Recent 10-K filed February 24, 2026, for year ended December 31, 2025

06-03-2026

Presurance Holdings, Inc. received a Nasdaq notice on March 3, 2026, stating non-compliance with the minimum bid price requirement under Rule 5550(a)(2), as its common stock (PRHI) closed below $1.00 per share for 30 consecutive business days. The company has 180 calendar days until August 31, 2026, to regain compliance by closing at or above $1.00 for 10 consecutive business days, potentially via a reverse stock split approved by shareholders in June 2025. Failure to comply risks delisting, with no assurance of success despite available options.

• ·Nasdaq Marketplace Rule 5550(a)(2) violated; Rule 5810(c)(3)(A) provides initial 180-day cure period.
• ·Board has authority to effect reverse stock split until June 3, 2026, if deemed in shareholders' best interests.
• ·Eligibility for second 180-day period requires meeting other Nasdaq Capital Market initial listing standards except bid price.

06-03-2026

Xanadu Quantum Technologies Inc. is pursuing a business combination with Crane Harbor Acquisition Corp. (Nasdaq: CHAC), forming NewCo with approximately $500M in gross proceeds ($225M from Crane Harbor’s trust assuming no redemptions, $275M from PIPE investors), expected to list on Nasdaq and TSX. The special shareholder meeting is scheduled for March 19, 2026, after the Registration Statement was declared effective on February 27, 2026. However, forward-looking statements highlight risks including potential redemptions reducing cash, historical net losses, limited operating history, and substantial doubt about Xanadu’s ability to continue as a going concern.

• ·Xanadu founded in 2016.
• ·Registration Statement on Form F-4 publicly filed and declared effective by SEC on February 27, 2026.
• ·Definitive proxy statement/prospectus mailed to Crane Harbor shareholders as of the record date.

06-03-2026

Amphastar Pharmaceuticals, Inc. entered into new executive employment agreements effective March 3, 2026, with existing executives Jacob Liawatidewi (EVP of Corporate Administration Center, Secretary, and board member) at an annual base salary of $525,800 and target bonus of 55% of base, and Rong Zhou (Senior EVP of Production Center) at $590,000 base and 53% target bonus. Agreements provide for 1-year initial terms with auto-renewal, at-will termination, and severance of 2x (highest base + average of prior two years' bonuses) plus 12 months health benefits and full equity vesting acceleration upon qualifying termination; enhanced severance applies post-change in control. No performance metrics or financial impacts from the agreements are disclosed.

• ·90 days advance notice required for non-renewal of agreements.
• ·Severance conditioned on execution of release; includes prorated bonus and prior year accrued bonus on certain terminations.
• ·100% equity vesting acceleration immediately prior to change in control.
• ·Section 280G parachute payment provisions to maximize after-tax benefits.

06-03-2026

Gran Tierra Energy Inc. announced the final results of its exchange offer, with $648.457M (90.52%) of its $716.34M outstanding 9.500% Senior Secured Amortizing Notes due 2029 tendered for new 9.750% Senior Secured Amortizing Notes due 2031. The company accepted $628.701M aggregate principal of existing notes for exchange, issuing $503.57M in new notes, achieving high participation but leaving $87.639M (12.23%) of existing notes outstanding after excluding $19.756M due to minimum denomination requirements. This extends maturities for most debt but at a slightly higher coupon rate.

• ·Early Participation Deadline: February 11, 2026 (5:00 p.m. New York City time)
• ·Expiration Deadline: February 27, 2026 (5:00 p.m. New York City time)
• ·Early Settlement Date: February 18, 2026
• ·Final Settlement Date: March 2, 2026
• ·Minimum denomination for New Notes: $200,000

06-03-2026

Tvardi Therapeutics, Inc. announced June 9, 2026, as the date for its 2026 Annual Meeting of Stockholders. Stockholder proposals under Rule 14a-8 must be received by March 16, 2026, to be included in the proxy materials, while advance notices for director nominations and other matters per the Bylaws are due by the same date, and Rule 14a-19 notices by April 10, 2026.

• ·Principal executive offices: 3 Sugar Creek Ctr. Blvd. Suite 525, Sugar Land, Texas 77478
• ·Registrant's telephone number: (713) 489-8654
• ·Common Stock: par value $0.001 per share, trading symbol TVRD

06-03-2026

Black Spade Acquisition III Co, a SPAC incepted on August 21, 2025, reported total assets of $3.7M as of December 31, 2025, driven by $3.3M in cash, but offset by $3.7M in liabilities including $3.3M in related party advances. The company incurred a net loss of $86k from general and administrative costs, leading to a shareholders' deficit of $61k despite issuing 5.75M Class B ordinary shares for $25k. No Class A shares are issued, and operations remain pre-business combination with ongoing offering costs.

• ·Basic and diluted net loss per Class B ordinary share: $0.02
• ·Accrued offering costs: $282k
• ·Accrued expenses: $43k
• ·Deferred offering costs: $384k
• ·Audited by PCAOB ID#100 firm

06-03-2026

Streamex Corp. (NASDAQ: STEX) announced the appointment of Shawn Matthews, former CEO of Cantor Fitzgerald & Co. (2009-April 2018) and Founder/CIO of Hondius Capital Management, as an independent director to its Board of Directors, effective around March 3, 2026. Matthews brings over 30 years of global investment, trading, and executive leadership experience to support the company's strategic growth, capital markets initiatives, and governance in tokenization and digital asset infrastructure. Morgan Lekstrom, Co-Founder & Executive Chairman, praised Matthews' expertise in capital markets and institutional investing.

• ·Shawn Matthews served as CEO of Cantor Fitzgerald & Co. from 2009 through April 2018.
• ·Matthews holds a Bachelor of Science in Finance from Fairfield University and an MBA from Hofstra University.
• ·Press release issued March 03, 2026; SEC 8-K filed March 06, 2026.

06-03-2026

Harvard Bioscience, Inc. (HBIO) held a Special Meeting of Stockholders on March 6, 2026, with 27,715,066 shares present (61.97% quorum), overwhelmingly approving a reverse stock split proposal (27,004,721 FOR vs. 677,700 AGAINST). The Board selected a 1-for-10 ratio, effective 4:30 p.m. ET on March 13, 2026, reducing outstanding common shares from 44,179,894 to approximately 4,471,989 while authorized shares remain at 80,000,000. The adjournment proposal was also approved (26,970,042 FOR), and split-adjusted trading under HBIO begins March 16, 2026, with a new CUSIP.

• ·Record date: January 21, 2026
• ·Proxy statement filed: January 30, 2026
• ·Adjournment Proposal votes: 26,970,042 FOR, 630,369 AGAINST, 114,655 ABSTAIN
• ·No fractional shares issued; cash payment from aggregated sale proceeds
• ·New CUSIP post-split: 416906204

06-03-2026

Total revenue slightly declined 0.6% YoY to $17.3M in 2025 from $17.4M, with software licenses down 4.4% to $7.3M while software maintenance rose 1.6% to $8.7M and services increased 9% to $1.3M. Net loss widened 32.5% to $5.9M (-34% of revenue) from $4.4M (-25%), as total costs and expenses rose to 138% of revenue from 133%, leading to a larger operating loss of $6.6M. Cash and equivalents fell sharply 44% to $7.3M from $13.0M, with operating cash use doubling to $5.4M.

• ·Net cash used in operating activities increased to $5.4M from $3.2M YoY.
• ·Marketable securities slightly increased to $15.0M from $14.8M.
• ·Research and development expense rose to $8.3M from $7.8M.
• ·Stock repurchases totaled $115K in 2025 vs $207K in 2024.
• ·Intangible assets declined to $1.6M from $2.0M.

06-03-2026

Sonic Automotive, Inc. (SAH) filed Definitive Additional Proxy Materials (DEFA14A) on March 06, 2026, pursuant to Section 14(a) of the Securities Exchange Act of 1934. The filing, marked as soliciting material under §240.14a-12, was submitted by the registrant with no fee required. No specific proposals, financial data, or substantive details are provided in the filing header.

06-03-2026

Velo3D, Inc. amended its January 2025 Senior Secured Convertible Note ($5M principal, now held by Arrayed Notes Acquisition Corp., controlled by CEO Arun Jeldi) to allow optional conversion of principal and accrued interest into common stock, following prior amendments extending maturity to February 14, 2027, and reducing interest to 12% per annum. The February 2025 Senior Secured Convertible Note ($10M principal, held by Thieneman Construction, Inc., controlled by director Kenneth Thieneman) was also amended to permit conversion of accrued interest into common stock, with the same prior maturity extension and interest rate reduction. No changes to principal amounts or other core terms were reported.

• ·January 2025 Note prior conversion price: $16.38 per share
• ·February 2025 Note prior conversion price: $10.50 per share
• ·Both notes maturity date extended to February 14, 2027 (prior amendment)
• ·Amendments dated March 4, 2026; filing dated March 6, 2026

06-03-2026

Banc of California, Inc. filed a new universal shelf registration statement on Form S-3 (File No. 333-293930) on March 2, 2026, which became effective immediately and replaced the prior 2023 shelf registration (File No. 333-270328). On March 6, 2026, the Company filed a prospectus supplement for the resale of shares of its voting common stock by certain selling stockholders, as required by the Registration Rights Agreement dated November 30, 2023. A legal opinion from Silver, Freedman, Taff & Tiernan LLP was included as Exhibit 5.1.

• ·2023 Registration Statement filed March 7, 2023 (File No. 333-270328)
• ·Prior prospectus supplement filed March 1, 2024 under 2023 Registration Statement
• ·Registration Rights Agreement dated November 30, 2023

06-03-2026

Athena Bitcoin's global Bitcoin ATM deployments declined 5% YoY from 3,111 in 2024 to 2,953 in 2025, while the overall ATM market grew modestly from 37.7 thousand to 39.2 thousand machines, with Australia showing the strongest regional growth at 43%. Global cryptocurrency owners rose 12.4% YoY to 741 million in 2025, driven by Ethereum owners (+22.6% to 175 million), though Bitcoin owners grew more slowly at 8.3% to 365 million.

• ·Athena Bitcoin, Inc. owns 99% of Athena Holdings El Salvador S.A. de C.V. (Eric Gravengaard holds 1% on behalf of company).
• ·Athena Bitcoin, Inc. beneficially owns Athena Holdings Colombia SAS (nominally Eric Gravengaard 95%, Matias Goldenhörn 5%).
• ·Australia added 600 Bitcoin ATMs (fastest growth).
• ·Potential 300,000 to 1.2 million additional people invested in BTC via US spot ETFs.
• ·Historical Athena Bitcoin ATMs: 65 (2017), 445 (2022), 1,829 (2023).

06-03-2026

Cencora, Inc. held its 2026 Annual Meeting of Shareholders on March 5, 2026, electing all eleven director nominees with strong majorities (For votes ranging from 163.3M to 168.5M, representing 97-99% approval, though Lon R. Greenberg faced the highest opposition at 5.3M Against votes). Shareholders approved on an advisory basis the fiscal 2025 named executive officer compensation (156.9M For, 93% approval) and ratified Ernst & Young LLP as independent auditors for fiscal 2026 (165.7M For, 93% approval). All proposals passed decisively despite some notable opposition levels of 3-7%.

• ·Proxy statement filed with SEC on January 22, 2026
• ·Fiscal year 2025 ended September 30, 2025
• ·Broker non-votes: 9,738,568 for Items 1 and 2

06-03-2026

Vine Hill Capital Investment Corp., a SPAC, is seeking shareholder approval for a business combination involving a merger with Odysseus (Cayman) Limited and acquisition of CoinShares International Limited via a $1.2B equity value Scheme of Arrangement, resulting in CoinShares becoming the primary subsidiary of renamed Holdco (CoinShares PLC). A $50M PIPE investment from an institutional investor provides 6,666,667 Holdco shares, supporting the deal. However, pro forma ownership for Vine Hill public shareholders ranges from 14.3% (no redemption) to 0% (maximum redemption), highlighting significant dilution risk from potential redemptions totaling up to $231.5M at ~$10.52 per share.

• ·Business Combination Agreement dated September 8, 2025.
• ·PIPE Investor holds 1,967,329 Vine Hill Class A Shares as of most recent Schedule 13G.
• ·CoinShares Options: 723,038 Holdco Ordinary Shares underlying assumed options (excluded from pro forma table).
• ·Redemption price estimate: $10.52 per share based on Trust Account as of September 30, 2025.
• ·Holdco to list Ordinary Shares on Nasdaq under 'CS' and Warrants under TBD symbol.

06-03-2026

Modular Medical, Inc. (MODD) announced the pricing of a $12.0 million public offering of 68,098,000 shares of common stock (or pre-funded warrants) and accompanying warrants at $0.1762 per share, priced at a premium to market. The warrants are exercisable immediately at $0.1762 and expire in five years, with gross proceeds expected before fees and expenses. Closing is anticipated on or about March 4, 2026, with Maxim Group LLC as sole placement agent.

• ·Warrants exercisable immediately upon issuance and expire five years from issuance date.
• ·Offering pursuant to effective S-1 registration statement (File No. 333-293842) declared effective March 3, 2026.
• ·SEC filing date: March 06, 2026; Press release date: March 3, 2026.

06-03-2026

On March 4, 2026, InTest Corporation's Compensation Committee maintained base salaries flat at 2025 levels of $428,915 for CEO Richard N. Grant, Jr. and $282,500 for CFO Duncan Gilmour. The Committee set 2026 short-term bonus targets at 85% of base for the CEO and 65% for the CFO (ranging from zero to exceeding targets), and approved long-term incentive awards with grant-date fair values of $600,000 for the CEO and $250,000 for the CFO, allocated equally to time-vesting RSUs, performance-vesting RSUs, and stock options.

• ·Long-term incentives allocated equally to: 4-year time-vesting RSUs, 3-year performance-vesting RSUs (metric: enterprise value as of Dec 31, 2028), and 4-year vesting stock options
• ·Equity grant date: close of business on second business day after 2025 fiscal year 10-K filing
• ·All awards subject to standard award agreements filed with SEC

06-03-2026

Borealis Foods Inc. received a Nasdaq letter on March 2, 2026, accepting its compliance plan and granting a one-month extension until May 31, 2026, to hold its overdue annual shareholders' meeting required under Listing Rule 5620(a), following an initial non-compliance notice on January 12, 2026. The delay is attributed to the company's challenging financial condition, which has hindered its ability to convene the meeting. While the company intends to regain compliance, failure to do so risks a delisting notice and potential appeal process.

• ·Previous 8-K disclosure of non-compliance: January 16, 2026
• ·Company fiscal year end: December 31
• ·Securities listed: Common Shares (BRLS), Warrants (BRLSW) on Nasdaq Capital Market
• ·Former name: Oxus Acquisition Corp. (name change: March 23, 2021)

06-03-2026

On March 3, 2026, Valmont Industries, Inc. dismissed Deloitte & Touche LLP as its independent registered public accounting firm and appointed KPMG LLP for the fiscal year ending December 26, 2026, following Audit Committee approval. There were no disagreements, reportable events, or prior consultations with KPMG during fiscal years ended December 27, 2025, and December 28, 2024, and Deloitte's audit reports for those years were unqualified. Deloitte provided a concurring letter as Exhibit 16.1.

• ·Appointment of KPMG subject to completion of client acceptance procedures and execution of engagement letter.
• ·Deloitte's letter dated March 5, 2026, filed as Exhibit 16.1.

06-03-2026

On March 5, 2026, Jaguar Health, Inc. received a Nasdaq notice of non-compliance with Listing Rule 5550(a)(2) due to its common stock (JAGX) bid price closing below the $1.00 minimum for 30 consecutive business days. The company is ineligible for a compliance period under Rule 5810(c)(3)(A)(iv) because of prior reverse stock splits with a cumulative ratio of 250:1 or more. Jaguar intends to appeal by March 12, 2026, but there is no assurance of success or regaining compliance.

• ·Nasdaq Listing Rule 5550(a)(2): minimum $1.00 bid price requirement.
• ·Nasdaq Listing Rule 5810(c)(3)(A)(iv): ineligibility for compliance period due to reverse stock splits with cumulative ratio of 250 shares or more to one over prior two-year period.
• ·Appeal request due by March 12, 2026; timely appeal stays delisting pending hearing.

06-03-2026

Workday, Inc. granted new CEO Aneel Bhusri, its co-founder and former Executive Chair, equity awards under the 2022 Equity Incentive Plan on March 5, 2026: a time-based RSU for 437,602 shares vesting over four years and a performance-based PVU award for 547,003 shares across four tranches tied to stock price hurdles of 25% ($171.39), 50% ($205.67), 75% ($239.94), and 100% ($274.22) increases from the baseline over five years. Mr. Bhusri will not receive additional equity awards until fiscal 2028. The awards include vesting acceleration provisions under the Executive Severance and Change in Control Policy.

• ·Bhusri RSU vests 1/4 on one-year anniversary of March 5, 2026, then 1/16 quarterly thereafter.
• ·PVU Tranches vest 1/20 quarterly over 20 quarters if price hurdles achieved, with two-year holding period on vested shares.
• ·PVU testing monthly using 45-day trailing simple moving average vs. 10-day baseline ending March 5, 2026.
• ·Earlier unachieved Tranches 1/2 may carry forward if later hurdles met.

06-03-2026

Quanex Building Products reported Q1 FY2026 net sales of $409.1M, up 2.3% YoY from $400.0M, with operating income of $2.9M versus a $7.0M loss prior year, aided by no restructuring charges. Hardware Solutions (+2.4%) and Custom Solutions (+4.8%) grew, but Extruded Solutions remained flat at $139.8M, the company posted a $4.1M net loss (improved from $14.9M), operating cash use worsened to $20.2M from $12.5M, inventories rose 6.5% to $270.6M, and total debt increased to $707.2M.

• ·Dividends paid $0.08 per share in both periods, totaling $3.7M in Q1 FY2026.
• ·Foreign currency translation gain of $11.1M drove comprehensive income to $7.0M from $30.8M loss YoY.
• ·Capital expenditures $11.3M in Q1 FY2026, similar to $11.6M prior year.
• ·Allowance for credit losses $2.5M as of Jan 31, 2026.

06-03-2026

On March 2, 2026, Miller Industries' Compensation Committee approved the Second Amended and Restated Severance Protection Plan, eliminating the prior 'single-trigger' change in control severance benefits and limiting payouts to qualifying terminations only. The Committee also reallocated the 2025 Executive Officer Annual Bonus Plan pool, increasing shares for CFO (14% to 16%) and others while removing the Chief Manufacturing Officer allocation, and adopted a new Amended Bonus Plan for 2026 with tiered pools (10-14% of pretax income over $20M) split between cash and RSUs. These changes align executive incentives more closely with performance but introduce stricter eligibility and vesting conditions.

• ·RSU grants under Amended Bonus Plan: half time-based (3-year graded vesting), half performance-based (0-200% cliff vesting after 3 years).
• ·Bonus eligibility requires employment at payment/grant time; subject to recoupment policy.
• ·Compensation Committee can adjust Pretax Income for non-recurring items, currency, etc.

06-03-2026

On March 4, 2026, Funko, Inc. and its subsidiary Funko UK, Ltd. entered into a Letter Agreement amending Andrew Oddie's Service Agreement dated May 12, 2022 (as previously modified), changing his title to Chief International Officer, eliminating his U.S. residency requirement for employment, and removing certain relocation terms while keeping his compensation otherwise unchanged. The amendment does not indicate any departure or new appointment but adjusts existing terms. Full details are in Exhibit 10.1.

• ·Original Service Agreement dated May 12, 2022, modified by letters dated May 1, 2024 and September 9, 2024.
• ·Filing signed on March 6, 2026.

06-03-2026

Core Scientific, Inc. (Nasdaq: CORZ) completed the initial closing of a $500M 364-day loan facility from Morgan Stanley, with an accordion feature allowing expansion up to $1B total commitments, subject to conditions. The facility bears interest at SOFR + 2.50% and proceeds will fund data center development, including equipment purchases and energy procurement. CEO Adam Sullivan highlighted that it strengthens liquidity and financial flexibility to accelerate project timelines.

• ·Facility term: 364 days
• ·Expected use of proceeds: general corporate purposes for data center assets, including equipment costs, pre-development, real property acquisition, and energy procurement agreements
• ·Transition strategy: converting facilities from digital asset mining to AI-related workloads and next-generation colocation

06-03-2026

Salesforce, Inc. announced that Robin Washington, its Chief Operating and Financial Officer, will assume the additional role of principal accounting officer effective March 9, 2026, as part of an internal finance reorganization. She will receive no compensation adjustment for this role. Sundeep Reddy will remain as Chief Accounting Officer.

• ·Announcement part of internal finance reorganization
• ·Washington's biographical information disclosed in Proxy Statement for 2025 Annual Meeting of Stockholders
• ·No arrangements or understandings with other persons for selection as PAO
• ·No family relationships with directors or executive officers
• ·No direct or indirect material interest in transactions per Item 404(a) of Regulation S-K

06-03-2026

Nathan’s Famous, Inc. has filed a preliminary proxy statement (PREM14A) for a special virtual stockholder meeting in 2026 to approve the Merger Proposal, a non-binding Compensation Advisory Proposal, and an Adjournment Proposal, with the Board unanimously recommending votes 'FOR' all items and directors/executives subject to a Voting Agreement supporting the merger. The merger, if approved, is expected to close in the first half of 2026, with appraisal rights available under DGCL Section 262 for dissenting stockholders. As of December 28, 2025, the company operated 225 restaurant locations, including 113 franchised.

• ·Special Meeting to be held virtually via audio webcast; record date [•], 2026.
• ·Merger requires majority of outstanding shares; abstentions/broker non-votes count as 'AGAINST'.
• ·Proxy solicitation expenses borne by company; no additional compensation to directors/officers/employees.

06-03-2026

CDT Equity Inc. seeks stockholder approval for three proposals: issuance of shares under an Equity Line of Credit (ELOC) Purchase Agreement dated January 16, 2026, potentially raising up to $25M but resulting in up to 80% dilution of outstanding common stock; issuance of up to 109,978,918 shares upon exercise of pre-funded warrants issued February 19, 2026, as part of acquiring 20% of Sarborg Limited for 598,006 shares and $8M deferred cash; and one or more reverse stock splits (1-for-2 to 1-for-100, aggregate up to 1-for-250) to avoid Nasdaq delisting due to low stock price. While these enable capital raising and strategic acquisition, they pose material dilution risks to existing stockholders' ownership and voting power, potentially impacting stock price and earnings per share.

• ·ELOC shares priced at $1.42 (closing price on January 16, 2026) without 9.99% ownership limit
• ·February Pre-Funded Warrants exercise price of $0.0001 per share
• ·Proposals require majority of votes cast at Special Meeting; Board recommends FOR all
• ·Reverse stock split authorized shares unchanged; Board discretion to abandon

06-03-2026

For the three months ended January 31, 2026, Cooper Companies reported net sales of $1,024.1M, up 6.2% YoY from $964.7M, driven by higher volumes, while operating income rose 16.9% to $212.8M and net income increased 25.4% to $130.8M with diluted EPS of $0.66. However, cost of sales grew 8.1% YoY to $328.9M and SG&A expenses were nearly flat at $390.2M, up 0.6%. Comprehensive income surged to $203.3M from $35.6M, boosted by a $76.5M foreign currency translation gain versus a $66.7M loss prior year.

• ·Net cash provided by operating activities increased 36.9% YoY to $260.9M from $190.6M.
• ·Cash flows from investing activities used $102.9M, up slightly from $96.8M YoY, mainly due to higher PP&E purchases.
• ·Financing activities used $147.9M net cash, including $92.5M stock repurchase and net debt changes.
• ·Allowance for credit losses on receivables: $58.7M at Jan 31, 2026 (up from $51.9M at Oct 31, 2025).
• ·Total inventories breakdown: Raw materials $180.0M (down from $193.1M QoQ), Finished goods $672.3M (up from $633.0M).

06-03-2026

Bridger Aerospace Group Holdings, Inc. reported FY2025 revenues of $122.8M, up 25% YoY from $98.6M, with strong growth in aerial surveillance (+33%), MRO (+54%), and fire suppression (+20%), though other services declined 16%. The company achieved net income of $4.1M, reversing a $15.6M loss, with Adjusted EBITDA up 21% to $45.3M from $37.3M; however, SG&A expenses were flat at up 1%, cash and equivalents fell to $31.4M from $39.3M due to investing outflows, and loss attributable to common stockholders improved to $22.9M but remained negative with EPS of -$0.42.

• ·Net cash provided by operating activities increased to $16.7M in FY2025 from $9.4M in FY2024.
• ·Net cash used in investing activities was $34.4M in FY2025 vs provided $2.1M in FY2024.
• ·Total liabilities rose to $265.6M as of Dec 31, 2025 from $237.3M.
• ·Stockholders’ deficit widened to $342.6M from $326.7M.
• ·Revenues from Spain grew 39% YoY to $14.0M, while US revenues up 23% to $108.8M.

06-03-2026

Kratos Defense & Security Solutions, Inc. completed its acquisition of Orbit Technologies Ltd. on March 2, 2026, via a merger, acquiring 100% of Orbit's ordinary shares for approximately $352.7 million in cash funded from its balance sheet, at $13.725 per share. Orbit, previously publicly traded on the Tel Aviv Stock Exchange, is now an indirect wholly owned subsidiary of Kratos. No financial impacts or performance metrics were disclosed in this filing.

• ·Merger Agreement dated November 4, 2025, previously disclosed in 8-K filed November 7, 2025
• ·Orbit ordinary shares delisted from Tel Aviv Stock Exchange post-merger
• ·All outstanding Orbit options fully vested and canceled for cash payment based on Merger Consideration

06-03-2026

Auddia Inc. reported zero revenue for the year ended December 31, 2025, flat at $0 YoY amid ongoing development of faidr and Discovr Radio platforms. Total operating expenses declined 2.8% to $7.7M, with improvements in sales and marketing (-3.6%), general and administrative (-27.4%), and depreciation (-21.6%), but offset by a new $1.15M restructuring charge and 12.2% higher R&D spending. Net loss narrowed 11.8% to $7.7M YoY; however, cash used in operations increased to $5.6M, auditors expressed substantial going concern doubts, and the company anticipates needing additional funding.

• ·Cash from investing activities improved to cash used of $0.88M from $1.0M YoY.
• ·Net change in cash was positive $0.48M in 2025 vs $1.9M in 2024.
• ·Auditors expressed substantial doubt about going concern due to recurring losses and need for additional capital.
• ·Material weaknesses identified in internal controls over financial reporting in the past.

06-03-2026

GigCapital7 Corp., a blank check company (SPAC), filed its 10-K for FY ended December 31, 2025, reporting no operating revenues or significant operations to date, with activities focused on its pending business combination with Hadron Energy, Inc. via a merger agreement dated September 27, 2025 (amended December 12, 2025). The company completed its IPO on August 30, 2024, raising $200M placed in trust, while Class A shares held by non-affiliates had a market value of $207.6M at the end of Q2 2025; as of March 5, 2026, 20M Class A ordinary shares and 13,333,333 Class B ordinary shares were outstanding.

• ·Sponsor holds 9,932,246 Founder Shares as of filing date.
• ·IPO registration statement effective August 28, 2024.
• ·Completion Window: 21 months from IPO closing (through approximately May 2026).
• ·GigCapital7 classified as a shell company and emerging growth company.

06-03-2026

HBT Financial, Inc. reported net income of $77M for the year ended December 31, 2025, up 7.3% YoY from $72M, supported by net interest income growth of 5.3% to $199M and noninterest income increase of 7.4% to $38M. However, noninterest expenses rose 4.4% to $129M, return on average stockholders' equity declined to 13.24% from 13.93%, and average loans grew only 1.3% while ending loans were flat at $3.46B. Total assets expanded modestly 0.8% to $5.07B with deposits up 0.9% to $4.36B.

• ·Provision for credit losses remained low at $3.2M in 2025, similar to $3.0M in 2024.
• ·Efficiency ratio improved slightly to 53.44% from 53.99%.
• ·Cost of total deposits declined to 1.19% from 1.30%.
• ·Card income declined 2.4% YoY to $10.8M; mortgage servicing down 7.3% to $4.1M.

06-03-2026

O’Reilly Automotive, Inc. entered into an Underwriting Agreement on March 5, 2026, with BofA Securities, Inc., J.P. Morgan Securities LLC, and Wells Fargo Securities, LLC as representatives of the underwriters for the issuance and sale of $850M aggregate principal amount of 5.100% Senior Notes due 2036. Estimated net proceeds of approximately $841M will be used to repay outstanding 3.550% senior notes due 2026 at maturity, repay a portion of commercial paper borrowings, and for general corporate purposes including working capital, share repurchases, acquisitions, and related fees.

• ·Underwriting Agreement includes customary representations, warranties, covenants, and indemnification of underwriters against certain liabilities.
• ·Common stock ($0.01 par value) trades on NASDAQ Global Select Market under symbol ORLY.

06-03-2026

NVIDIA Corporation's Compensation Committee adopted the Variable Compensation Plan for Fiscal Year 2027 on March 2, 2026, providing eligible executive officers with variable cash payments based on FY2027 revenue performance goals at threshold, base, and stretch levels. CEO Jen-Hsun Huang has a base target award of $4M (200% of FY2027 base salary), while Colette M. Kress, Ajay K. Puri, Debora Shoquist, and Timothy S. Teter each have $1.5M targets (150% of base salary). Eligibility requires continued employment through the payment date.

• ·Fiscal Year 2027 ends January 31, 2027
• ·Performance goals based on FY2027 revenue with threshold, base, and stretch compensation plan levels
• ·Filed as Exhibit 10.1

06-03-2026

Gaia, Inc. reported FY2025 net revenues of $99.0M, up 10.8% YoY from $89.3M, driven by steady quarterly growth and gross profit margin expansion to 87.1% from 86.1%. However, operating loss narrowed only modestly to $5.1M from $5.7M amid higher selling/operating expenses (+9.5%) and corporate/general/admin costs (+21%), with net loss nearly flat at $5.4M versus $5.4M prior year. Cash position strengthened significantly to $13.5M from $5.9M, supported by $12.1M in financing inflows, though operating cash flow declined 18.1% to $5.7M.

• ·Equity compensation plans (shareholder-approved): 2,273,791 outstanding options/warrants/rights at weighted average exercise price of $8.33; 424,645 securities available for future issuance.
• ·FY2025 corporate, general and administration expenses: $9.4M, up 21% YoY.
• ·Total liabilities: $52.5M as of Dec 31, 2025, up from $47.2M.
• ·Gaia, Inc. shareholders' equity: $87.9M as of Dec 31, 2025, up from $80.7M.

06-03-2026

Albemarle Corporation completed the sale of a controlling stake in Ketjen Corporation’s refining catalyst solutions business to KPS Capital Partners on March 2, 2026, retaining a minority stake and 100% ownership of Ketjen’s Performance Catalyst Solutions business. Combined with the January 2026 sale of its 50% interest in the Eurecat joint venture to Axens SA, Albemarle received $670M in pre-tax proceeds for debt reduction and general corporate purposes. The transaction strengthens portfolio focus and financial flexibility, with no declines or flat metrics reported.

• ·Goldman Sachs & Co. LLC acted as exclusive financial advisor and K&L Gates LLP as legal advisor to Albemarle.
• ·KPS has majority Board control and operational control of Ketjen.

06-03-2026

Krispy Kreme reported FY2025 net revenues of $1.52B, down 8.6% YoY from $1.67B, driven by U.S. declines of 13.8% and impacts from Insomnia Cookies divestiture, though International revenues grew 3.1% YoY to $535M. The company posted a significant net loss of $524M versus $4M profit in FY2024, primarily due to $356M goodwill impairment and $56M shop closure expenses, with Adjusted EBITDA falling 27.5% to $140M. Organic revenue declined 1.3% overall, with U.S. organic down 3.5% while International organic rose 3.3%.

• ·U.S. sales per Hub declined to $4.7M from $4.9M YoY.
• ·International sales per Hub declined to $9.7M from $9.9M YoY.
• ·Market Development revenues declined 14.9% YoY to $74M.
• ·Corporate expenses within Adjusted EBIT increased 9.3% to $76M.

06-03-2026

Stem, Inc. entered into an Open Market Sales Agreement with Jefferies LLC on March 6, 2026, establishing an at-the-market equity offering program for up to $30M in common stock shares. The company has no obligation to sell any shares and can suspend or terminate the program at any time, with Jefferies receiving a commission of up to 3.0% of gross proceeds. The offering utilizes a shelf registration statement (No. 333-291820) effective December 11, 2025, supplemented on March 6, 2026.

• ·Registration Statement on Form S-3 (No. 333-291820) declared effective by SEC on December 11, 2025
• ·Prospectus supplement filed with SEC on March 6, 2026
• ·Shares to be sold on NYSE or otherwise at prevailing market prices

06-03-2026

Cricut, Inc. (CRCT) filed Amendment No. 1 to its Form 10-K for the fiscal year ended December 31, 2025, on March 6, 2026, solely to revise Exhibits 32.1 and 32.2 containing CEO and CFO certifications pursuant to Section 906 of the Sarbanes-Oxley Act. No revisions were made to financial statements, disclosures, or other content, and the amendment does not reflect subsequent events. The aggregate market value of non-affiliate common stock as of June 30, 2025, was $333.4 million based on a $6.77 closing price.

• ·Closing market price of $6.77 per share used for non-affiliate market value calculation as of June 30, 2025
• ·Original 10-K filed on March 4, 2026

06-03-2026

Duke Energy Corporation entered into an Equity Distribution Agreement dated March 6, 2026, authorizing the issuance and sale of common stock (par value $0.001 per share) with an aggregate sales price of up to $6 billion through multiple Agents and Forward Purchasers for at-the-market offerings and forward transactions. The program is pursuant to an automatic shelf Registration Statement on Form S-3 (File No. 333-290475) effective under Rule 462. No shares have been sold yet; this establishes the sales framework during the Commitment Period until termination.

• ·Registration Statement: Form S-3 (File No. 333-290475)
• ·Agents appointed to sell Issuance Shares and Forward Hedge Shares using commercially reasonable efforts
• ·Forward transactions include Initially Priced Forwards and Collared Forwards
• ·Agreement compliance with aggregate sales price limit is Company's sole responsibility

06-03-2026

Amprius Technologies reported revenue growth of 202% YoY to $73M for FY 2025 from $24M in 2024, achieving positive gross profit of $8M (11% margin) versus a prior-year loss of $18M. However, operating expenses surged 97% to $55M, primarily due to a $23M impairment charge (up 1,110%), resulting in a steady operating loss of $47M and net loss narrowing only 1% to $44M. Cash used in operations improved to $31M from $33M, supported by $71M in financing inflows.

• ·Stock-based compensation remained nearly flat at $7.4M in FY 2025 vs. $7.3M in FY 2024 (+1%).
• ·Net cash used in investing activities increased to $4.4M from $3.2M.
• ·Warrants exercisable at $11.50 per share, traded as AMPX.W.

06-03-2026

FirstSun Capital Bancorp's 2025 net income rose 29.5% YoY to $97.9M from $75.6M, supported by net interest income growth of 6.9% to $317.4M and noninterest income up 13.4% to $101.9M, while total assets expanded 4.8% to $8.5B and deposits grew 6.5% to $7.1B. However, noninterest expenses increased 2.9% to $271.8M, provision for credit losses of $24.6M remained elevated above 2023's $18.2M, net charge-offs rose to 0.43% from 0.32%, and key profitability ratios like ROE at 8.88% and NIM at 4.10% trailed 2023 levels of 12.50% and 4.23%, respectively.

• ·No cash dividends declared or paid in 2025, 2024, or 2023.
• ·Merger related expenses net of tax: $2.6M in 2025 (down from $9.9M in 2024).
• ·Total risk-based capital ratio: 15.73% in 2025 (up from 15.42% in 2024).
• ·Loan to deposit ratio declined to 93.9% in 2025 from 95.6% in 2024.
• ·Allowance for credit losses to loans: 1.27% in 2025 (down from 1.38% in 2024).

06-03-2026

Solid Power, Inc. (Nasdaq: SLDP) provides a company overview highlighting its market capitalization of $811.9M, 2025 revenue of $21.7M, and total liquidity of $336.5M as of December 31, 2025, strengthened by ~$91M from 2025 ATM offerings and ~$130M from January 2026 direct offering, with no debt and a DOE grant up to $50M. The company operates pilot facilities SP1 and SP2, current electrolyte capacity of 30MT/year planned to expand to 75MT/year by end-2026, and strong IP with >20 US patents issued. However, as an R&D-stage company with ~230 employees, it notes a history of financial losses and expectation of significant ongoing expenses and losses.

• ·Founded in 2011 with facilities in Louisville and Thornton, Colorado.
• ·Plans Korean partnership for commercial-scale electrolyte production.
• ·Solid Power cell technology licensed to BMW and SK On.

06-03-2026

Absci Corporation (Nasdaq: ABSI) appointed Ransi Somaratne, M.D., FACC, MBA, former Senior Vice President of Clinical Development at Vertex Pharmaceuticals, as Chief Medical Officer to lead clinical development of its AI-designed therapeutics pipeline, including flagship ABS-201 for hair regrowth and endometriosis. Concurrently, Chief Innovation Officer Andreas Busch, Ph.D., will retire from executive duties effective March 31, 2026, but will continue as co-chair of the Scientific Advisory Board. This transition strengthens clinical leadership while retaining key scientific expertise.

• ·Announcement date: March 3, 2026; Filing date: March 6, 2026
• ·Absci headquartered in Vancouver, WA, with AI Research Lab in New York City and Innovation Center in Switzerland
• ·Dr. Somaratne co-authored over 30 peer-reviewed papers, including in NEJM and JAMA

06-03-2026

Docusign, Inc. appointed Brian Roberts to its Board of Directors as a Class I director, effective March 5, 2026, to fill an existing vacancy, with his term expiring at the 2028 Annual Meeting of Stockholders. The Board determined Mr. Roberts to be independent under applicable standards, with no arrangements or material interests requiring disclosure. He will receive standard director compensation and has entered into the Company's indemnity agreement.

• ·Mr. Roberts qualifies as an independent director pursuant to the Securities Act of 1933 and Nasdaq listing standards.
• ·Compensation per Amended and Restated Director Compensation Program (filed in 10-Q on September 7, 2023).
• ·Indemnity agreement per standard form (filed in 8-K on December 3, 2020).

06-03-2026

On March 3, 2026, AGCO Corporation's Talent and Compensation Committee approved amendments to the 2026 Annual Incentive Plan, updating individual award opportunities, performance metrics, and their weightings to align with current program design. The changes eliminate individual award limits, broaden adjustment provisions for the committee's discretion, and add recoupment under clawback policies, reflecting legal updates post-repeal of Section 162(m) exceptions. No specific financial impacts or performance data were disclosed.

• ·Amendments qualified by reference to Exhibit 10.1 (full Plan text)
• ·Plan designated as management contract or compensation plan

06-03-2026

On March 3, 2026, the Board of Directors of GoodRx Holdings, Inc., upon recommendation of the Compensation Committee, approved a discretionary cash bonus of $72,918 for 2025 performance to Romin Nabiey, the company's Chief Accounting Officer. The 8-K filing was submitted on March 6, 2026, and signed by Christopher McGinnis, Chief Financial Officer & Treasurer. No other financial metrics, performance comparisons, or changes in officer status were disclosed.

• ·Event date: March 3, 2026
• ·Filing date: March 6, 2026
• ·Company address: 2701 Olympic Boulevard, Santa Monica, California 90404

06-03-2026

Conduent Incorporated (Nasdaq: CNDT) announced on March 6, 2026, the appointment of Greta Van, Chief Audit Executive at Jack Henry & Associates, to its Board of Directors, bringing over two decades of experience in finance, audit, enterprise risk management, and strategy from global public companies including PRGX, Infor Global Solutions, Crawford & Company, Internap, Comverge, and Accretive Solutions. CEO Harsha V. Agadi praised her expertise in modernizing functions and strengthening risk frameworks to support strategic priorities. The company operates with approximately 51,000 associates, disbursing $80B in government payments annually.

• ·Enables approximately 2.0 billion customer service interactions annually
• ·Empowers millions of employees through HR services every year
• ·Filing Date: March 06, 2026; Items: 5.02, 7.01, 9.01

06-03-2026

Wayfair Inc. repurchased approximately $56M in aggregate principal amount of its outstanding 3.50% convertible senior notes due 2028 for $99M plus accrued interest, using proceeds from its 6.75% senior secured notes due 2032, between February 25 and March 4, 2026, with settlements by March 5, 2026. This action, part of the company's ongoing liability management strategy, aims to reduce upcoming maturities and manage potential equity dilution, leaving $533M principal outstanding on the 2028 Notes. The company indicated it may pursue additional repurchases or restructurings based on market conditions, though such actions could impact note liquidity and common stock price.

• ·Repurchases conducted in open market transactions between February 25, 2026 and March 4, 2026, all settled by March 5, 2026
• ·Filing date: March 6, 2026; Earliest event date: March 4, 2026

06-03-2026

On March 2, 2026, the Audit Committee of Joby Aviation, Inc. dismissed Deloitte & Touche LLP as its independent registered public accounting firm effective immediately and appointed PricewaterhouseCoopers LLP (PwC) as the new firm for the fiscal year ending December 31, 2026, subject to standard procedures. Deloitte's audit reports for fiscal years ended December 31, 2025 and 2024 were unqualified with no disagreements or reportable events noted through the interim period to March 2, 2026. Deloitte was informed on March 3, 2026, and provided a concurring letter as Exhibit 16.1.

• ·No consultations with PwC occurred in fiscal years 2024 and 2025 or interim period through March 2, 2026, regarding accounting principles, audit opinions, disagreements, or reportable events.
• ·Securities registered: Common Stock (JOBY) and Warrants (JOBY WS) on New York Stock Exchange.

06-03-2026

At the 2026 Annual Meeting of Stockholders on March 4, 2026, Helmerich & Payne, Inc. stockholders elected 10 directors, including Raymond John Adams III (80.4M for, 0.9M against), Randy A. Foutch (70.9M for, 10.4M against), and John D. Zeglis (75.0M for, 6.3M against), while most received over 79M for votes. Stockholders also ratified Ernst & Young LLP as auditors for fiscal year ending September 30, 2026 (89.1M for, 3.2M against), approved executive compensation advisory vote (79.2M for, 1.9M against), and approved the Amended & Restated 2024 Omnibus Incentive Plan (76.3M for, 4.9M against), with consistent broker non-votes of 11.0M across proposals.

• ·Proxy Statement filed with SEC on January 22, 2026, includes full text of A&R 2024 Plan as Appendix A
• ·Fiscal year ends September 30, 2026

06-03-2026

International Money Express, Inc. (IMXI) reported total revenues of $608M for FY 2025, down 8% YoY from $659M in 2024, primarily due to a 9% decline in wire transfer and money order fees to $502M, while foreign exchange gains were flat at $87M and other income grew 24% to $18M. Net income dropped sharply 44% to $33M from $59M, with operating income falling 41% to $56M amid elevated transaction costs ($10M), goodwill impairment ($1M), and higher SG&A expenses. Adjusted EBITDA declined 20% to $97M from $121M, though restructuring costs decreased significantly to $1M.

• ·Total operating expenses $552M (91% of revenues) in FY2025 vs $564M (86% of revenues) in FY2024.
• ·Transaction costs rose to $10M in FY2025 from $2M in FY2024.
• ·GAAP diluted EPS $1.08 in FY2025 vs $1.79 in FY2024; Adjusted diluted EPS $1.66 vs $2.14.
• ·Net cash used in investing activities $22M in FY2025 vs $44M in FY2024.
• ·Cash and cash equivalents increased to $169M at end of FY2025 from $131M.

06-03-2026

Federal Signal Corporation's DEF 14A proxy statement outlines the Annual Meeting on April 21, 2026, to elect eight directors (reducing board size from nine, with Dennis J. Martin not standing for re-election), approve advisory vote on NEO compensation, and ratify Deloitte & Touche LLP as independent auditors for FY 2026. The record date is February 23, 2026, with 60,892,151 common shares outstanding. All director nominees are current directors, and the Board recommends voting 'FOR' all proposals.

• ·Annual Meeting location: 1333 Butterfield Road, Suite 500, Downers Grove, IL 60515 at 8:30 a.m. CDT.
• ·Proxy materials first mailed March 6, 2026 via Notice of Internet Availability at www.proxyvote.com.
• ·Messrs. Maue and Vaillancourt appointed as directors on February 26, 2026.

06-03-2026

Orion Energy Systems, Inc. filed an S-3 shelf registration statement with the SEC on March 6, 2026, enabling the company to offer up to $100M in securities, including debt securities, common stock, preferred stock, warrants, subscription rights, stock purchase contracts, and units, from time to time. Proceeds are intended for working capital, general corporate purposes, capital expenditures, sales and marketing, acquisitions, or investments in businesses, products, and technologies. The filing provides a general description of potential offerings without specific terms or current financial performance data.

• ·Operates in four business segments: Orion Distribution Services Division, Orion Services Group Division, Orion U.S. Markets Division, and Orion Electric Vehicle Charging Division.
• ·Principal lighting customers: large national account end-users, electrical distributors, electrical contractors, and energy service companies.
• ·Principal EV charging customers: municipalities, higher education facilities, mass transportation companies, and other commercial customers.
• ·Corporate headquarters: 2210 Woodland Drive, Manitowoc, Wisconsin 54220; telephone: (920) 892-9340; website: www.orionlighting.com.
• ·References Risk Factors from Annual Report on Form 10-K for year ended March 31, 2025.

06-03-2026

Rogers Communications Inc filed its 40-F annual report for FY2025 ended December 31, 2025, detailing operations across Wireless, Cable, and Media segments with year-over-year comparisons to FY2024 and FY2023. The filing discloses the MLSE Transaction on July 1, 2025, involving Maple Leaf Sports & Entertainment Ltd., including assets classified as held for sale, property, plant & equipment, intangibles, and depreciation details. Equity structure includes Class A Voting Shares and Class B Non-Voting Shares, with notes on credit facilities like the Canada Infrastructure Bank Credit Facility due 2052; no specific performance improvements or declines quantified.

• ·Filing date: March 06, 2026
• ·Reporting period: January 1, 2025 to December 31, 2025
• ·Comparative periods: FY2024 (2024-01-01 to 2024-12-31) and FY2023
• ·MLSE Transaction date: July 1, 2025
• ·Disposal groups classified as held for sale: December 2025
• ·Credit facilities include Canada Infrastructure Bank Credit Facility Due 2052, Revolving Credit Facility 1, Accounts Receivable Securitization Program

06-03-2026

Solid Biosciences Inc. entered into a securities purchase agreement on March 6, 2026, for a private placement of 14,973,257 shares at $5.61 per share and pre-funded warrants to purchase 27,807,482 shares at $5.609 each, expecting $240M gross proceeds and $226.8M net proceeds, closing around March 9, 2026. Preliminary unaudited cash, cash equivalents, and available-for-sale securities stood at $187.9M as of December 31, 2025. Combined with existing cash, net proceeds extend the cash runway into the first half of 2028 to fund pipeline development, business development, and general corporate purposes.

• ·Private placement closing expected on or about March 9, 2026, with investors restricted from trading until after March 11, 2026.
• ·Registration rights agreement requires resale registration statement filing within 30 days of closing, with effectiveness targets and 1% monthly liquidated damages for delays.
• ·Pre-funded warrants exercisable at $0.001 per share immediately until fully exercised, subject to beneficial ownership caps.

06-03-2026

Burford Capital Limited's subsidiary entered into an amended employment agreement with Aviva Will, transitioning her from President to Vice Chair effective March 11, 2026, after which she will no longer be an executive officer. The agreement includes a $1M annual base salary over a two-year initial term, a one-time $1.76M cash retention payment, $300K in RSUs plus 4,240 additional RSUs, and carried interest at prior levels. It features severance protections up to $1M plus health benefits, alongside restrictive covenants.

• ·Agreement dated March 3, 2026, with initial two-year term unless terminated earlier.
• ·Severance upon termination without cause: greater of remaining term salary or $1M cash, plus 12 months health coverage (subject to release).
• ·Contains perpetual confidentiality/non-disparagement and one-year post-employment non-competition/non-solicitation covenants.

06-03-2026

On February 25, 2026, American Rebel Holdings, Inc. received a $250,000 release from a deposit account control agreement tied to a prior $5.47M secured promissory note with Streeterville Capital, LLC. Simultaneously, the company exchanged 490 shares of Series E Preferred Stock for 2,450,000 shares of common stock via five Exchange Agreements, resulting in significant equity dilution for existing shareholders. These transactions were exempt from registration under Section 4(a)(2) and Regulation D.

• ·Original note purchase agreement dated June 26, 2025.
• ·Series E Preferred Stock originally issued pursuant to August 22, 2025 Note Purchase Agreement.
• ·Five identical Exchange Agreements executed, varying only in conversion amounts and shares.

06-03-2026

On March 3, 2026, Waste Management, Inc.'s Management Development and Compensation Committee granted performance share units (PSUs), stock options, and annual cash incentive awards to its named executive officers, including CEO James C. Fish, Jr., under the 2023 Stock Incentive Plan. PSU grants ranged from 7,272 to 49,350 units per executive, tied to cash flow generation (50%) and relative TSR vs. S&P 500 (50%), with payouts from 0-200% as of December 31, 2028; stock options ranged from 8,405 to 57,034 shares at $241.55 exercise price, vesting over three years. Annual cash incentives target base salary percentages, based on 2026 operating EBITDA, margin, and revenue growth, adjustable by up to 10% via sustainability scorecard and 25% via committee discretion.

• ·PSU performance period ends December 31, 2028, with payout after committee certification.
• ·Stock options have 10-year term; vesting: 34% year 1, 33% year 2, 33% year 3.
• ·Annual cash incentives require employment through December 31, 2026, except for death (prorated).
• ·Detailed termination provisions for PSUs and options include full payout on death/disability post-2026 retirement, forfeiture on cause termination.

06-03-2026

Beauty Health Co (SKIN) filed an 8-K on March 6, 2026, under Items 8.01 and 9.01, attaching Exhibit 99.1: Notice of Pendency and Proposed Settlement of Derivative Action, as required by a Delaware Court of Chancery Scheduling Order dated February 20, 2026. The notice and full stipulation details are available on the company's website at https://www.beautyhealth.com/legal-notices. The filing was signed by CFO Michael Monahan.

• ·Delaware Court of Chancery Scheduling Order entered on February 20, 2026
• ·Reference to prior SEC filing on November 6, 2025

06-03-2026

On March 2, 2026, Blackstone Real Estate Income Trust, Inc. sold 4,234,209 unregistered Class S-2 shares for aggregate consideration of approximately $60.4 million as part of its continuous private offering to accredited investors. The transaction was exempt from Securities Act registration under Section 4(a)(2) and Regulation D, with upfront selling commissions of $253,832 retained by or reallowed to participating broker-dealers. The purchase price was based on net asset value per Class S-2 share as of January 31, 2026.

• ·Shares sold to accredited investors in continuous private offering
• ·Purchase price equal to NAV per Class S-2 share as of January 31, 2026, plus commissions

06-03-2026

Beyond Meat, Inc. received a Nasdaq deficiency notice on March 4, 2026, stating that its common stock (BYND) closing bid price was below the $1.00 minimum for 30 consecutive business days, violating Listing Rule 5450(a)(1). The Company has 180 calendar days until August 31, 2026, to regain compliance by achieving a $1.00 closing price for 10 consecutive business days, with no immediate impact on trading. While stockholders approved reverse stock split options on November 19, 2025, there is no assurance of compliance, potentially leading to transfer to Nasdaq Capital Market or delisting.

• ·Stock continues to trade on The Nasdaq Global Select Market under symbol BYND
• ·Stockholder special meeting on November 19, 2025, approved 30 alternate amendments to Restated Certificate of Incorporation for reverse stock split
• ·Proxy statement filed with SEC on October 17, 2025

06-03-2026

Omada Health, Inc. reported total revenue of $260.2M for YE Dec 31, 2025, up 53% YoY from $169.8M in 2024, driven by 53% growth in Services ($241.0M) and 60% in Hardware ($19.2M), with gross profit expanding 66% to $170.9M and gross margin improving to 66% from 61%. Operating loss narrowed significantly to $12.0M from $43.7M, and net loss to $12.8M from $47.1M, aided by operating expenses rising only 25% as a percentage of revenue declined across categories. However, the company remains unprofitable with Partner B concentration in accounts receivable rising to 45% from 28%.

• ·Revenue concentration stable at 93% Services and 7% Hardware across 2023-2025.
• ·Share-based compensation increased 38% YoY to $13.0M in 2025.
• ·Amortization of intangible assets declined to $1.9M from $2.0M YoY.
• ·Total depreciation and amortization rose 30% to $3.6M in 2025.

06-03-2026

Equity Bancshares Inc reported net income of $22.7M for 2025, down 64% YoY from $62.6M in 2024, driven by a $53.2M net loss on securities transactions and higher merger expenses of $8.1M, resulting in ROAA declining to 0.40% from 1.23%. However, net interest income rose 22% to $226.1M on 20% loan growth to $4.20B and total assets expanding 20% to $6.37B, with deposits up 17% to $5.14B. Core diluted EPS remained stable at $4.39, while capital ratios stayed strong but ticked lower, with CET1 at 13.08%.

• ·Shares outstanding: 20,992,139 Class A Common Stock (Feb 27, 2026); 0 Class B.
• ·Equity compensation plans available for future issuance: 1,040,294 securities.
• ·Provision for credit losses: $9.0M in 2025 vs $2.5M in 2024.
• ·Common Equity Tier 1 Capital Ratio: 13.08% (2025) vs 14.51% (2024).
• ·Efficiency ratio stable at 60.90% (2025) vs 60.77% (2024).

06-03-2026

Genco Shipping & Trading Ltd filed a DEFA14A on March 6, 2026, disclosing participants in the proxy solicitation for the 2026 Annual Meeting of Shareholders, including independent directors Paramita Das, Kathleen C. Haines, Basil G. Mavroleon, Karin Y. Orsel, Arthur L. Regan, and executives John C. Wobensmith, Peter Allen, Joseph Adamo, Jesper Christensen. The filing urges shareholders to review the upcoming definitive proxy statement on Schedule 14A, white proxy card, and related SEC documents available free on SEC.gov and the company's investor relations site at https://investors.gencoshipping.com/. It references the prior 2025 proxy statement filed April 9, 2025, and multiple Form 4 filings detailing participants' changes in security ownership from May 2025 to February 2026.

• ·Prior proxy statement for 2025 Annual Meeting filed with SEC on April 9, 2025.
• ·Form 4 filings for participants: May 22, 2025; June 3, 2025; August 26, 2025; September 10, 2025; September 15, 2025; November 12, 2025; November 26, 2025; February 18, 2026; February 23, 2026.
• ·Investor contact: Peter Allen, (646) 443-8550; Media contact: Leon Berman, (212) 477-8438, lberman@igbir.com.

06-03-2026

On March 2, 2026, 374Water Inc. terminated Russell Kline as Chief Financial Officer as part of a company restructuring and appointed Adrienne Anderson as Interim CFO and principal financial/accounting officer, with a base salary of $216,000 per year. Ms. Anderson, who previously served in the role from January 8, 2024, to December 16, 2024, brings extensive PCAOB audit experience from firms like D. Brooks and Associates and WithumSmith + Brown. Terms of Kline's separation and Anderson's potential equity grant remain undetermined.

• ·Adrienne Anderson, age 47, is a CPA licensed in Florida and Illinois; previously served as Audit Committee Chair for SharpLink Gaming Ltd.
• ·No arrangements, family relationships, or material transactions involving Ms. Anderson under Item 404(a) of Regulation S-K.
• ·Equity grant under 2021 Equity Incentive Plan terms to be announced via 8-K amendment.

06-03-2026

Howard Hughes Holdings Inc.'s Board of Directors determined on March 5, 2026, to hold the 2026 annual meeting of stockholders on June 4, 2026, with a record date of April 6, 2026. Due to the meeting date changing by more than 30 days from the 2025 annual meeting anniversary, deadlines for Rule 14a-8 stockholder proposals and bylaw nominations are both March 17, 2026, while universal proxy rule notices under Rule 14a-19 are due by April 5, 2026. Additional details will be in the definitive proxy statement.

• ·Stockholder proposals under Bylaws must be delivered not earlier than the 120th day prior to the Annual Meeting and not later than the 90th day prior or 10th day after public announcement if less than 100 days prior.

06-03-2026

Illumination Acquisition Corp. I, a blank check company, consummated its IPO on March 2, 2026, selling 23,000,000 units (including 3,000,000 from over-allotment) at $10.00 per unit for gross proceeds of $230M, plus a simultaneous private placement of 625,000 units for $6.25M. Proceeds funded a $230M trust account at $10.00 per public share. The balance sheet as of March 2 reflects total assets of $231.1M but a shareholders' deficit of $7.1M primarily due to $13.3M in transaction costs including $8.05M deferred underwriting fees.

• ·Underwriting over-allotment option exercised in full on February 27, 2026, eliminating forfeiture of 1,000,000 Class B founder shares.
• ·Sponsor purchased 395,000 Private Placement Units; BTIG, LLC purchased 230,000.
• ·Each warrant exercisable for one Class A ordinary share at $11.50.
• ·Company incorporated November 18, 2025; registration statement effective February 26, 2026.

06-03-2026

Donegal Group Inc reported net income of $79.3M for the year ended December 31, 2025, a 56% increase from $50.9M in 2024, supported by a lower combined ratio of 95.4% versus 98.6% and higher net investment income of $52.6M. However, total net premiums written declined 4.0% YoY to $904.8M, driven by a sharp 13.5% drop in personal lines to $340.8M despite modest 3.0% growth in commercial lines to $564.0M, while total revenues edged down 1.2% to $978.0M. Gross liability for unpaid losses and loss expenses ended the year at $1.1B, down from $1.121B.

• ·Donegal Mutual purchased 274,125 Class A shares at avg $19.73 and 43,404 Class B shares at $17.50 in Oct-Dec 2025 under open-ended program.
• ·Provision for net losses incurred in current year decreased to $574.6M in 2025 from $619.1M in 2024.
• ·Favorable development on prior years' losses: $10.3M reserve release in 2025 vs $15.0M in 2024.

06-03-2026

Kirby Corporation's 2026 Proxy Statement summarizes a record 2025 with consolidated revenues up 3% YoY to $3.4B, net earnings of $354.6M, and EPS up 16% to $6.33 over the prior record of $5.46 (excl. one-time items). Marine transportation revenues grew 1% to $1.9B, with coastal up 8% and strong margins around 20%, while distribution and services increased 6% led by 26% power generation growth, though oil and gas revenues declined YoY and on-highway activity softened. The proxy seeks stockholder votes to elect three Class I directors, ratify KPMG LLP as auditors for 2026, approve executive compensation advisory vote, and amend the 2005 Stock and Incentive Plan and 2000 Nonemployee Director Stock Plan.

• ·Annual Meeting: April 27, 2026 at 10:00 a.m. CDT, 55 Waugh Drive, Suite 1100, Houston, TX
• ·Record date for stockholders: March 2, 2026
• ·Proxy materials available: on or about March 10, 2026 at www.proxydocs.com/KEX
• ·Richard R. Stewart concludes board service at 2026 Annual Meeting
• ·Board composition: 9 directors, majority independent, diverse in gender (4F/5M) and skills including M&A, finance, risk management
• ·KDS 2026 outlook: flat to slightly higher revenues YoY
• ·Inland marine 2026 outlook: modest YoY improvement

06-03-2026

WhiteHorse Finance, Inc. discloses total assets of $615.1 million, debt outstanding of $328.5 million, and net assets of $259.8 million as of December 31, 2025, with a weighted average cost of funds at 5.35%; a hypothetical higher leverage scenario projects $806.2 million in assets and $519.6 million in debt at 5.56% cost. The 10-K highlights investment risks such as shares trading at a discount to NAV, potential dilution, stock repurchase program volatility, and structural subordination of debt to subsidiary obligations. Illustrative incentive fee calculations over Years 1-4 show payments ranging from $7.0 million to $14.0 million annually, with minor deferrals in Year 3.

• ·RIC qualification requires at least 90% gross income from dividends, interest, securities gains, or qualified partnerships.
• ·RIC asset test: at least 50% in cash equivalents, U.S. government securities, other RICs, with no more than 5% in any one issuer or 10% of issuer's voting securities.
• ·Illustrative incentive fees: Year 1 $8.0M paid; Year 2 $14.0M paid; Year 3 $7.0M paid with $1.0M deferred; Year 4 $9.2M paid including prior deferral.

06-03-2026

IPG Photonics Corporation filed Amendment No. 1 to its Form 10-K for the fiscal year ended December 31, 2025, solely to correct the cover page disclosure regarding incorporation by reference to its proxy statement for the 2026 Annual Meeting; no changes were made to financial statements or other disclosures from the original filing on February 23, 2026. The amendment includes new Section 302 certifications but omits others as no financials are revised. Aggregate market value of non-affiliate common stock was approximately $1.8B as of June 30, 2025, with 42,191,353 shares outstanding as of February 20, 2026.

• ·Registrant is a large accelerated filer.
• ·Proxy statement for 2026 Annual Meeting to be filed within 120 days of December 31, 2025.

06-03-2026

On March 6, 2026, Iveda Solutions, Inc. received a Nasdaq notice stating its common stock (IVDA) failed to maintain a $1 minimum bid price for 30 consecutive business days, violating Listing Rule 5550(a)(2). The company has 180 calendar days until September 2, 2026, to regain compliance by achieving a $1 closing bid for 10 consecutive business days, with no immediate listing impact but potential delisting risk thereafter. Warrants (IVDAW) are also referenced as listed on Nasdaq.

• ·Nasdaq Listing Rule 5810(c)(3)(A) governs the 180-day compliance period.
• ·Company headquartered at 1744 S. Val Vista, Suite 213, Mesa, Arizona 85204.
• ·Appeal to Nasdaq Hearings Panel possible if delisting notice issued.

06-03-2026

Curanex Pharmaceuticals Inc (CURX) entered into employment agreements effective March 1, 2026, with CEO and President Jun Liu (annual base salary $393,600 plus $3,998 monthly car lease) and COO Dr. Liqin Xie (annual base salary $180,000), formalizing their continuing roles since February 2024 and June 2024, respectively. Both agreements provide eligibility for equity incentives, employee benefits, and 3-month salary continuation plus accelerated vesting upon termination without cause or for good reason. The CEO agreement has an initial 4-year term, renewable annually by mutual consent.

• ·CEO Jun Liu originally appointed to CEO and President roles in February 2024.
• ·COO Dr. Liqin Xie originally appointed on June 17, 2024.
• ·Agreements entered on March 2, 2026; CEO term ends on fourth anniversary unless terminated earlier.
• ·Both agreements include non-compete, non-disclosure, non-solicitation covenants and require Proprietary Information and Invention Assignment Agreement.

06-03-2026

bioAffinity Technologies, Inc. disclosed that directors Robert Anderson and Roby Joyce informed the Board on March 5, 2026, that they will not stand for re-election at the 2026 Annual Meeting of Stockholders, scheduled for April 30, 2026. Their decisions did not stem from any disagreements with the Company regarding operations, policies, or practices. No other changes or impacts were reported.

• ·Company is an emerging growth company.
• ·Common Stock ticker: BIAF; Warrants ticker: BIAFW, both on Nasdaq Capital Market.
• ·Principal executive offices: 3300 Nacogdoches Road, Suite 216, San Antonio, Texas 78217.

06-03-2026

TOMI Environmental Solutions, Inc. filed an 8-K on March 6, 2026, providing a legal opinion related to its previously disclosed Equity Purchase Agreement with Hudson Global Ventures, LLC, dated November 5, 2025, which allows the Company to sell up to $20M of common stock over a 24-month period. The opinion, dated February 24, 2026, from Morgan, Lewis & Bockius LLP, is incorporated by reference into the Company's Form S-3 (File No. 333-291563). No new financial metrics or performance data were reported.

• ·Agreement initially disclosed on November 12, 2025
• ·Shares offered pursuant to Form S-3 (File No. 333-291563)
• ·24-month term for stock sales under the agreement

06-03-2026

Interactive Strength Inc. (TRNR) increased the maximum aggregate offering price of its common stock under the At-The-Market Offering Agreement with H.C. Wainwright & Co. LLC, dated May 17, 2024, to $6.057M on March 6, 2026, and filed a corresponding prospectus supplement. Prior to this amendment, the company had sold approximately $1.673M in shares over the last 12 calendar months pursuant to General Instruction I.B.6 of Form S-3 and $12.13M in aggregate under the Sales Agreement. No new shares were issued in this update.

• ·Shelf registration statement on Form S-3 (File No. 333-288405) filed June 27, 2025, declared effective September 22, 2025.
• ·Prospectus supplement originally filed January 23, 2026, amended March 6, 2026.
• ·Legal opinion on legality of shares from Lucosky Brookman LLP filed as Exhibit 5.1.

06-03-2026

Alzamend Neuro, Inc. entered into an At-the-Market Issuance Sales Agreement with Ascendiant Capital Markets, LLC on March 6, 2026, enabling the sale of up to $3.0 million in common stock through an ATM offering pursuant to its effective shelf registration statement on Form S-3 (No. 333-273610). The agreement allows flexible sales based on company instructions, subject to market conditions and regulatory compliance, with either party able to suspend or terminate upon notice. No shares have been sold under the agreement as of the filing date.

• ·Shelf registration statement on Form S-3 (File No. 333-273610) filed August 2, 2023, and declared effective August 10, 2023
• ·Prospectus supplement filed with SEC on March 6, 2026
• ·Sales Agreement filed as Exhibit 10.1
• ·Legal opinion of Olshan Frome Wolosky LLP filed as Exhibit 5.1
• ·Common stock par value: $0.0001; trading symbol: ALZN on Nasdaq Capital Market

06-03-2026

Vicarious Surgical Inc. amended employment agreements for President Adam Sachs and CTO Sammy Khalifa, voluntarily reducing their annual base salaries to $270,810 and $318,600 respectively (50% and 25% cuts from prior levels), effective March 9, 2026, while preserving bonus and severance calculations on pre-amendment salaries. This cost-cutting measure occurs amid NYSE delisting proceedings initiated March 3, 2026, with shares now trading OTC under 'RBOT'. No departures or new appointments were announced.

• ·Amendments signed March 4, 2026, explicitly waive 'Good Reason' claims for salary reductions.
• ·Class A common stock delisted by NYSE on March 3, 2026, now quoted on OTCID tier as 'RBOT'.

06-03-2026

Medalist Diversified REIT, Inc.'s subsidiary, MDR Ashley Plaza, LLC, entered into a Purchase and Sale Agreement on March 5, 2026, to sell the 156,012 square foot Ashley Plaza retail property in Goldsboro, North Carolina, for total consideration of $16.6M, subject to prorations and adjustments. The purchaser, HPX Goldsboro Ashley Center LLC, must provide earnest money deposits totaling $300k. The transaction is expected to close within 90 days, though several conditions remain unsatisfied and there is no assurance of completion.

• ·Property address: 201–221 North Berkeley Boulevard, Goldsboro, North Carolina
• ·Closing expected within 90 days of March 5, 2026, subject to customary conditions, representations, warranties, covenants, and indemnities

06-03-2026

indie Semiconductor, Inc. (INDI) announced a proposed private offering of $150M aggregate principal amount of Convertible Senior Notes due 2031 to qualified institutional buyers, with an option for initial purchasers to buy up to an additional $22.5M. The company intends to use a portion of net proceeds to repurchase up to $100M of its 4.50% Convertible Senior Notes due 2027 via negotiated transactions, with the remainder for working capital and general corporate purposes including potential acquisitions. Final terms including interest rate and conversion rate are subject to pricing, and the notes carry redemption options after March 20, 2029, with forward-looking risks noted regarding market impacts from hedging activities.

• ·Interest on new notes payable semiannually starting September 15, 2026.
• ·Notes mature March 15, 2031, unless earlier repurchased, redeemed, or converted.
• ·Initial purchasers' option exercisable over 13-day period from issuance.
• ·Hedged holders of 2027 notes may unwind hedges, potentially impacting common stock price and notes conversion price.

06-03-2026

Diversified Energy Company (DEC) filed an 8-K on March 6, 2026, providing unaudited pro forma condensed combined financial information for the year ended December 31, 2025, related to its acquisition of Canvas Energy Inc., which closed on November 26, 2025. The pro forma statements are included as Exhibit 99.1. No specific financial metrics, period-over-period comparisons, or performance highlights (positive or negative) are detailed in the filing body.

• ·Acquisition of Canvas Energy Inc. previously announced and closed on November 26, 2025, as disclosed in prior 8-K.
• ·Pro forma financials cover statement of comprehensive income for year ended December 31, 2025.

06-03-2026

Five Point Holdings, LLC reported total revenues of $110.0M for the year ended December 31, 2025, down 54% YoY from $237.9M, driven by a 70% plunge in land sales to $42.5M from $139.1M and a 32% drop in management services-related party revenue to $65.3M, while operating properties revenue remained nearly flat at $2.3M. However, equity in earnings from unconsolidated entities surged 54% to $203.6M, boosting net income to $183.5M (up 3% YoY) and net income attributable to the company to $71.0M (up 4%), with Class A basic EPS rising to $1.01 from $0.98. Total assets grew to $3.25B, inventories increased to $2.44B, and notes payable declined to $443.3M from $525.7M.

• ·Cash flow from operating activities declined to $105.2M from $116.0M YoY.
• ·Valencia segment reported a loss of $(2.2)M in 2025 vs profit of $35.7M in 2024.
• ·San Francisco segment loss widened slightly to $(4.7)M from $(4.1)M YoY.
• ·Cash and cash equivalents decreased to $425.5M from $430.9M.

06-03-2026

Canadian Pacific Railway Company completed an offering of $600M aggregate principal amount of 4.000% notes due 2029 and $600M aggregate principal amount of 5.500% notes due 2056, for a total of $1.2B, guaranteed by parent Canadian Pacific Kansas City Limited. The notes were issued pursuant to an Eighth Supplemental Indenture dated March 6, 2026, following an Underwriting Agreement dated March 4, 2026, with lead underwriters Goldman Sachs & Co. LLC, Barclays Capital Inc., Citigroup Global Markets Inc., and SMBC Nikko Securities America, Inc. The offering was registered under a Form F-10 (File No. 333-285353).

• ·Underwriting Agreement dated March 4, 2026
• ·Eighth Supplemental Indenture dated March 6, 2026
• ·Prospectus dated March 6, 2025, supplemented March 4, 2026
• ·Original Indenture dated September 11, 2015
• ·Registration statement on Form F-10 (File No. 333-285353) filed February 27, 2025

06-03-2026

Jet.AI Inc. reported revenues of $9.2M for the year ended December 31, 2025, a 34.5% YoY decline from $14.0M in 2024, resulting in a reduced gross loss of $0.3M versus $1.0M prior year; however, operating loss improved to $10.1M from $12.6M due to lower operating expenses. The company swung to net income of $4.6M from a $12.7M loss, driven by a $14.5M unrealized gain on investments, amid ongoing going concern risks, operating losses history, and a proposed divestiture of aviation assets to flyExclusive to focus on AI data centers.

• ·SPAC investment faces total loss risk if no acquisition by April 6, 2027
• ·Stock-based compensation: $1.6M in 2025 vs $4.3M in 2024
• ·Weighted average shares basic: 3.0M in 2025 vs 0.3M in 2024; Diluted EPS $0.33 in 2025

06-03-2026

Grab Holdings Ltd reported FY2025 revenue of $3,370 million, up 20% YoY from $2,797 million, with Deliveries up 20% to $1,800 million, Mobility up 16% to $1,219 million, and Financial Services surging 37% to $347 million. The company achieved an operating profit of $65 million, swinging from a $168 million loss, and net profit of $200 million versus a $158 million loss. However, cost of revenue increased 18% to $1,914 million (57% of revenue vs. 58% prior), net impairment losses rose 47% to $140 million, and R&D expenses grew 4% to $428 million while G&A declined 10%.

• ·Revenue by country: Philippines +19% to $316M, Singapore +26% to $727M, Thailand +14% to $288M, Vietnam +12% to $255M.
• ·Sales and marketing expenses up 13% to $367M (11% of revenue vs 12% prior).
• ·Other income up 17% to $20M.

06-03-2026

Home Bancorp, Inc. reported net income of $46.1M for the year ended December 31, 2025, up 26% YoY from $36.4M, with diluted EPS increasing to $5.87 from $4.55 and ROA improving to 1.33% from 1.08%. Total assets grew 1.4% to $3.49B, deposits rose 6.9% to $2.97B, and net interest income increased 10.8% to $133.3M. However, asset quality deteriorated sharply with non-performing loans jumping to 1.25% of total loans from 0.50% and non-performing assets rising to 1.03% of total assets from 0.45%, while loans grew only 0.9% YoY.

• ·Provision for loan losses was $1.1M in 2025, down from $2.4M in 2024.
• ·Shareholders’ equity increased to $435.1M as of Dec 31, 2025 from $396.1M.
• ·Tier 1 risk-based capital ratio strengthened to 14.09% from 13.28%.
• ·Cash dividends per share rose to $1.14 in 2025 from $1.01.

06-03-2026

BKV Corp reported total production of 305.0 Bcfe in 2025, up 5.7% YoY from 288.4 Bcfe in 2024, driven by Barnett growth (+10.2%) but offset by a sharp NEPA decline (-20.1%). Revenues surged 73.6% YoY to $1.01B, fueled by 75% higher natural gas revenues ($675.1M), though midstream revenues fell 17% and Section 45Q tax credits dropped 16%. PV-10 value jumped to $2.79B from $672M, while operating expenses rose 7.6% to $791.2M amid higher costs in several areas.

• ·Average production costs total company $1.32/Mcfe in 2025 vs $1.25/Mcfe in 2024 (+5.6%).
• ·DD&A expenses declined 28% YoY to $157.5M in 2025.
• ·Proved reserves PV-10 at Dec 31, 2025 alternative $3.08B.

06-03-2026

OS Therapies Incorporated (OSTX) entered into a Securities Purchase Agreement dated March 4, 2026, to issue and sell securities, including Notes and Warrants, to certain Purchasers in a private placement exempt under Section 4(a)(2) and Regulation D, with Ceros Financial Services, Inc. as placement agent. The transaction is subject to a 19.99% cap on shares issuable upon conversion or exercise without stockholder approval. Proceeds are to be used for working capital and general corporate purposes, excluding debt repayment, redemptions, litigation settlements, or violations of FCPA/OFAC.

• ·Closing Date: Trading Day when all Transaction Documents executed and conditions met, no later than 2nd Trading Day following March 4, 2026
• ·Use of proceeds excludes satisfaction of debt (except trade payables), redemption of Common Stock or equivalents, settlement of litigation, or FCPA/OFAC violations
• ·SEC Filing Date: March 06, 2026 (Items 1.01, 2.03, 3.02, 9.01)

06-03-2026

HF Sinclair Corporation (DINO) appointed Vivek Garg, age 52, as Acting Chief Financial Officer effective February 24, 2026, while he continues in his roles as Vice President, Chief Accounting Officer, and Controller. As additional compensation, Garg will receive a $25,000 monthly cash stipend commencing March 1, 2026, and a one-time $375,000 restricted stock unit grant vesting 50% on December 1, 2026, and 50% on December 1, 2027. The appointment involves no arrangements with other persons, family relationships, or disclosable transactions under Item 404(a).

• ·Appointment previously announced in Form 10-K filed February 27, 2026
• ·Stipend prorated for partial months of service
• ·RSU governed by HF Sinclair Corporation Amended and Restated 2020 Long Term Incentive Plan
• ·Garg eligible for ongoing annual bonus, health/welfare plans, and existing Change in Control and Indemnification Agreements

06-03-2026

Greenidge reported preliminary Q4 2025 total revenue of $11.5M, down $3.7M or ~24% QoQ from Q3, with cryptocurrency mining revenue declining $1.6M and datacenter hosting down $3.0M, though power and capacity revenue improved $0.8M; net income fell to $1.9-2.9M QoQ. For FY2025, revenue was $58.8M, down $0.8M or ~1% YoY from FY2024, with mining revenue down $3.8M and bitcoin production down 570 to 371, but net income improved to $4.2-5.2M, power revenue rose $11.4M, and debt was reduced to $39M. The company secured 100MW of future power capacity and a Title V Air Permit renewal for the Dresden facility, supporting AI/HPC transition.

• ·Secured 60MW non-curtailable power at Dresden facility and 40MW at Mississippi greenfield site by Q1 2027.
• ·Initiated NYISO study for additional 200MW at Dresden.
• ·Agreement with NYSDEC for Dresden permit renewal post-public comment, extending C-Pond closure to Oct 2027.
• ·Senior unsecured debt reduced from $157.5M in 2023 and $68.5M at FY2024 end to $39M.
• ·SG&A expenses reduced from $26.1M in 2023 to $12.1M in FY2025.

06-03-2026

Medicus Pharma Ltd. disclosed sales of 4,471,038 common shares to YA II PN, Ltd. (Yorkville) under the Standby Equity Purchase Agreement (SEPA) dated February 10, 2025, for total consideration of $3,846,910 across multiple transactions from December 19, 2025, to March 6, 2026. Part of the net proceeds were used to prepay a portion of an outstanding debenture with Yorkville. The shares were issued pursuant to the Section 4(a)(2) exemption from registration.

• ·SEPA dated February 10, 2025; sales occurred on specific dates including December 19, 2025 (71,099 shares for $122,868), December 29, 2025 (62,159 shares for $98,600), January 9, 2026 (100,000 shares for $150,640), and others up to March 6, 2026.
• ·Prepayment of debenture referenced in prior 8-K dated September 18, 2025.
• ·Yorkville may resell shares under an effective registration statement filed by the Company.

06-03-2026

Nurix Therapeutics, Inc. entered into Amendment No. 3 to its Equity Distribution Agreement with Piper Sandler & Co. on March 6, 2026, authorizing 'at the market' offerings of up to $413.65 million in common stock shares under its Automatic Shelf Registration Statement. This amendment follows prior amendments in 2021, July 2024, and October 2024, with related prospectus supplements filed on October 31, 2024, and March 6, 2026. No sales have been specified in this filing, and it does not constitute an offer to sell.

• ·Equity Distribution Agreement originally dated August 4, 2021, with Amendment No. 1 on July 11, 2024, and Amendment No. 2 on October 31, 2024.
• ·Automatic Shelf Registration Statement on Form S-3 (File No. 333-280117) filed July 11, 2024.
• ·Prospectus Supplement dated October 31, 2024, and Amendment No. 1 to Prospectus Supplement dated March 6, 2026.

06-03-2026

Artius II Acquisition Inc., a Cayman Islands blank check company (SPAC), entered into a promissory note dated March 6, 2026, with Artius II Acquisition Partners LLC for principal advances of up to $1,000,000 to fund ongoing operations, interest-free, with a minimum drawdown of $10,000. The note matures upon closing of the initial business combination or company liquidation and is convertible at the payee's election into Private Placement Shares at a 10% premium ($11/share equivalent) upon business combination, liquidation, or default. No amounts have been drawn down as of the filing.

• ·Note governed by New York law; no personal liability for officers/directors/shareholders.
• ·Payee waives claims against the SPAC's IPO trust account.
• ·References Private Placement Units Purchase Agreement dated February 12, 2025.

06-03-2026

On March 5, 2026, Terry Jimenez, a director of Turtle Beach Corporation (TBCH), notified the company of his resignation from the Board, effective March 6, 2026. The Board expressed appreciation for his service and contributions. No successor was named, and no reason for the departure was disclosed.

• ·Filing date: March 6, 2026
• ·Securities: Common Stock (TBCH) and Preferred Stock Purchase Rights on Nasdaq Global Market

06-03-2026

InMed Pharmaceuticals Inc. ratified the wind down of its wholly-owned subsidiary BayMedica LLC's commercial operations, the company's sole revenue-generating segment, due to H.R. 5371 legislation effective November 12, 2026, with completion targeted by fiscal year-end June 30, 2026. This will incur approximately $550,000 in severance and employee costs plus $120,000 in other expenditures, partially offset by interim sales profits. Pro forma financials for six months ended December 31, 2025, eliminate $1.94M in sales and $587k gross profit but reduce operating expenses, resulting in a slightly narrower continuing operations loss of $3.91M versus the as-filed total; for FY 2025, continuing loss widens to $8.47M after removing $4.94M sales and $1.71M gross profit.

• ·H.R. 5371 effective November 12, 2026, prohibiting aspects of BayMedica's cannabinoid business.
• ·BayMedica to continue limited operations until fiscal year-end June 30, 2026.
• ·Pro forma cash decreases by $215K to $6.74M as of Dec 31, 2025; inventories and receivables eliminated.

06-03-2026

Boeing's 2026 DEF 14A Proxy Statement discloses 2025 compensation for named executive officers (NEOs), with CEO Robert K. Ortberg receiving total pay of $23.6M, up 28% from $18.4M in 2024, driven by $9.6M in option awards and $3.9M incentive pay. Other NEOs like Stephanie F. Pope saw total comp rise 44% to $14.4M from $10.0M, while new CFO Jesus Malave, Jr. earned $20.2M including an $8.5M bonus; however, stock option grants to NEOs in February 2025 occurred amid a 3.8% decline in share price following material nonpublic information disclosure. The filing reaffirms robust clawback and insider trading policies with no interlocks or excessive risk in comp design.

• ·No stock options granted to NEOs during blackout periods around 10-K/10-Q/8-K filings except specified Feb 2025 grants.
• ·Clawback policy adopted June 27, 2023, applies to incentive comp earned on/after Oct 2, 2023.
• ·No Compensation Committee interlocks in 2025; independent review by FW Cook confirms no excessive risk in comp programs.

06-03-2026

On March 5, 2026, Midland States Bancorp, Inc. terminated Eric Lemke from his position as Chief Financial Officer of the Company and its subsidiary Midland States Bank, with no specified reason provided. The Company promptly appointed Claire Stack, age 37 and previously Corporate Controller since November 2025, as Vice President – Chief Accounting Officer and interim CFO, leveraging her 15+ years of accounting and finance experience. A Change of Control Agreement was entered with Ms. Stack, offering severance of 150% of salary plus average prior three-year bonuses upon qualifying termination post-change of control, though the CFO departure raises potential governance concerns.

• ·Claire Stack joined as Corporate Controller in November 2025; holds BS in Accounting and Technology Management from Indiana University’s Kelley School of Business; Certified Public Accountant (CPA).
• ·Change of Control Agreement initial term through December 31, 2026; auto-renews annually unless 90 days' nonrenewal notice; post-termination non-compete/non-solicit for 12 months; COBRA coverage up to 12 months on qualifying termination.
• ·Agreement form filed as Exhibit 10.4 to 2025 Form 10-K.

06-03-2026

LQR House Inc. completed a conversion from a Nevada corporation to a Delaware corporation via a Certificate of Conversion filed with the Delaware Secretary of State on March 2, 2026, at 4:12 PM, effective immediately. The company, originally formed on January 11, 2021, retains the name LQR House Inc., with the document executed by CEO Sean Dollinger. No financial impacts or operational changes are disclosed in the filing.

• ·Certificate authenticated on March 4, 2026; SR# 20260978975, File Number 10530384
• ·8-K filed on March 6, 2026, covering Items 3.03, 5.03, 5.07, 9.01

06-03-2026

CorMedix Inc. released an updated investor presentation and reaffirmed FY2027 DefenCath sales guidance at $100-140M, correcting an inadvertent lower range of $100-125M stated during the March 5, 2026 earnings call. Pro forma FY2025 net revenue reached $401M, a significant increase from CorMedix's standalone FY2024 revenue of $44M driven by the Melinta acquisition, with Q4 2025 revenue of $129M including $91M from DefenCath. However, FY2026 total revenue guidance is $300-320M, projecting a ~20-25% YoY decline from FY2025 pro forma levels, and DefenCath FY2026 sales guidance of $150-170M is expected to decline further to $100-140M in FY2027.

• ·FY2026 adjusted EBITDA guidance: $100-125M
• ·Products sold to 500+ hospitals, infusion centers, and clinics
• ·Cash flow generating portfolio with eight diversified products

06-03-2026

The Invesco Galaxy Solana ETF (QSOL) reported net assets of $2.24M as of December 31, 2025, with 180,000 shares outstanding, NAV per share of $12.45, and investments in Solana valued at $2.24M (cost basis $2.49M). For the inaugural period from October 16 to December 31, 2025, it generated $1,445 in staking income (net investment income $1,186) but suffered a $244,798 unrealized loss on Solana holdings and sponsor fees of $259, resulting in a net loss of $243,612. Total return at NAV was -50.20% over the full period (or -10.04% annualized from December 10 commencement of operations), while market value per share ended at $12.41.

• ·Commencement of operations: December 10, 2025
• ·Commencement of trading on exchange: December 15, 2025
• ·Net asset value per share at beginning of Dec 10-31 period: $13.84
• ·Paid-in capital: $2,485,077
• ·Distributable earnings (loss): $(243,612)
• ·Cash held by custodian: $500

06-03-2026

Dyadic International, Inc. entered into an At-The-Market Issuance Sales Agreement with Craig-Hallum Capital Group LLC on March 6, 2026, enabling the sale of up to $4.2M in common stock through at-the-market offerings on Nasdaq. The sales agent will receive up to 3.0% commission on gross sales prices, providing the company flexible access to capital. However, any sales would dilute existing shareholders.

• ·Sales Agreement pursuant to Form S-3 registration statement (File No. 333-273829) effective August 25, 2023.
• ·Either party may suspend or terminate the offering upon notice.
• ·Company to reimburse sales agent for certain expenses and provide indemnification.

06-03-2026

iQSTEL Inc. filed an 8-K on March 6, 2026, furnishing a Corporate Presentation under Item 7.01 Regulation FD Disclosure for use in investor meetings. The presentation provides updates on current operations, major projects, strategic plans, growth initiatives, outlook, and forecasts for future performance and industry development. No specific financial metrics or period-over-period comparisons are disclosed in the filing.

06-03-2026

On February 27, 2026, the FDA issued a Complete Response Letter (CRL) for Incyte's sBLA seeking approval of Zynyz (retifanlimab-dlwr) injection (375mg) in combination with platinum-based chemotherapy for adult patients with metastatic NSCLC, citing inspection findings at third-party fill-finish facility Catalent Indiana, LLC (part of Novo Nordisk) as the sole approvability issue. While the CRL did not identify concerns with Zynyz's efficacy or safety data from the Phase 3 POD1UM-304 trial (announced December 2024) or the drug substance manufacturer, the manufacturing compliance issue delays potential approval. Incyte is collaborating with the FDA and Catalent Indiana to resolve the findings for a possible sBLA resubmission.

• ·sBLA supported by positive efficacy and safety data from POD1UM-304 trial announced in December 2024
• ·CRL inspection findings not specific to Zynyz
• ·No approvability concerns cited for efficacy, safety data, or third-party drug substance manufacturer

06-03-2026

Civista Bancshares reported net income of $46.2M for 2025, up 46% YoY from $31.7M in 2024, driven by net interest income growth of 19% to $138.6M and net interest margin expansion to 3.61% from 3.21%, with total assets reaching $4.34B. However, noninterest income declined 10% YoY to $34.0M amid lower lease revenue, while noninterest expenses remained flat at $113.9M, and net income remained below 2023's $43.0M peak. The company completed the Farmers Savings Bank acquisition, issuing shares worth $31.2M.

• ·Diluted EPS $2.64 in 2025, up from $2.01 in 2024 but below $2.73 in 2023
• ·Provision for credit losses $3.4M in 2025, down from $5.4M in 2024
• ·Common dividends $0.68 per share in 2025, up from $0.64
• ·Shareholders’ equity $543.5M at Dec 31, 2025, up 40% from $388.5M in 2024
• ·Noninterest-bearing deposits flat at $702M end-2025 vs $695M end-2024

06-03-2026

Icon Energy Corp filed a Form F-1 registration statement to register up to 9,811,933 Common Shares for resale by YA II PN, Ltd. (Yorkville) under a $20M Standby Equity Purchase Agreement (SEPA) dated August 27, 2025, with $7.19M already utilized leaving $12.81M remaining capacity through August 27, 2028. The company has issued 81,435 Commitment Shares and notes potential dilution from additional issuances at 96-97% of VWAP, alongside a multi-class capital structure where CEO Ismini Panagiotidi holds Series A and B Preferred Shares controlling 99.9% of voting power. While providing flexible funding access, the resale of shares poses downward pressure on stock price and further dilutes common shareholders.

• ·Reverse stock split: one-for-five effected on January 8, 2026, with all share amounts retroactively adjusted.
• ·Previous registration: Form F-1 (File No. 333-290206) effective September 22, 2025, covering Previously Sold SEPA Shares.
• ·SEPA pricing: 96% of VWAP (Option 1) or 97% of lowest VWAP over 3 days (Option 2), with volume thresholds and 4.99% Beneficial Ownership Cap.
• ·Series A Preferred convertible into Common Shares until July 15, 2032; Series B Preferred has voting power equivalent to 1,000 Common Shares each.

06-03-2026

NeOnc Technologies Holdings, Inc. (NTHI) announced on March 4, 2026, data from the dose-escalation portion of its Phase 1/2 clinical trial for NEO212 via a press release (Exhibit 99.1). The company hosted an investor conference call to discuss the data, furnishing the investor presentation (Exhibit 99.2) and call transcript (Exhibit 99.3). The disclosures are under Regulation FD and not deemed 'filed' for liability purposes.

06-03-2026

Nerdy Inc. was notified by the NYSE on March 5, 2026, that it is not in compliance with continued listing criteria under Section 802.01C due to its Class A common stock's average closing price being less than $1.00 over a consecutive 30 trading-day period, posing a delisting risk. The company intends to cure the deficiency within a six-month period, potentially via a reverse stock split subject to stockholder approval at its 2027 annual meeting, while its stock continues to trade on the NYSE. As of December 31, 2025, the company reported $47.9M in cash and equivalents, stating ample liquidity to support operations and growth.

• ·Compliance cure possible if closing share price >= $1.00 and 30-day average >= $1.00 on last trading day of any month in six-month period.
• ·Notice does not impact business operations, SEC reporting, or term loan.
• ·Press release issued March 6, 2026, attached as Exhibit 99.1.

06-03-2026

Robert Lighthizer resigned from the Board of Directors and its committees of Trump Media & Technology Group Corp., effective March 6, 2026. The resignation did not arise from or relate to any dispute with management or the Board. The Company thanked Amb. Lighthizer for his distinguished service.

• ·Event reported as of March 4, 2026; filing dated March 6, 2026.
• ·Securities: Common stock (DJT) on Nasdaq and NYSE; Redeemable Warrants (DJTWW) exercisable at $11.50 per share on Nasdaq and NYSE.

06-03-2026

CID Holdco, Inc. entered into a secured loan agreement dated December 4, 2025, with J.J. Astor & Co. for up to $5M in funding across an initial $2M tranche and up to three $1M additional tranches, issuing notes with original issue amounts of $2.6M initial and $1.3M each additional, subject to lender discretion and stock price/volume conditions. The loans carry 4% origination fees ($80K initial, $40K per additional) deducted from proceeds, with net funding at 96%, and are secured by a senior lien on all company assets. No prior period comparisons available as this represents new debt financing.

• ·Loans secured by senior first priority lien on all assets of Company and Subsidiary Guarantors via Security Agreement and Subsidiary Guarantees.
• ·Additional tranches subject to Lender's sole discretion, Company's Common Stock meeting Minimum Closing Prices and Minimum Volume Requirements.
• ·Exemption from securities registration under Section 4(a)(2) and/or Rule 506(b) of Regulation D.

06-03-2026

Perfect Moment Ltd. entered into a Further Amended and Restated Promissory Note with Chairman Max Gottschalk on March 6, 2026, extending the maturity date of a $3.39M unsecured loan (originally Note #1, part of $5.09M total loans provided in August 2025) from March 9, 2026, to March 23, 2026, at 12% interest. This follows prior amendments, including one on October 30, 2025. The second $1.7M note remains due August 18, 2030.

• ·Loans are unsecured with monthly interest payments.
• ·Note #1 originally due November 8, 2025; first amended October 30, 2025 to March 9, 2026.
• ·Note #2 due August 18, 2030.

06-03-2026

Sadot Group Inc. (SDOT), a retail-eating and drinking places company based in Burleson, TX, filed an 8-K on March 6, 2026, under Items 1.01 (entry into a material definitive agreement), 3.03 (material modifications to rights of security holders), and 9.01 (financial statements and exhibits). The filing, sized at 2 MB, indicates significant corporate developments but lacks specific quantitative details on the agreement or modifications in the provided index. No period-over-period financial metrics are disclosed.

• ·CIK: 0001701756
• ·SIC: 5810 - RETAIL-EATING & DRINKING PLACES
• ·State of Incorporation: NV
• ·Fiscal Year End: December 31
• ·Business Address: 295 E. RENFRO STREET SUITE 300, BURLESON, TX
• ·Formerly: Muscle Maker, Inc. (through 2023-07-24)

06-03-2026

LEE Enterprises, Inc., a digital-first subscription and marketing services company, filed an S-3 registration statement on March 6, 2026, for the resale of shares of its Common Stock by Selling Stockholders, with the company receiving no proceeds. The prospectus incorporates by reference recent SEC filings, including the Annual Report for FY ended September 28, 2025, and the 10-Q for the quarter ended December 28, 2025, and outlines standard business risks such as declining print revenue and liquidity concerns. It describes the company's authorized capital stock of 43.5M shares, including 40M shares of Common Stock.

• ·Corporate headquarters: 4600 E. 53rd Street, Davenport, IA 52807; phone: (563) 383-2100; website: www.lee.net
• ·Fiscal year end: September 29
• ·Common Stock listed on Nasdaq under symbol 'LEE'; transfer agent: Equiniti (EQ) Shareowner Services
• ·Credit Agreement dated January 29, 2020, restricts cash dividends on Common Stock and Class B common stock
• ·No shares of Class B common stock or serial convertible preferred stock currently issued and outstanding
• ·All Class B shares converted to Common Stock in March 2011 per sunset provisions

06-03-2026

Planet 13 Holdings Inc. terminated the employment of its Chief Administrative Officer, Lee Fraser, effective March 6, 2026, following his placement on administrative leave on January 5, 2026. The 8-K filing was signed by Co-Chief Executive Officers Robert Groesbeck and Larry Scheffler. No additional financial or operational impacts were disclosed.

• ·Company is an emerging growth company.
• ·Principal executive offices: 2548 West Desert Inn Road, Suite 100, Las Vegas, Nevada 89109.
• ·I.R.S. Employer Identification Number: 83-2787199.

06-03-2026

AMC Entertainment Holdings, Inc. entered a commitment letter with Deutsche Bank AG New York Branch for a new $425M senior secured credit facility for subsidiary Odeon Finco PLC to refinance its 12.750% Senior Secured Notes due 2027, featuring a 10.50% fixed interest rate term loan due 2031 with 2.00% OID, expected to strengthen the balance sheet, extend maturities, and reduce interest costs upon closing by April 6, 2026. The company decided not to proceed with its previously announced senior notes and term loan offering. AMC operates approximately 855 theatres and 9,640 screens globally.

• ·Odeon Credit Facility subject to definitive documentation and customary closing conditions
• ·Company operates as largest movie exhibition company in US, Europe, and worldwide

06-03-2026

Textron Inc. filed its DEFR14A definitive proxy statement on March 6, 2026, for the 2026 Annual Meeting of Shareholders to be held virtually at www.virtualshareholdermeeting.com/TXT2026. The proxy covers Item 1: Election of Directors, Item 2: Ratification of Appointment of Independent Registered Public Accounting Firm, corporate governance highlights including director independence and committee structures, and executive compensation disclosures such as Summary Compensation Table, Pay versus Performance for fiscal years 2021-2025, and related analyses. No specific quantitative compensation or performance metrics are detailed in the provided filing excerpt.

• ·Fiscal year end: January 3
• ·Annual meeting voting options: telephone, mail, internet at www.proxyvote.com, or virtually during the meeting
• ·Shareholder inquiries: (401) 457-2288 or irdepartment@textron.com
• ·Business address: 40 Westminster St, Providence, RI 02903
• ·Pay versus Performance disclosures structured for PEO and Non-PEO NEOs across fiscal years 2021-2025

06-03-2026

AIM ImmunoTech Inc. (AIMI) filed an 8-K on March 06, 2026, reporting under Items 1.01 (entry into a material definitive agreement), 3.03 (material modifications to rights of security holders), 5.03 (amendments to articles of incorporation or bylaws), 8.01 (other events), and 9.01 (financial statements and exhibits). Exhibit 3.1 was attached, likely containing the amended governing documents. No financial metrics or period-over-period comparisons were disclosed.

• ·Filing items: 1.01, 3.03, 5.03, 8.01, 9.01
• ·Subcategory: Material Agreement Entry
• ·Exhibit: EX-3.1 (likely amended articles of incorporation or bylaws)

06-03-2026

Laird Superfood, Inc. filed a supplement to its February 9, 2026 proxy statement for the Special Meeting of Stockholders on March 11, 2026, disclosing the names and biographical details of four Nexus Designees—Doug Behrens, Michael Cohen, Kayla Dean Obia, and Kristin Patrick—to be appointed to the Board effective upon closing of the Investment Agreement. Grant LaMontagne will remain as the fifth Nexus Designee, with the Board size fixed at nine directors following resignations. No stockholder vote is required on these appointments, and existing proxy cards remain valid.

• ·Proxy Statement originally filed February 9, 2026
• ·Supplement filed and made available on or about March 6, 2026
• ·Company address: 5303 Spine Road, Suite 204, Boulder, Colorado 80301
• ·Special Meeting includes Proposal 1: Stock Issuance Proposal (unchanged)

06-03-2026

Black Hawk Acquisition Corp reported net income of $1.33M for FY ended November 30, 2025, down 30.6% YoY from $1.92M, driven by higher G&A expenses ($796K, +62% YoY) and a larger operating loss despite interest income from the Trust Account. The Trust Account balance plummeted 66.8% to $23.8M from $71.8M due to $51M in redemptions paid to public shareholders, leaving cash at a critically low $40K (down 85% YoY) and worsening shareholders' deficit to $(3.85M). New liabilities emerged including $575K due to target company and $595K convertible notes to related party, signaling ongoing acquisition pursuit amid liquidity pressures.

• ·Deferred underwriting fee payable steady at $2.415M.
• ·Net cash used in operating activities increased to $650K from $554K YoY.
• ·Proceeds from promissory note to related party: $600K in FY 2025.

06-03-2026

Fairfax Financial Holdings Limited (FRFXF) filed its Form 40-F annual report for the fiscal year ended December 31, 2025, on March 6, 2026, incorporating IFRS disclosures on insurance contracts, investments, associates, and segments including Property & Casualty Insurance & Reinsurance, Life Insurance & Run-off, Non-Insurance, and Investment Management. The report details maturity analyses of liabilities in USD, GBP, EUR, and CAD across time buckets (not later than one year, 1-5 years, 5-10 years, 10-15 years), fair value inputs for investment properties, intangibles, and sensitivities, with references to global subsidiaries and associates but no specific numerical financial results in the provided content. Prior year (2024) comparisons are indicated structurally across segments and geographies including North America, Europe, International, Asia, India, and Latin America.

• ·Geographic disclosures include US, CA, Europe.
• ·Segments: NorthAmericanInsurers, InternationalInsurersAndReinsurers, GlobalInsurersAndReinsurers, RunoffReportableSegment, RestaurantsAndRetail, FairfaxIndia.

06-03-2026

For the 12 weeks ended January 23, 2026, Bridgford Foods Corp reported net sales of $55.3M, up 5.3% YoY from $52.5M, with gross margin improving 3.7% YoY to $13.4M and operating cash flow turning positive at $4.3M versus a $4.6M outflow prior year. However, the company still incurred a net loss of $0.8M (improved from $1.1M YoY) and basic EPS of ($0.09), while total assets declined 1.8% QoQ to $144.6M and inventories dropped 12.0% QoQ to $32.6M. Shareholders' equity decreased slightly 0.7% QoQ to $114.7M.

• ·Allowance for credit losses: $75 (Jan 23, 2026) vs $50 (Oct 31, 2025)
• ·Promotional allowances: $2,226 (Jan 23, 2026) vs $1,903 (Oct 31, 2025)
• ·Revolving credit facility unchanged at $2,000
• ·Basic loss per share: ($0.09) vs ($0.12) YoY
• ·Cash paid for interest: $120 (current) vs $88 (prior YoY)

06-03-2026

Horizon Technology Finance Corporation (HRZN) filed supplemental disclosures to its Joint Proxy Statement ahead of the March 13, 2026 special meeting, addressing shareholder lawsuits alleging misleading merger disclosures with Monroe Capital Corporation (MRCC), while denying any merit and reaffirming the board's unanimous recommendation to vote for the merger issuance and director elections. Prospective financial projections show HRZN standalone net investment income per share slightly declining from $1.05 in 2026 to $1.02 in 2027 before modest recovery, with flat $1.00 dividends, while pro forma combined company NII remains flat initially at $1.05-$1.02 then grows to $1.24 by 2030. MRCC standalone projections indicate low NII per share around $0.26-$0.31 with flat growth in NAV per share.

• ·Merger Agreement and Asset Purchase Agreement both dated August 7, 2025.
• ·Putative class action complaint filed January 30, 2026 in Delaware Court of Chancery; two similar complaints in New York Supreme Court.
• ·Special meeting of HRZN stockholders on March 13, 2026 at 2:30 p.m. ET.
• ·Projections prepared as of June 30, 2025; not updated and subject to uncertainties.
• ·Financial advisors: Oppenheimer (HRZN Special Committee), Houlihan Lokey (MRCC Special Committee).

06-03-2026

Hennessy Capital Investment Corp. VII (HVII), a SPAC, filed its 10-K on March 6, 2026, disclosing a Proposed Business Combination with ONE Nuclear Energy LLC per agreement dated October 22, 2025, with a 24-month completion window from IPO closing. The filing details a $6.9M private placement of 690,000 units at $10.00 each, permitted withdrawals up to 5.0% of trust interest annually, and highlights experienced board members; however, it emphasizes extensive SPAC-specific risks including failure to complete a business combination, liquidity issues, conflicts of interest, and regulatory challenges.

• ·24 months from IPO closing as completion window for initial business combination, after which public shares redeem at ~$10.00 per share
• ·Private placement units consist of one Class A ordinary share and one right to 1/12 Class A ordinary share upon business combination
• ·Form S-4 (File No. 333-292440) filed for Proposed Business Combination

06-03-2026

Sotera Health Company announced that on March 4, 2026, certain selling stockholders entered into an underwriting agreement with Wells Fargo Securities, LLC for the sale of 25,000,000 shares of SHC common stock at $15.27 per share, totaling approximately $382M. The transaction closed on March 6, 2026, with the Company not issuing any shares or receiving proceeds. None of the Company's executive officers participated in the sale.

• ·Underwriting Agreement filed as Exhibit 1.1
• ·Opinion of Cleary Gottlieb Steen & Hamilton LLP filed as Exhibit 5.1
• ·Date of Report (Earliest Event): March 4, 2026
• ·Filing Date: March 6, 2026

06-03-2026

T3 Defense Inc. (formerly Nukkleus Inc.) disclosed on March 3, 2026, that it received a summons and complaint filed on February 24, 2026, in the Supreme Court of the State of New York by Kingswood Capital Partners, LLC against Star 26 Capital, Inc., Nukkleus, Inc., and the Company, alleging entitlement to an investment banking success fee from a prior transaction. The Company denies all allegations, states the claims are without merit, and intends to vigorously defend the action. No financial impact or settlement details were provided.

• ·Filing submitted March 6, 2026, under SEC File Number 001-39341.
• ·Securities: Common Stock (DFNS) and Warrants (DFNSW) listed on Nasdaq Stock Market LLC.
• ·Company address: 575 Fifth Avenue, 14th Floor, New York, NY 10017.

06-03-2026

Dynamix Corp, a SPAC, reported a net loss of $13.2M for the year ended December 31, 2025, compared to $0.1M loss for the period from inception (June 13, 2024) through December 31, 2024, driven by higher G&A expenses ($5.4M vs $0.4M) and a sharp increase in warrant liability fair value loss ($14.9M). While investments held in the Trust Account grew to $173.4M from $167.2M, cash balances declined significantly to $0.2M from $1.5M, total liabilities rose to $27.3M from $9.1M, and shareholders' deficit deepened to $27.1M from $7.6M.

• ·Company inception date: June 13, 2024
• ·Class A ordinary shares redemption value: $10.45 per share (2025) vs $10.07 (2024)
• ·Change in fair value of warrant liabilities contributed $14.9M expense in 2025
• ·PCAOB ID Number 100 for Independent Registered Public Accounting Firm

06-03-2026

Newbury Street II Acquisition Corp, a blank check company, reported net income of $6.6M for the year ended December 31, 2025, up significantly from $1.0M in the prior partial period, driven by $7.3M in interest income as the Trust Account grew 4.2% to $181.8M at a redemption value of $10.54 per share. However, operating losses widened to $0.69M due to higher G&A costs, cash balances declined 38% to $0.77M, current assets fell 38%, and shareholders' deficit worsened 14% to $(5.3M).

• ·Company inception date: June 18, 2024
• ·Filing date: March 06, 2026

06-03-2026

On March 6, 2026, Open Lending Corporation entered into a Cooperation Agreement with Palogic Value Management, L.P., Palogic Value Fund, L.P., and Palogic Capital Management, LLC, agreeing to nominate William Dabbs Cavin as a Class III director at the 2026 Annual Meeting and recommend stockholder support for a non-binding proposal to declassify the Board. Charles D. Jehl informed the Board he will not stand for re-election at the 2026 Annual Meeting, with no disagreements noted. Palogic committed to voting in line with the Board's recommendations and standstill provisions during the Cooperation Period, including ownership caps.

• ·Cooperation Period extends from March 6, 2026, until 30 calendar days prior to the opening of the nominating period for the 2027 Annual Meeting.
• ·Standstill restrictions include no proxy solicitations, additional director nominations, or stockholder proposals by Palogic during the Cooperation Period.
• ·Mutual non-disparagement provisions apply during the Cooperation Period.

06-03-2026

For Q3 FY2025, Greenwave Technology Solutions reported revenue growth of 49% YoY to $12.7M, driven by higher sales, while gross profit was nearly flat at $3.5M and net loss widened to $5.3M amid higher operating expenses. Over the nine months ended September 30, 2025, revenue rose 25% YoY to $31.0M with flat gross profit of $9.1M, operating loss improved to $13.5M from $16.2M, but net loss available to common stockholders was $17.9M; total assets declined 5% to $59.9M, cash fell to $1.5M, and stockholders' equity dropped 12% to $32.7M with substantial doubt about going concern.

• ·Related party property and equipment net declined to $10.7M from $11.8M.
• ·Non-convertible notes payable increased to $7.96M total (current + long-term) from $6.77M.
• ·Operating cash flow used $5.9M in 9M 2025 vs $14.8M in 9M 2024 (improved).
• ·Financing activities provided $5.8M net cash in 9M 2025, primarily from common stock and warrants issuance.
• ·Substantial doubt about going concern noted.
• ·Nasdaq listing standards risk and ineligibility for Form S-3 mentioned.

06-03-2026

Grayscale Avalanche Trust (AVAX) filed Amendment No. 6 to its Form S-1 registration statement (No. 333-289829) on March 6, 2026, to register an indeterminate number of Shares for continuous public offering and listing on NASDAQ under the symbol GAVA, with plans to rename to Grayscale Avalanche Trust ETF upon effectiveness. The Trust holds AVAX digital assets to provide investors exposure via Shares created/redeemed in Baskets of 10,000 Shares, primarily in-kind with AVAX or via cash orders through Authorized Participants. No prior public market exists for the Shares, and the filing notes the Trust's status as a non-accelerated filer, smaller reporting company, and emerging growth company.

• ·Registration No. 333-289829
• ·Trust incorporated in Delaware with SIC code 6221 and I.R.S. Employer ID 99-6715858
• ·Index Price based on CoinDesk Avalanche Benchmark Rate at 4:00 p.m. New York time
• ·NASDAQ approval for in-kind creations/redemptions with AVAX

06-03-2026

Ategrity Specialty Insurance Co Holdings (ASIC) reported robust growth for the year ended December 31, 2025, with gross written premiums up 33.1% YoY to $582M, net written premiums surging 41.9% to $425M, and underwriting income increasing 141.2% to $43M, leading to net income of $76M (up 41.1% YoY) and an improved combined ratio of 88.2% from 93.9%. Net investment income rose 76.2% to $42M, boosting income before taxes by 44.7% to $96M. However, net realized and unrealized gains on investments declined 55.0% to $13M, cash equivalents investment income fell 58.0%, and net cash used in investing activities widened to $274M from $363M.

• ·Loss ratio improved to 58.7% from 60.3% YoY.
• ·Expense ratio declined to 29.5% from 33.6% YoY.
• ·Diluted EPS increased to $1.58 from $1.28 YoY.
• ·Adjusted diluted EPS rose to $1.61 from $1.32 YoY.
• ·Net cash change was positive $3M in 2025 vs negative $238M in 2024.

06-03-2026

Lendbuzz Inc., a fintech company using AI and machine learning for auto loans to underserved consumers (credit invisibles and near-prime), filed Amendment No. 1 to its S-1 registration statement on March 6, 2026, for an initial public offering of common stock on Nasdaq under symbol 'LBZZ', with shares offered by the company and selling stockholders and underwritten by Goldman Sachs, J.P. Morgan, and others. The company reported rapid growth with Aggregate Originations and Total revenue, net CAGRs of 82% and 83% from 2020 to 2025, positive net income each year since 2021, and 100%+ net dollar retention for 19 consecutive quarters as of December 31, 2025, while partnering with 2,344 active dealerships in a fragmented market of over 55,000 dealerships. No declines or flat metrics were disclosed in the filing.

• ·Principal executive offices: 100 Summer St., Boston, Massachusetts, 02110
• ·Incorporated in Delaware, SIC code 6141, EIN 47-5047556
• ·Non-accelerated filer status
• ·Founders launched company in 2015 focusing on auto finance for underserved populations
• ·Positive Adjusted Net Income (non-GAAP) for 20 consecutive quarters as of Dec 31, 2025

06-03-2026

Arcellx, Inc. filed an SC 14D9 tender offer response statement disclosing Centerview Partners LLC's fairness opinion dated February 23, 2026, confirming that the merger consideration is fair, from a financial point of view, to holders of common shares (excluding certain excluded shares). The filing summarizes financial projections for the fiscal year ended December 31, 2025, and beyond, prepared on a standalone basis without reflecting the proposed merger or tender offer effects, with extensive disclaimers on their speculative nature and lack of updates. Centerview's analysis reviewed historical 10-Ks (2022-2024), interim reports, internal forecasts, and comparables, but no specific deal value or performance metrics were quantified.

• ·Fairness opinion initially rendered orally on February 22, 2026
• ·Projections cover fiscal year ended December 31, 2025 and subsequent periods
• ·Centerview reviewed 10-Ks for years ended December 31, 2022, 2023, and 2024

06-03-2026

DigitalBridge Group, Inc. filed a preliminary proxy statement (PREM14A) dated March 6, 2026, for a special online stockholder meeting to approve the merger with Duncan Holdco LLC pursuant to an Agreement and Plan of Merger dated December 29, 2025, under which DigitalBridge will survive as a wholly owned subsidiary following the merger of Merger Sub I with DigitalBridge and Merger Sub II with DigitalBridge Operating Company, LLC. The DigitalBridge Board unanimously recommends voting FOR the merger proposal, FOR the non-binding advisory vote on named executive officer merger-related compensation, and FOR the adjournment proposal if needed to solicit more votes. Dissenting stockholders have appraisal rights under Maryland law.

• ·Merger agreement attached as Annex A; opinions of Barclays Capital Inc. (Annex B) and J.P. Morgan Securities LLC (Annex C); appraisal rights detailed in Annex D.
• ·Proxy solicitor contact: 800-676-7437 (toll-free) or 212-931-0845 (banks/brokers).
• ·Special meeting to be held online; record date [•], 2026.

06-03-2026

Bunker Hill Mining Corp. reported total assets of $151M as of Dec 31, 2025, up 55% YoY from $98M, driven by process plant investments ($97M) and increased cash to $19M from $4M, supported by $73M in net financing inflows primarily from equity issuances that quadrupled shares outstanding to 40M. However, the company posted a net loss of $93M, more than tripling the prior year's $25M loss due to $49M silver loan fair value loss and $43M derivative liability change, while total liabilities rose 38% to $207M and shareholders' deficiency worsened to $56M from $52M. Operating cash use intensified to $18M from $10M amid ongoing pre-production development.

• ·Process plant increased to $97.2M from $66.4M (+46%) due to $36.4M expenditures.
• ·Silver loan liability surged to $80.7M from $31.8M amid $49.4M fair value loss.
• ·Derivative warrant liability jumped to $75.2M from $1.1M.
• ·Forward-looking Bunker Hill Project NPV (5%) $63M, IRR 36%, payback 2.1 years; annual avg Zinc eq production 93M lbs.
• ·Ongoing Crescent Mine litigation risk noted.

06-03-2026

Compass Digital Acquisition Corp., a blank check SPAC with no operating history or revenues, filed its 10-K for the fiscal year ended December 31, 2025, continuing its search for an initial business combination, potentially the KMC Business Combination. The company has extended its Combination Period multiple times through shareholder votes, most recently at the 2025 EGM to April 20, 2026, but faced significant redemptions including 16,045,860 shares in 2023, 2,713,143 in 2024, and 2,370,619 in 2025, reducing outstanding Public Shares. The per-share Redemption Price has risen to approximately $11.67 as of December 31, 2025, from prior levels around $10.54-$11.25, supported by the initial $200M Trust Account.

• ·Combination Period extended up to April 20, 2026 via 2025 EGM.
• ·No initial Business Combination completed as of December 31, 2025.
• ·Blank check company with no revenues or operating history.
• ·Sponsor: HCG Opportunity, LLC following Sponsor Handover on August 31, 2023.

06-03-2026

Ring Energy, Inc. (NYSE American: REI) granted inducement awards to new Executive Vice President, Chief Financial Officer, and Treasurer Sonu Johl, effective March 5, 2026, consisting of 317,460 restricted stock units (RSUs) vesting in three equal annual installments starting March 5, 2027, and 476,190 performance stock units (PSUs, up to 952,380 shares earned). The PSUs cover the performance period from January 1, 2026, to December 31, 2028, with 50% vesting based on total shareholder return relative to peers and 50% on annual cash return on capital employed hurdles. The awards, approved unanimously by the Board including independent directors, comply with NYSE American Section 711 as material inducement for Johl's employment.

• ·Awards granted outside the 2021 Omnibus Incentive Plan but subject to substantially consistent terms.
• ·RSUs subject to continued service through applicable vesting dates.
• ·PSUs subject to performance goals, continued service through December 31, 2028.

06-03-2026

Reservoir Media, Inc. entered into amended and restated employment agreements effective April 1, 2026, with CEO Golnar Khosrowshahi, President & COO Rell Lafargue, and CFO James Heindlmeyer, superseding prior agreements to retain these Named Executive Officers. Base salaries are set at $600,000 for Khosrowshahi and Lafargue (with 3% annual increases) and $425,000 for Heindlmeyer (with 3% annual increases), alongside target cash bonuses of 100% of base salary for the former two and 50% for the latter, plus immediate-vesting equity awards of 100% and 75% of base salary respectively. Initial terms are three years for each, with automatic or optional renewals and board re-appointment rights, plus customary non-compete and termination provisions.

• ·Agreements signed March 5, 2026; Khosrowshahi term auto-renews every 2 years after initial 3 years; Lafargue and Heindlmeyer terms have Company option to extend by 2 years
• ·Exhibits 10.1, 10.2, 10.3 contain full agreements